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Abstract
Febrile illness is the primary cause of childhood outpatient attendance, admission to
hospital and death in Africa. This series of studies were aimed at ascertaining the
treatable causes of infection in children admitted to a district hospital typical of those
found throughout East Africa, in an area of high transmission of malaria. The studies
were also designed to determine the clinical correlates of infection and predictors of
mortality, looking in particular at malaria, invasive bacterial disease and HIV
infection. These studies also explored to what extent clinical examination by one
group of staff was replicable by another.
After informed consent a detailed history and structured examination was performed
on all children admitted to the hospital. Blood was drawn for culture, microscopy for
malaria, HIV testing, full blood count, bedside haemoglobin, blood glucose and
lactate measurement and HRP-2 based rapid diagnostic test for falciparum malaria.
Outcomes were recorded at death or discharge.
Sufficient data was available on 3,639 children including 184 deaths (5.1%).
Invasive bacterial disease was detected in 341 children (9.4%) and HIV in 142
(3.9%). Children with HIV and those with evidence of recent malaria were
significantly more likely to have invasive bacterial disease. The most common
organisms isolated were non-typhi Salmonella (46.9%), Strep, pneumoniae (16.4%)
and Haemophilus influenzae b (11.4%). The most frequently encountered pathogen
was P. falciparum, with 2,195 children found to have asexual parasitaemia (60.3%).
Falciparum parasitaemia was detected in 100 children with invasive bacterial disease
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(29.3%). Falciparum malaria was detected in over half (51.6%) of childhood deaths,
invasive bacterial disease was documented in 31.5%.
In children with a positive blood slide for malaria, WHO severe malaria criteria
identified 91.6% of the children that died. A multivariate analysis showed that signs
of malnutrition, respiratory distress, altered consciousness, hypoxia according to
pulse oximetry, hypoglycaemia, raised blood lactate, invasive bacterial disease and
female sex were all associated with an increased risk of death. In children with
negative blood slides signs of malnutrition, respiratory distress, altered
consciousness, hypoglycaemia, raised blood lactate and invasive bacterial disease
were all independently associated with mortality by multivariate analysis.
WHO defined criteria of syndromes which would warrant antibiotics predicted 56%
of cases of coinfection with invasive bacterial disease and malaria and 69.7% of
cases of invasive bacterial disease in slide negative children. Treating all children
with severe malaria for bacterial disease would result in 71% of children with
coinfection being treated. In children with negative slides including severe anaemia
or prostration as syndromes requiring antibiotic therapy would have resulted in
74.7% of children with invasive bacterial disease receiving antibiotic therapy. There
was moderate agreement between staff over the presence of clinical signs in children,
with hospital nurses performing as well as hospital clinical officers. Agreement was
better in children over 18 months of age and in children who were not crying during
examination.
Current WHO guidelines on antibiotic use performed poorly in this setting. Gram
negative infections were the most common cause of invasive infection and many of
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these are likely to be resistant to penicillin and other commonly used antibiotics.
Consideration should be given to expanding the indications for antibiotic use and
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1 Introduction & Overview
The majority of childhood deaths globally are due to infectious causes; although data
are poor,2"3 in Africa up to 90% of deaths outside the neonatal period are estimated
to be due to infection3"17 and over a third of deaths in under 5s may be avoided by
improving the treatment of childhood infections.18 Progress towards the 4th
Millennium Development Goal of a two-thirds reduction in childhood mortality has
been slow and a clear focus on infection is needed if it is to be met.19"20 Eastern
Africa is estimated to contribute 30% of Africa's 5 million deaths in children under
215 , so gains here will be important and knowledge from this region may be
applicable elsewhere.
Febrile illness is the commonest cause of childhood outpatient attendance and
admission to hospital in Africa.22"27 Considerable effort has rightly gone into the
community management of febrile disease (focusing largely on malaria), but less
attention has been paid to investigating ways of improving hospital care.28"32 Snow
et al., in a study from the Kenyan coast, estimated that childhood mortality had been
reduced by 44% as a result of inpatient care in a rural community served by a district
hospital.33 The advantage of such an approach is that it can be tailored to the local
health needs. It is likely that as the campaign to eradicate malaria gathers pace there
will be areas where there is a reduction in episodes of clinical malaria, through the
increased use of insecticide treated bed nets, residual spraying and other
interventions.7 34-37 In these and other areas where malaria is less common other
infections can be prioritised.38 Additionally, a large proportion of children are still
taken first to traditional healers or given medicines bought over the counter when
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they become sick.39"45 By sidestepping the medical system these children have no
chance of receiving diagnostic tests or effective triage and may be at increased risk
of being prescribed inappropriate and substandard (or even counterfeit) drugs.46"51
Improving the standard of hospital care can only improve the treatment seeking
behavior of patients and caregivers; if we wish parents to access care and follow
referral advice it is essential that the care provided to children be of a higher calibre.
The Integrated Management of Childhood Infections (IMCI) strategy was set up by
WHO and UNICEF to improve children's health and development.52 The first phase
of IMCI addressed the management of children in the community, at health clinics
and dispensaries (analogous to primary care). Here it has shown improvements in
health worker performance and mortality in most areas,52"58 though its impact on
mortality has not been universal with a recent study from Bangladesh showing no
significant mortality benefit.39 There has been some progress in the design of
appropriate interventions for inpatient care. A study from Malawi showed that the
introduction of ETAT (emergency triage assessment and treatment)60 reduced
inpatient mortality from 10-18% to 6-8%61. In 2000 the IMCI strategy was extended
to cover children at the first level of referral (district hospital admissions) with the
development of the "referral care manual".62 In 2005 this was adopted as policy in
Tanzania. A study performed over the previous year demonstrated the need for
upgrading hospital care, with a high number of missed diagnoses and inappropriate
treatments across a range of clinical syndromes; for example malnutrition was




Improving paediatric hospital care is clearly a complex intervention, with problems
in infrastructure, supplies and human resources all needing to be addressed.28 It is
also clear that more research data, and in particular data at a local level, are key to
ensuring that guidelines are relevant and up to date.63 Recently there have been
suggestions that local or regional development of guidelines may be necessary if we
are going to reach WHO child mortality goals.64
Several studies from Africa have shown that the majority of inpatient deaths occur in
the 48 hours following admission.65 66-70 To impact on this early mortality identifying
the children at greatest risk and establishing the correct initial management are
clearly of high priority. There are several important questions that need to be
addressed to assist in this:
• What is the range of treatable pathogens occurring in children admitted to a
hospital in an area of high malaria transmission and how often is a mixture of
pathogens found (co-infection)?
• Can those children at risk of death be reliably predicted at the bedside?
• Do current WHO guidelines accurately predict invasive bacterial disease and
therefore required treatments?
• Are clinical examination findings, necessary to predict the above,
reproducible between different observers?
18
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1.1THE AETIOLOGY OF FEBRILE DISEASE & THE IMPLICATIONS OF
INFECTIONS
1.1.1 The role of blood cultures and other diagnostic tests
The major treatable causes of febrile disease in East Arica are malaria
(predominantly due to Plasmodiumfalciparum) and invasive bacterial disease. The
exclusion of malaria is in principle relatively straightforward and quick using a
simple blood smear or rapid diagnostic test (RDT), the intricacies of these will be
explored later. Diagnosing invasive bacterial disease is somewhat more difficult.
Whilst bacterial disease can manifest itself as a local collection of infection causing
abscesses, pneumonia or meningitis, certainty in diagnosis is only provided by
growth of a relevant organism in culture. Normally sterile body fluids, such as blood,
cerebrospinal fluid (CSF) or urine are ideal as there can be little debate as to the
implications of the finding of pathogenic bacteria (in contrast to the upper respiratory
tract where even pathogenic organisms may be found as commensals). Serious
infections of any body system will often seed bacteria into the blood, or organisms
may pass through the blood before seeding to a specific organ.
Thus, for the clinician a blood culture offers a relatively accessible site from which to
determine the aetiology of an infectious process. However the number of organisms
present in blood is often small leading to potentially low yields. Studies looking at
sequential blood cultures taken from adult patients have shown that not only does the
yield depend on the volume of blood cultured, but also the number of cultures drawn
- only 65-73% of positive cultures were obtained on the first sample.71"72 This is in
contrast with malaria, where it is considered highly unusual for a patient to have
significant (life-threatening) clinical disease with a negative blood slide.73 Whilst
visitors, or residents in areas where exposure to malaria is less frequent, are likely to
have febrile disease related to the finding of parasites on a blood slide,74"75 in highly
endemic areas a positive blood slide is often not associated with a febrile illness at
all.74"85 A study of asymptomatic children with positive slides in Kampala, Uganda
demonstrated that the risk of developing symptomatic malaria within 30 days in a
child with a positive slide was 50%, and approximately half of these were with the
same strain.86"87 Other studies have shown that children may have asymptomatic
infections with multiple strains concurrently.88"92 These data justify the treatment of
all cases where parasites are seen, but clearly care must be taken to treat or look for
an alternative cause of fever.
Attempts to improve the specificity of malaria microscopy have mainly focused on
the concept of'attributable fractions'.82 93"94 This is based on comparing the
proportion of children with varying degrees of malaria parasitaemia that have fever.8"
93
A similar process can be done on children admitted to hospital with 'severe
malaria' comparing the number of children with only malaria found and the number
where an alternative cause for their illness was found at different parasite densities.94
At best such an approach informs the clinician the probability that in the community
(or hospital) a child with a given parasitaemia may have a fever (or severe illness)
resulting from it. Such calculations require large numbers in order to have any
precision. It is well documented that parasitaemia varies over even short times within
a given patient.88 92 It is also known that the parasite density at which fever is likely
to occur varies with the many factors that are associated with the acquisition of
immunity.74 80 95"97 I'1 the light of this, faced with a severely ill child, it would seem
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imprudent for a clinician to withhold antimalarial therapy on the basis of a malaria
parasite density that was 'too low'.
Rapid diagnostic tests for malaria (RDTs) have high sensitivity but can lack
specificity in areas where malaria transmission is high.98"110 Malaria RDTs rely on
the detection of malaria specific antigen in blood. They cannot discriminate between
asymptomatic malaria infection and parasites causing clinical disease, currently no
available test can. Indeed the absence of a parasite count makes them inferior to well
performed microscopy in this respect. The most commonly used RDTs are
Plasmodium specific Lactate Dehydrogenase (pLDH) and Histidine Rich Protein 2
(HRP-2). HRP-2 tests are possibly more heat stable and are being progressively
deployed.111 However HRP-2 appears to remain detectable in the blood for several
weeks after a clinical episode of malaria has resolved.112113 This leads to a poor
specificity for this group of tests in endemic regions where a large portion of children
may have had recent infections.98 In view of these considerations parasite density
cutoffs have not been used in this study, or in any of the published literature that 1
have reviewed.
The majority of studies exploring the comparative roles of malaria and bacterial
disease have focused on blood slides and blood cultures, with some inclusion of CSF
culture through lumbar puncture. That this is likely to underestimate the importance
of bacterial disease is becoming increasingly recognized,116 as is the role of both co-
infection with invasive bacteria and malaria and recent malarial infection.117118
Although there have been several published studies describing the results of blood
cultures performed in African children, there have been few systematic studies
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looking at malaria, bacterial disease and HIV in children and their clinical contexts.
Such data are essential to draft and assess guidelines on the use of antibiotics by
demonstrating the pathogens that need to be covered. Previous studies from the
literature are described below and have been grouped according to region and
summarized in Table 1.
1.1.2 Eastern A frica
The largest recent study on the epidemiology of invasive bacterial disease in African
children admitted to hospital involved 19,339 children admitted to Kilifi District
Hospital, Kenya over a 4 year period."9 All children other than those admitted for
elective procedures or for observation following trauma were enrolled. The study
found a 12.8% rate of community acquired bacteraemia in children in the first 2
months of life, and a 5.9% rate of bacteraemia in children aged 2 months to 13 years.
There was a high contamination rate in this study (14.3% of the total) and
contaminants were excluded from the analysis (had these been considered negative
the overall bacteraemia rate would have fallen from 6.6% to 5.6%). S. Pneumoniae
was the most commonly isolated organism with non-typhi Salmonellae and
Haemophilus influenza (Hib) the next most common. Gram negative organisms made
up 58.3% of the total isolates. The most common organisms isolated from children
are shown in Table 1. Most (98.8%) of the children with bacteraemia were tested for
HIV (with 17.8% found to be positive), a randomly selected portion (6.7%) of those
without bacteraemia, frequency-matched for age were tested for HIV (with 5.5%
found to be positive). Although malaria was not studied directly, the authors did note
that over the study period 23.3% of deaths were associated with bacteraemia alone,
18.7% with Plasmodium falciparum parasitaemia alone and 4.8% with malaria and
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bacterial disease. They noted that 20.5% of the 'malaria' deaths also had positive
blood cultures (and I note that 20.8% of the bacterial deaths had a positive blood
slide for malaria). Another publication from the same team addressed some of these
children in rather more detail.120 This study found that of 11,847 paediatric
admissions recruited over 34 months (children included in the previously cited study)
7.1% had an invasive bacterial infection (positive blood or CSF culture) and 44.7%
tested positive for malaria, with 1.3% of all admissions testing positive for malaria
and bacterial infection (3.0% of those that had a positive malaria test). Another study
from the same hospital looking at outpatient visits found that 22 out of 1,093 (2%)
randomly selected children under 5 years age had positive blood cultures when they
attended the outpatient clinic, 9 of these children were then admitted. '"'Although the
numbers were small, S. pneumoniae represented half of the isolates in outpatients.
In Malawi 2,123 children aged 1 day to 14 years, with 'clinically suspected
bacteraemia', were enrolled in a study that recruited over one year. 122 17.2% of
children were found to have positive blood cultures. Non-typhi Salmonellae were the
most common isolates and again Gram negative organisms made up the bulk (73.2%)
of organisms isolated. Although the study claims to be the largest study at the time
to report bacteraemia in children with P. falciparum parasitaemia, the study design
involved performing blood cultures in children with malaria only if they failed to
respond to anti-malarial therapy. Thus children that died or resolved their infection
spontaneously would not have been picked up and some nosocomial infections may
have been wrongly included as community acquired infections. The authors reported
that 23% of the bacteraemic children had positive slides for malaria. HIV testing was
not performed as part of this study.
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Also in Malawi, a study that recruited children for whom the admitting physician had
prescribed antimalarial, antimicrobial or antituberculous medication found 35 of 229
children recruited had positive blood cultures.123 Almost all (225/229) children were
tested for HIV and 28% were found to be positive. Malaria was found in 13 (5.7%)
children, with positive cultures in 2 of these (15.4%). The study took place in the dry
season, which may explain the low rate of malaria parasitaemia. Non-typhi
salmonella species were again the most common isolate, found in 77% of the
children with positive blood cultures.
A study by Blomberg et al, conducted in Tanzania at Muhimbili National Hospital in
the economic capital Dar es Salaam looked at 1,828 consecutive admissions with
fever or hypothermia or other suspicions of systemic infection.124 Overall the rate of
community acquired bacteraemia was 7.7%, though an additional 0.8% of children
were found to have candidaemia. These were not considered contaminants by the
authors as they were associated with a significantly increased mortality. The most
common pathogens isolated here were again Gram negatives but the lack of any S.
pneumoniae or Hib is unusual. Hib vaccination was not policy in Tanzania at the
time of this study. The setting may explain some of the unusual findings; Muhimbili
Hospital serves as a national referral center and it is possible that many of the
children admitted had been treated at other centers prior to referral or had underlying
malignancy or chronic disease. 51% of children were tested for HIV infection, 16.8%
of these children were positive. In contrast to the study by Berkley et al., this study
found no significant difference in the rate of bloodstream infection between HIV
positive and negative children. However no details concerning the method of patient
recruitment for HIV testing in the study by Blomberg et al. are provided and it is
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possible that selection bias may have mitigated against any effect. Malaria slides
were performed on 90% of admissions and were positive in 21.6% of these children.
Looking at the deaths during the study period, 17.7% of deaths had malaria alone,
22.4% had bloodstream infections (including fungi) alone and 6.5% had both. Once
again approximately one fifth of deaths occurring in children with bacteraemia had
malaria parasites visible on a blood smear.
An older study by Ghiorghis et al. in Addis Ababa, Ethiopia showed that 7.7% of
children under 14 years age attending the outpatients department without malaria had
bacteraemia.125 The bacteriology reported was limited, with the authors neither
discriminating between NTS and S. typhi nor between S. pneumoniae and other
Streptococci. Nonetheless Enterobacteriacae made up the majority of isolates.
Malaria was excluded in these children and there was no systematic testing for HIV.
1.1.3 WestAfrica
A study in rural Gambia, found much lower rates of non-typhi Salmonella amongst
1,162 children being investigated for pneumonia, meningitis or septicaemia.126 This
study used lung aspirates and urinary antigen detection (for pneumococcus and Hib)
in addition to blood culture. These techniques are likely to have emphasized the
importance of these two pathogens, as well as picking up children who would be
missed by simple blood culture. The authors found that there were seasonal changes
in the aetiology of invasive bacterial disease - with a rise in the isolation of non-
typhi Salmonellae and coliforms during the rainy season, also the season with high
malaria transmission. Similar seasonality trends in invasive NTS disease have been
noted in studies from Eastern Africa. 118127 The researchers found that 31.3% of the
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children had positive tests for malaria, and noted that 19% of the children presenting
during the rainy season with Salmonella infections and 29% of those presenting with
Hib infections had positive blood slides for malaria, this difference was not
statistically significant. However they also noted that leukocytes with malaria
pigment were identified in significantly more children with Salmonella bacteraemia
(relative risk 4.05, p<0.005), possibly indicating a link between recent malaria
infection and invasive salmonellosis.
A 15 month study from an urban setting in The Gambia, looking at admissions of all
ages in whom the attending clinician felt a blood culture was indicated found that
11.4% of the 686 children aged 2 months to 15 years had positive cultures.128 As in
the previous Gambian study126 the most common pathogen isolated was S.
Pneumoniae, with NTS playing a relatively minor role. It is telling to note that whilst
in the study by O'Dempsey et al., 126 prior to the introduction of the Hib vaccine to
The Gambia, this organism was the second most prevalent isolate, by the time of this
study in The Gambia (after the roll out of Hib vaccine) there was only 1 case of
invasive Hib reported. HIV testing was not performed in a systematic way, but rather
where the clinicians felt this was clinically indicated, 36 of 119 (30.3%) patients
tested positive for HIV, though figures for how many of these were children are not
given. Results of malaria films were not provided, nor were there enough NTS
isolates to explore seasonality.
An early study in Benin City, Nigeria by Akpede et al. sought to address the problem
of fever without localizing signs in children presenting to hospital129. Their study,
running prospectively over a year from 1988 to 1989 looked at all children with a
fever of less than 7 days duration and no localizing signs. Of 642 children enrolled
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the overall prevalence of bacteraemia was 10.4%; 62.8% had a positive malaria slide,
3.7% had bacteraemia and 6.7% had a combination of malaria and bacteraemia. The
investigators found Staphylococcus aureus to be the most common pathogen,
occurring in 43% of children. The next most common organisms were coliforms
(undifferentiated by the authors). There were no cases of Hib and S pneumoniae was
only isolated in 3 % of bacteraemic children.
Meremikwu et al. looked at blood culture results from children admitted to hospital
in Calabar, Nigeria over a six year period.130 Children had blood cultures performed
when the attending clinician felt it was indicated. 1,201 children were included in the
study with a large cohort of neonates (44.4% of the total). This may explain why the
most frequent organism identified was Staphylococcus aureus (in 48.7% of positive
cultures) and the high overall rate of positive cultures (46%). However the rate of
coagulase negative Staphylococus (9 isolates from 1201 patients, 0.7%) seems
surprisingly low in a group that often have a high rate of contamination and must
raise some question over the quality of reagents used. The study did not look at HIV
infection, nor did it comment on malaria infection.
1.1.4 Central A frica
Bahwere et al studied 932 consecutive admissions over a one year period to a rural
hospital in the Democratic Republic of Congo, obtaining blood cultures in 779.131 Of
these children 15.9% were found to have a pathogenic bacterial isolate at admission.
Similar to the East African studies, Enterobacteriacae were the most common finding
and S. pneumonia was isolated in only 4% of positive cases. The authors found that
28.8% of 632 children tested had a positive blood slide for malaria. A study from
Kigali, Rwanda by LePage et al, now over 20 years old, is interesting in that the most
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frequent isolate was Salmonella typhi, rather than NTS.132 Although the majority of
bacteraemic children were later admitted, the study took place in an outpatient
setting, making the high proportion of positive cultures more worrying. In Rwanda,
the investigators found that 27% of children with bacteraemia also had malaria
parasitaemia, in the DRC study this figure was 42.1%, with bacterial disease
significantly more common in the children with positive malaria films than those
with negative slides, a finding not replicated in any of the other studies where
malaria parasitaemia was documented. (Table 2)
1.1.5 Southern A frica
The only study from a malaria endemic region in Southern Africa found that 8% of
19,896 children admitted over a 5 year period had invasive bacterial disease.133 All
children under 15 years were included in the study and 84% had blood collected for
culture. Non-typhi salmonella species were the most commonly isolated organisms in
children aged less than 5 years, but outside the neonatal period. 44% of the children
with positive cultures had malaria parasites on blood film. 64% of children had
malaria parasites seen on microscopy with bacterial co-infection found in 8.9% of
these. HIV status was not documented, though the level in pregnant women attending
the antenatal clinic was high at 23.6%.
A second study from Southern Africa by Cotton et al from Cape Town, South Africa
was performed in a setting with a Mediterranean climate and no malaria.134 The
study considered all 8,524 paediatric admissions as eligible, but fails to describe how
many actually had blood cultures taken - leading to some doubt as to whether the
figure of 1.5 cases of community bacteraemia per 100 admissions is an accurate one.
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Nonetheless the distribution of disease is interesting in that this is the only site
reporting a significant prevalence of N meningitides (11.4% of positive isolates).
1.1.6 Studies in severe malaria
The studies outlined above and in Table 1 were looking at all children (with
exceptions as described). Other studies have chosen to look only at severely ill
children, often with severe malaria (either confirmed by blood test or clinically
suspected), and determine what the aetiology of disease in these children is. These
studies are reviewed below and in Table 3.
Berkley et al., working in Kilifi, Kenya reviewed the clinical and laboratory features
of 783 Kenyan children admitted with a diagnosis of severe malaria between April
1993 and May 1996.117 Data were collected prospectively and criteria for inclusion
were prostration (the inability to breast feed in a child aged under 1 year or inability
to sit unaided in a child aged 1 year and older), impaired conscious level (as defined
by the Blantyre coma score135) or respiratory distress. Importantly children who were
severely ill, with a positive malaria film, but had another primary diagnosis (e.g.
meningitis diagnosed by lumbar puncture) were not included. 643 of the children had
blood cultures drawn, the rate of contamination was again high (103 cultures, 16%)
and these children were excluded. Of the remaining 540 children with severe malaria
a pathogenic organism was grown in 42 cases (7.8%). The pattern of organisms
grown was similar to that seen in the larger study of all children from this site,"9
with S. pneumoniae the most frequently isolated bacterial pathogen. The
investigators found that the mortality in children with a clinical picture of severe
malaria and both bacteraemia and a positive malaria blood slide was significantly
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higher than that in children with malaria alone (33.3% vs. 10.4%, p<0.001). They
found that younger children were more at risk, with 18.5% of children with severe
malaria under 6 months of age having positive blood cultures. Based on their
findings the authors proposed that all young children with severe malaria be treated
with antibiotics in addition to antimalarials. It should be noted that the definition of
severe malaria adopted was narrower than the WHO definition, 1 most notably by the
exclusion of children with severe malarial anaemia only. Further the group found that
in children with severe anaemia (Hb <5g/dl) and prostration, but without impaired
consciousness or deep breathing, there were no cases of bacteraemia (though there
were only 25 children in this group).
A study of 251 children presenting with signs and symptoms of severe malaria in
Kumasi, Ghana showed quite different results.136 The definition for severe malaria
used by the group was more in line with those proposed by the WHO; coma or
prostration, severe anaemia or respiratory distress. Only 182 of the children had
parasites detected on a blood film. Although 23 (12.6%) of the children with severe
disease and a positive blood slide for malaria had a positive blood culture, this group
did not have a worse outcome when compared with the children with severe malaria
alone (mortality 8.7% vs. 8.8%). Of the children who tested negative for malaria
40.6% had positive cultures with very high mortality (39.2%). Few details of how the
children were managed are given, though one can speculate that the children with
negative slides would have been treated for bacterial disease, the situation for those
with a positive blood slide is less clear. One would expect that this would, if
anything, worsen the outcomes for those with co-infection yet this was not the case.
NTS was the most common isolate in both slide positive and slide negative children.
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However the authors themselves remarked that the laboratory had difficulty in
growing S. pneumonia and the results may have been skewed as a result.
A third study in Blantyre, Malawi between 1996 and 2005 analysed blood culture
results from all children admitted with severe malaria during the rainy season.137 The
study recruited 1, 388 children with severe malaria. The criteria for eligibility for the
study are vague - the authors stating that not all children with severe malaria were
admitted - but 88% of the children described had cerebral malaria (Blantyre coma
score < 2) with or without severe malarial anaemia. All children were at least 6
months of age. Bacteraemia was detected in 4.6% of children, with NTS the most
commonly isolated organism. Of the total 1,119 children (80.6%) were tested for
HIV, with 15.9% of the children testing positive. HIV positive children with severe
malaria were at significantly increased risk of NTS bacteraemia (4.5% of HIV
positive children vs. 2% of HIV negative children, p=0.48) but not at increased risk
of bacteraemia overall. The study found that although there was no significant
association between either HIV infection or bacteraemia and death in this patient
group there was a non-significant increase in mortality in children co-infected with
malaria and invasive bacterial disease (21.8%) compared with those with malaria
alone (16.0%, p=0.22).
1.1.7 SUMMARY
There is clearly variation between sites in the spectrum of bacteria causing invasive
disease. This may relate to local vaccination rates, malaria endemicity or other
factors l38"140 In most of Africa there is little if any community surveillance to
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establish the relative roles of infectious agents in population morbidity and mortality.
In such a situation the best results may be obtained through the use of high quality
inpatient data to guide policy makers on targets for vaccination and other preventive
strategies. However most hospitals in the region have no microbiology services, with
reliance instead being placed on sentinel sites for bacterial surveillance supported by
groups such as the Hib-Paediatric Bacterial Meningitis Surveillance Network (Hib-
PBM), the Pneumococcal Vaccines Accelerated Development Programme (Pneumo-
ADIP) and in East Africa, the Network for Surveillance of Pneumococcal Disease in
the East Africa Region (netSPEAR).141 These sites tend to be inpatient facilities
where committed clinical and laboratory staff have been identified who can ensure
that data and microbiological samples are collected. Nonetheless resources for such
surveillance are scarce, with finances often available for education and database
support, but little for increased staff and supplies that are necessary for expanded
surveillance through blood culture. Of 14 sites involved with netSPEAR only 5 sites
collect blood culture data, at least 2 of which are supported largely by research funds
(including this study).I4lAdditionally, local data is invaluable in the preparation of
antibiotic guidelines appropriate to local sensitivity patterns. We set out to produce
such data for national and regional use.
An important unresolved issue remains the impact of bacteraemia on mortality in
children with severe malaria, with different results emerging from different sites, as
outlined above. Much of the evidence discussed has become available only recently,
thus current guidelines are a little vague on this important point. The WHO
guidelines on the treatment of malaria suggest a low threshold for antibiotic
treatment in children with severe malaria.142 Perhaps because of the lack of firm
guidance on which clinical signs should trigger antibiotic therapy, or what that
therapy should be, the national malaria treatment guidelines of Kenya, Tanzania,
Uganda and Malawi make little mention of antibiotic treatment. The more integrated
"WHO Management of the child with a serious infection or severe malnutrition:
guidelines for care at the first level of referral in developing countries"62 suggests
that antibiotic treatment be given to children with malaria and signs of meningitis in
whom meningitis cannot be excluded and those with signs of circulatory shock.
There is a clear need for further data on this issue and it was the intention of these



















































































































































































































































Berkleyfa1999117Prost ation,impairedconsciousness,r sp.distresAll5407.8%10.433 3 Evansefa/2004136Coma,Severeana miA||182Z %gt8?bt Resp.Distress,Pro tration Bronzanefa/2007137^oma'>6months1,3884. %21.8r Severeana mia Table3.Prevalencendc sfat lityofbacter em ainsev rm la iudies *p<0.001 +Notsignificant
37
1.2 Can those children at risk of death be reliably predicted at
the bedside?
In resource limited environment it is clearly important to be able to target therapies
to those children who are most in need. District hospitals in East Africa are
commonly understaffed with overcrowded wards, drug shortages and poor
facilities.29"31 Clear guidelines for clinicians on which patients have the poorest
prognosis are essential or health care workers will become overwhelmed. There
have been several studies that have addressed risk factors for death in children with
malaria, pneumonia and other illnesses but few studies that have looked at all
children systematically. Children commonly present with multiple problems and the
clinician involved may not be able to describe the nature of each at the outset as
many of the features of these illnesses overlap. Difficulties will always arise as the
high sensitivity desirable to ensure that all children at risk are identified is usually at
the expense of specificity. There is no simple answer to this - the optimal balance
will vary from location to location depending on staff levels and expertise and other
local factors.
1.2.1 Studies in children with malaria
Early studies identified hypoglycaemia, deep coma, hyperparasitaemia and raised
CSF lactate with poor outcome in falciparum malaria.135143"146 An early classification
of severe malaria defined it as the presence of asexual Plasmodium falciparum
parasites with any one of 10 features (Table 4).147 However it was not until a
landmark publication in 1995, describing the clinical features associated with death
in children with malaria in Kenya, 65 that the sensitivity of such clinical and bedside
criteria were explored in a large study of African children. This study of 1,844
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children with a primary diagnosis of malaria, demonstrated that impaired
consciousness, respiratory distress, hypoglycaemia and jaundice were independently
associated with an increased risk of death. The presence of either impaired
consciousness or severe respiratory distress predicted 84.4% of the fatalities. With
the addition of severe anaemia over 90% of deaths were predicted. Children with
none of these features had a low mortality (0.6%). Risk of death seemed to be
additive, with the highest mortality occurring in children with all three features. This
Kenyan study gathered together threads from previous studies, prior to and following
the 1990 WHO guidelines, which had shown an increased mortality in children with
cerebral malaria, severe anaemia, hypoglycaemia and acidosis. 69 135145148-149
Subsequently, other studies have emphasized the importance of acidosis (best
demonstrated through the clinical sign of deep breathing)150 in addition to circulatory
shock. 151 Based on these and other studies the WHO Communicable Diseases
Cluster published revised definitions for the classification of severe malaria (Table
5)-'
Across a range of settings in Africa65 67-68 70 152-157 and elsewhere138 (Table 6), further
studies have also shown high mortality in children with impaired consciousness and
respiratory distress, with lower mortality in severe anaemia. Four African studies
describe mortality in the group that was not labeled as having severe malaria.65 67 70
157 In a Tanzanian study the authors added a further criteria of 'dehydration', though
it is unclear how many deaths occurred in children with dehydration alone. Mortality
in children without respiratory distress, severe anaemia or cerebral malaria was 1%.
70 A study from Mozambique found that only 45/62 (73%) deaths in children with
malaria were predicted by the WHO severe malaria criteria.67 Whilst in Yemen no
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children died outside of those identified by the WHO definition as having severe
malaria and all deaths occurred in children with severe anaemia, respiratory distress
or neurological features.158 The study by Taylor et al. involved the collection of data
from 6 well established research sites across Africa. Overall the mortality in children
with malaria that did not have severe anaemia, cerebral malaria, hyperlactataemia or
deep breathing was 1.2%, though this varied from site to site (range 0-2.2%). It is
interesting to note that even in these well established research centers there was
considerable variation in the sensitivity of WHO criteria of severe malaria for
predicting death, ranging from 68.6% in Kenya, at the site of the previous study by
Marsh et al., to 95% in Malawi.157 Sensitivities and specificities of prognostic
categories for identifying at admission children that went on to die, using the
different strategies in studies where all children with malaria were enrolled, are
shown in Table 7.
1.2.2 Studies in children with pneumonia
Acute lower respiratory tract infection is the most common cause of death in young
children worldwide.159"160 As such, considerable attention has been paid to
identifying which children should have focused care because of an increased risk of
death. The WHO has produced guidelines on diagnostic categories for pneumonia,
aiming to allow clinicians to prioritise care.62161 These guidelines base the clinical
diagnosis of pneumonia on a history of cough or difficulty in breathing supplemented
by clinic findings, such as tachypnoea or chest wall indrawing, that allow the child to
be ranked in term of severity (Table 8). Studies have sought to evaluate these
guidelines in prospective observational studies, though relatively few in an inpatient
African setting where the clinical signs of malaria and pneumonia can overlap.162"164
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A study from the Central African Republic, using earlier WHO guidelines,165 found
49 (12.4%) inpatient deaths amongst 395 children, aged 2months to 5 years, with a
clinical diagnosis of pneumonia or severe pneumonia.166 They found that 47/48
(97.9%) children with a history of cough or difficulty in breathing who died showed
chest wall indrawing (defined as either lower chest wall or intercostals indrawing)
when first assessed (in one child who went on to die there was no record). This gives
an impressive sensitivity for such a simple observational sign. Of children who
survived, 204 showed chest indrawing giving a positive predictive value of 18.1%.
Chest indrawing is a component of both the 1990 guidelines,165 and the updated
2000/2005 guidelines,62 161 indicating a clinical diagnosis of severe pneumonia. This
should have resulted in treatments aimed at reducing the mortality, potentially
underestimating the importance of this sign. Other clinical signs found to be
significant and predictive of inpatient mortality included hepatomegaly (Adjusted
Odds Ratio 6.7), aged between 2 and 11 months (AOR 6.4), grunting (AOR4.5),
acute malnutrition (AOR 2.7) and a moderate or severe alteration in 'general status'
(AOR 3.2). In the same multivariate model chest indrawing had an AOR of 8.4. The
authors went on in a separate publication to specifically address the WHO
pneumonia and severe pneumonia categories for their sensitivity and specificity in
identifying inpatient deaths.167 They found that 43/47 (91.5%) of deaths were in
children assigned to the severe pneumonia category. The source of discrepancy with
the initial publication, where 47/48 inpatient deaths amongst children with a history
of cough or difficulty in breathing had chest indrawing, is unclear - though may be
due to different interpretations of the term 'chest indrawing'. The authors also
proposed that a 'second tier' of severity be added to allow the more precise targeting
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of scarce resources, such as oxygen, to those at the highest risk of dying. This group
of'very severe pneumonia' would include all children that had chest indrawing
(lower chest wall or intercostals) and in addition showed either nasal flaring or
respiratory grunting. They calculated that this group would comprise 72% of the
inpatient deaths, whilst treating intensively only 3.4 children for each child that died
(as opposed to 5.5 if every child with indrawing received intensive treatment).
As part of a study to determine their utility in targeting appropriate treatment, a large
study of 11,847 children admitted to hospital in Kenya gathered data on the
performance of the more recent WHO guidelines 62 in predicting outcome.120 These
data demonstrated that, in children with clinical pneumonia, WHO 'severe' or 'very
severe pneumonia' predicted 108/123 inpatient deaths (sensitivity of 87.8%).
However 1,766 children were assigned to these two severity categories - requiring
that 16.4 children receive a high level of care for each death targeted. The more
selective category of'very severe pneumonia' included only 56/123 (45.6%) of
deaths in children with pneumonia, but had a very high mortality (56/296, 18.9%).
In South Africa, McNally et al found that WHO 'very severe pneumonia' was
significantly associated with both treatment failure and in-hospital mortality
compared with children admitted with 'severe pneumonia' (OR 3.5 and 6.1
respectively), as was HIV positive status (OR 2.6 for treatment failure and 8.1 for
inpatient death).168 As all children with pneumonia were not assessed it is not
possible to determine how the categories performed in predicting mortality generally.
A smaller study of 132 children with 'severe' or 'very severe pneumonia' admitted to
hospital in Zambia found 21 deaths (mortality of 16%) and though HIV infection was
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associated with an increased risk of a fatal outcome (OR 2.6) this did not reach
clinical significance (p=0.079).169
Three studies from outside Africa have addressed the issue of predicting death in
children with pneumonia in the developing world. Spooner et al. assessed the utility
of clinical signs in predicting death in 897 children aged under 5 years presenting to
hospital in Papua New Guinea.170 Cyanosis, poor feeding grunting, nasal flaring and
younger age were all associated with a significant increased risk of mortality, similar
to many of the studies from Africa. Chest indrawing was an eligibility criteria for the
study and therefore not amenable to analysis. In contrast to previously mentioned
studies bronchial breathing, a sign associated with consolidation of the underlying
lung, was also significantly associated with inpatient death (OR 3.35, pO.OOl).
Cyanosis was found to be the strongest predictor of death with 89% of deaths in
children noted to be cyanosed. This study recorded signs present at any time during a
child's admission, potentially biasing the study towards the demonstration of signs
associated with the process of death, rather than true predictors.
Shann et al., working at the same hospital in Papua New Guinea in the 3 years prior
to the cohort enrolled in the study by Spooner et al., prospectively studied 748
children admitted with severe pneumonia (defined as cough and chest indrawing plus
one of: severe indrawing; a pulse rate over 160/minute with hepatomegaly; failure to
feed; bronchial breathing; grunting; cyanosis; severe chest radiograph changes; or a
total white blood cell count over 30,000 cells/pl).171 The study identified 9 criteria
that predicted a high risk of death in children with severe pneumonia: prolonged
illness (more than 5 days); failure to feed; cyanosis; absence of fever; hepatomegaly;
malnutrition; pulse rate of less than 160; leukocytosis; severe chest radiograph
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changes. Two features that appear incongruous warrant further explanation; absence
of fever was associated with severe malnutrition, a group that had a high mortality;
pulse <160 was likewise associated with an absence of temperature and consequently
severe malnutrition. The most sensitive signs were a history of over 5 days illness
and severe chest radiograph changes (72% and 67% respectively), though the signs
felt by the authors to be most amenable to assessment by paramedical staff were
inability to feed and cyanosis (together picking up 77% of children who went on to
die).
Djelantik et al., working in three hospitals in Lombok, Indonesia, prospectively
studied 4,351 children aged under 2 years hospitalised with pneumonia to identify
screening criteria for mortality.172 There were 505 (1 1.6%) inpatient deaths amongst
children with pneumonia, in a multivariate model hypoxia, young age (<4months),
low respiratory rate, raised white blood cell count and severe anaemia were all
associated with death. The most common factors associated with death were hypoxia
and young age, occurring in 83% of children who died. Several important variables
associated with death in other studies, such as cyanosis, bronchial breathing, grunting
and malnutrition, were not addressed in this large study.
It is always difficult to generalize from one location to another; this is made more
difficulty when malaria endemic and non-malarial regions are compared. The clinical
similarity between pneumonia and malaria may result in many children diagnosed
with clinical pneumonia having malaria162"163, with different risk factors for death.
Possibly as a result of this clinical similarity hypoxia is less prevalent in malaria
endemic regions173 and many clinical signs consequent on it may have less
prognostic significance in children fitting the case definitions of pneumonia but
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suffering from malaria (clearly the same is true of children with malaria parasites
who are actually suffering pulmonary infection).
Several studies have addressed the prediction of hypoxemia as a surrogate of
predicting mortality, as it has been strongly associated with outcome.167172174-175
This has the advantage that the factor being predicted (hypoxemia) will not be
affected by subsequent interventions in the same way that subsequent treatment
based on clinical severity will affect outcome. This topic was reviewed by Usen &
Weber176 in 2001, since then a further 3 studies were identified in the course of
writing this thesis. Features of these studies are shown in Table 9. Published
combination models for predicting hypoxaemia are shown in Table 10.
Reviewing these tables it is clear that there is significant heterogeneity between the
studies, though there are several consistent features. Amongst single signs, head
nodding and cyanosis are consistently specific findings, whilst chest indrawing and
crepitations appear to be sensitive in the majority of studies. However, given that the
children enrolled in most studies were children with a diagnosis of pneumonia, for
which chest indrawing is a marker of eligibility; it is not surprising that many
children had this sign. The high sensitivity of crepitations may similarly also
represent selection bias, and another study found no connection between crepitations
audible on auscultation in children and lobar consolidation on chest X-ray.177
Only one study looked at indicators of hypoxia in children that were not preselected
by a diagnosis of pneumonia or lower respiratory tract infection. This study, by Duke
et al. in Papua New Guinea, showed that cyanosis was the most specific sign
(98.1%), but lacked sensitivity (37.9%), whilst a combination model of cyanosis or
poor feeding or a respiratory rate >60bpm had a sensitivity of 81.9% and specificity
of 49% when applied to children with acute lower respiratory tract infection but
82.8% and 58.2% respectively when applied to children with other diagnoses.178 The
high specificity of cyanosis is worthy of further consideration, yet the physical sign
is estimated to require between 4 and 6g/dl of deoxygenated haemoglobin in the
capillary beds viewed.179 In malaria endemic parts of Africa up to 40% of children in
the community may have a blood haemoglobin under 8g/dl, l80"l81and this proportion
will be higher amongst admissions, requiring a level of hypoxia before cyanosis can
be detected that may not be compatible with life.
Combinations of signs again show a wide variation, with sensitivities ranging from
59% to 82% and specificities from 49% to 94% depending on the site and signs used.
In terms of the provision of scarce oxygen supplies the specificity of the Weber
model (Table 10) is appealing, although there needs to be an awareness that many
children at increased risk of death will not be covered by such a definition.
One might expect specificity of clinical signs to detect hypoxia to be lower in studies
conducted in malaria endemic regions as many of the clinical signs can be caused by
acidosis relating to malaria, rather than hypoxia. This did not appear to be the case;
with the exception of nasal flaring in the study by Usen et al. in the Gambia there
appeared to be no real distinction between studies from areas endemic for falciparum
malaria and those not.182
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1.2.3 Studies addressing all children admitted to hospital
Only two studies have systematically assessed all paediatric admissions with a view
to assessing the factors at presentation associated with death. Both studies are from
the same site and involved largely the same children.66 120
In their earlier study, Berkley et al. prospectively assessed factors associated with
immediate (within 4 hours of admission), early (within 4-48 hours of admission) and
late deaths (after 48 hrs) in all 8,477 children aged over 90 days admitted to a district
hospital in Kenya between July 1st 1998 and June 30th 2000.66 The clinical features
identified were then used to construct a prognostic score which was validated on
4,802 children admitted over the following year. The features associated with death
and their assigned individual prognostic scores are shown in Table 11. The
mortalities associated with summed prognostic scores, when applied to the children
admitted in the third year of the study, are shown in Table 12. Thus a cut off of an
'early death' score of 3 or above had a sensitivity of 24/26 (92%) in identifying
children that died with a specificity of 79%. The same 'late death' score would give a
sensitivity and specificity of 81% and 72% respectively for late deaths. Early deaths
were more evenly spread amongst the summed prognostic score, a score of 3 or
above would only give a sensitivity of 43% but a specificity of 95%. The sensitivity
improved to 87.5% if the cut off was reduced to a score of 1 or above, but specificity
dropped to 59%.
In their later study Berkley et al. assigned WHO clinical diagnoses62 to all 14, 987
children aged 0 to 13 years admitted between February 1999 and December 2001.120
The definitions of clinical diagnoses used are shown in Table 13. This study will be
described further in the next section, but the authors found that the presence of any
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one of the WHO clinical diagnoses had a 93% sensitivity and specificity of 50% for
inpatient death. When children outside the neonatal age are excluded the sensitivity
fell to 89% and specificity rose to 55%.
The chief detraction from these impressive studies, and the data that they have
generated, is simply that they have been performed in a single center, and one with a
well established, highly skilled and expert research team. The need to establish how
such findings would translate to other settings was one of the reasons for the studies
described in this thesis.
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Defining criteria ofsevere malaria
Cerebral Malaria (unrousable coma)
Severe anaemia (Haematocrit <15%/Hb<5g/dl in the presence of >10 OOOparasites/pl
Renal failure (urine output <12ml/kg/24hrs)
Pulmonary oedema
Hypoglycaemia (whole blood glucose <2.2mmol/l)
Circulatory collapse/shock





Impaired consciousness, but rousable
Prostration, extreme weakness
Jaundice
Hyperpyrexia (rectal temp >40°C)
Table 4. 1990 WHO criteria of severe malaria
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Prevalpnrp
CombinationStudyH poxiaensitivitypec f cPPVN Cyanosis/headoddingUsenetal.18263/1072(6%).380 417 89 6 Cyanosis/grunting/reduced consciousness/resp.rateDyketal.18447/91(52%)70.26 >90 Cyanosis/beadWebertal.18669/180(38%)59.493 7857 nodding/inabilitytcryv' Cyanosis/notfeeding/resp.Dukeeta|i7B162/223( 3%)81.949 048 1 rate>60v' Table10.estcharacteristicsofombinationsignsindete i ghyp xia.
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Immediate Deaths Early Deaths Late deaths
(<4 Hrs) (4-48 Hrs) (>48 Hrs)
Indicator Indicator Indicator Indicator Indicator Indicator
Present Absent Present Absent Present Absent
History >7days +1 +0
Severe anaemia +1 +0
Jaundice +1 +0 +1 +0
Subcostal




+1 +0 +2 +0 -1 +0
Prostrated
without seizures
+3 +0 +2 +0 +0 +0
Impaired
consciousness +2 +0 +2 +0 +1 +0
with seizures
Impaired
consciousness +3 +0 +3 +0 + 1 +0
without seizures
Temp <36 +1 +0 +1 +0
Temp >39 -1 +0 -1 +0
Wasting +1 +0 + 1 +0
Kwashiorkor + 1 +0 + 1 +0
Constant +2 +0 +2
Table 11. Prognostic scores for death in children admitted to hospital in Kenya from
Berkley et al.
Scores are summed in columns for each of immediate, early and late death.
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Immediate Early Late
Score No Deaths (%) No Deaths (%) No Deaths (%)
0 698 0 2779 11 (0.4) 15 0
1 2196 1 (0.1) 1101 16 (1.5) 1081 2(0.2)
2 657 1 (0.2) 668 23 (3.4) 2310 26 (0.8)
3 612 5 (0.8) 183 23 (13) 869 26 (3.0)
4 217 4 (1.8) 55 10 (18) 347 38 (11)
5 72 3 (4.2) 15 5 (33) 170 22 (13)
6 34 3 (8.8) 1 0 10 2(20)
7 31 4 (13) 0 0 0 0
8 12 3 (25)
9 2 1 (50)
10 1 1 (100)
Table 12. Numbers of admissions, deaths and CFR (%) in children admitted to hospital in
Kenya, data from Berkley et al. Score based on sum of prognostic scores in Table 1 1.
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I.3 Do CURRENT WHO GUIDELINES ACCURATELY PREDICT INVASIVE
BACTERIAL DISEASE AND THEREFORE REQUIRED TREATMENTS?
Whereas rapid diagnostic tests for malaria (RDTs) can provide bedside information
on the likelihood that P. falciparum has a role in a child's febrile illness, there are no
such tests for bacterial disease. Even when available, blood culture is insensitive and
takes a minimum of 24 hours before results become available. This means clinicians
are reliant on clinical examination, supplemented by whatever bedside tests are
available, to make decisions on what, if any, antibiotic they should prescribe. In
developed countries hospitals often have in-house protocols based on local data on
the prevalence of different bacteria and antibiotic sensitivity patterns. As I have
discussed such local data are lacking in much of East Africa. To fill this void WHO
have developed protocols on the presumptive use of antibiotics in various clinical
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scenarios.
Only one study, in an area of moderate malaria transmission, has systematically
assessed the ability of these guidelines to accurately target invasive bacterial
disease.120 This study, by Berkley et al. in Kenya, has been briefly described in the
preceding section. All 11,847 acute paediatric admissions over a 34 month period
were assessed clinically and had blood drawn for culture and malaria slide
microscopy. Children were categorized into WHO syndromes associated with
presumptive antibiotic therapy. (Table 13) The authors excluded children with an
obvious diagnosis (such as trauma, tetanus, sickle cell crises etc.), children with
missing data and 1,752 children with contaminated blood cultures. Of the remaining
II,847 children 843 (7.1%) had evidence of invasive bacterial disease (positive
culture of a pathogen from CSF or blood). Of all admissions 52.8% had clinical
58
features associated with one of the clinical syndromes; this group also included 80%
of all invasive bacterial disease and 93% of all inpatient deaths. This is initially
impressive, but a closer analysis by the authors shows that 24% of cases of
laboratory proven meningitis would not have received parenteral antibiotics under
syndromic treatment rules. Moreover sensitivity of the syndromes for identifying
invasive bacterial disease in children co-infected with malaria was only 66%
compared with 83% in aparasitaemic children.
It is not clear how intense transmission of P.falciparum might change the clinical
presentation of invasive bacterial disease; infection with non-typhi salmonella is
relatively common in areas where malaria transmission is intense and these
infections have been associated with non-specific presentations,190 severe anaemia
and HIV infection,118'"9 any of which may be missed by the current guidelines on
the use of antibiotics. In view of these considerations this study aimed to assess
whether current WHO guidelines could accurately predict invasive bacterial disease




























Severe pneumonia Respiratory distress Penicillin
Mild pneumonia
Tachypnoea for age11 plus
a history of cough or Oral amoxicillin
difficulty in breathing
Skin/soft tissue infection Cellulitis, abscess,
pyomyositis
Cloxacillin
Table 13. Definitions of clinical syndromes used by Berkley et al.
Blantyre coma score <3
f
Weight for age Z score <-4
* Lower chest in drawing or abnormally deep breathing
s Inability to sit in child > lyr or inability to breastfeed if aged <1 yr
**
Sa02 < 90% on air by pulse oximeter
>50 breaths per minute if aged 60d — lyr, > 40 breaths per minute if > 1 yr old
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1.4 Are clinical examination findings reproducible between
different observers?
A relatively small number of standard clinical signs are in common use to assess
children admitted to district hospitals in resource-poor settings. Many of these are
specified in the integrated management of childhood illness (IMCI) and some have
originated from clinical research (e.g. prostration or the Blantyre coma scale).62 135 I
have discussed the use of many of these clinical signs in the early assessment of
children with fever to determine the severity of their illness, its potential aetiology
and possible treatments. Application of case management guidelines, such as those
formulated by WHO, is dependent on the accurate assessment of these signs. It is
therefore critical that such signs are perceived in the same way by different observers
(low inter-observer variability), or their sensitivity and specificity may be lost.
Studies published on this have tended to use the k (Kappa) statistic, which is a
measurement of the agreement between observers beyond that expected by chance. K
values vary from -1 to +1, with +1 demonstrating perfect agreement and -1 perfect
disagreement, 0 would be the result if the level of agreement was purely that
achieved by chance. A scale for the interpretation of k has been proposed; values of
0- 0.20 indicate slight agreement; 0.21 - 0.40 fair agreement; 0.41 - 0.60 moderate
agreement; 0.61 - 0.80 substantial agreement and 0.81 - 1.00 almost perfect
191
agreement.
Two studies have addressed this by using video recordings, thereby standardizing the
clinical signs. A study looking at respiratory signs in children admitted to a hospital
in Kenya found that agreement between 5 observers on 51 clinical cases for
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recession, nasal flaring and severe recession was moderate (k values in the range
0.41-0.60)191 whilst that for deep breathing and a summary impression of respiratory
distress was substantial (k values in the range 0.61 - 0.80).
A second study, using 104 video recordings of 11 clinical features, analysed
agreement between 32 leading paediatric clinical researchers (expert panel).192 The
agreement between the expert panel was slight to fair (k <0.4) for 29/104 videos. No
particular signs were highlighted by the authors as showing consistently poor
agreement, indeed for almost all of the signs there were high consensus videos,
where k values were above 0.61 and low consensus videos, where k values were
below 0.2. The only exceptions to this were for the signs 'delayed skin pinch' and
responsive only to pain, where there were no low consensus videos. A selection of
videos was then also shown to a range of clinicians from interns to consultants,
performance tended to be poor in the same videos where consensus among experts
was lacking. Amongst the high consensus videos the sensitivity and specificity of the
heath workers was reassuringly good in picking up the abnormal signs (sensitivities
between 90% and 98%, specificities between 81% & 89%).
Together these studies appear to show there is room for optimism that, potentially,
clinicians can pick up the same signs present in ill, febrile children. Studies from the
bedside have shown that signs that are detected by inspection tend to have a higher
level of agreement than signs that require either palpation or auscultation, but that
across a range of signs clinicians appear able to show acceptable levels of
agreement.193"196
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Despite their importance these signs are often not documented, or looked for in
children being assessed for admission to hospital.2931 197 Possible reasons include the
lack of time to examine children in busy outpatient departments with extreme
constraints on staff numbers. In such a situation nurses may be able to assist in
assessing children on the wards. As part of the study I sought to determine the ability




Figure 1. Map of Tanzania showing the study site on the coastal plain near the
Kenyan border.
The studies described were conducted at Teule Hospital, Muheza, NE Tanzania.
Teule hospital functions as the referral hospital for the population of Muheza district
(approx 277,000). The population is largely rural. 17% of the population are under 5
years of age and child mortality is 165/1,000 (Tanzanian census 2002). Malaria
transmission is intense (previously measured as between 50 and 700 infected
bites/person/year) and perennial, with two peaks coinciding with the short and long
rains (October and April).198 HIV prevalence was 10.2% in antenatal clinic attendees
(hospital data, 2004-5). The hospital has two paediatric wards each of 35 beds,
though the wards often run at over capacity. Children are admitted based on a
decision by hospital staff (clinical officers) working in the outpatient clinic.
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3 Methods
The study was a prospective observational study. To facilitate the study an Acute
Assessment Unit (AAU) was established (Figs 2 - 4), staffed by four Tanzanian
clinical officers (a non-physician clinician grade of staff who receive 3 years basic
training in Tanzania), four nurses, two support workers and myself. It was felt that,
although costly and time consuming, setting up such a unit would provide a
destination for all children in whom an admission was requested. This would ensure
full recruitment during the study period. This set up also allowed reproducibility of
examinations to be enhanced as the conditions that the children were being examined
in were similar. By using staff specifically recruited for the task the number of
examiners could be minimized and their skills could be more easily monitored.
After approximately six months of recruitment (just over 1 year after my arrival) a
Tanzanian doctor joined the team (GM). The research staff received training in the
recognition of clinical signs, using classroom, video and bedside methods. One
member of staff (clinical officer) had previously received IMCI training at an
approved government facility, but received the additional training to ensure that
study definitions, where different to IMCI definitions, were followed. IMCI had been
part of Clinical Officer training in Tanzania since 2000 but was not in routine use at
the hospital prior to the study.
Classroom training lasted one week, with bedside training continuing throughout the
piloting period. Two members of staff (1 nurse and 1 clinical officer) were recruited
and received the classroom training prior to my arrival. All other staff involved were
recruited, selected and subsequently trained by me.
Figure 2. Child having blood drawn in the AAU
Figure 3. The AAU from the ward
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Figure 4. Waiting area for the AAU
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Research staff were also trained in how to fill out the research pro forma, the
principles of research data collection and the principles and importance of obtaining
informed consent. The clinical support workers were trained by me in standardized
anthropometry and in filling in relevant parts of the case record forms.
I supervised the research clinical staff onsite, later aided by my Tanzanian colleague
(GM). The study was piloted for three months prior to data collection. All initial
resuscitation, assessments and early treatment was performed in the AAU by
research staff.
3.1 Enrolment & the study population
The study ran for one year from June 2006 - June 2007. Children were judged as
needing admission by hospital staff at the Mother and Child Health (MCH) clinic.
These hospital staff were also trained by me in Emergency Triage Assessment and
Treatment (ETAT) principles 161 and were provided with colour coded triage cards to
enable children who were judged to be in need of more urgent care to be identified
on arrival at the AAU. During this period consecutive admissions from the hospital
outpatients department with fever or history of fever were triaged for their need for
emergency resuscitation on arrival at the AAU according to ETAT guidelines.
Children were then screened for eligibility. (Box 1) Children admitted for trauma,
surgery or those with known severe congenital abnormalities were excluded.
Children under the age of two months were also not eligible. Children involved in a
birth cohort study (MOMS) that was ongoing early in the study were initially not
enrolled at the request of the MOMS study PI. We enrolled patients over 5
consecutive days each week. During the first seven months of the study these were
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Monday - Friday, for the last 5 months the study enrolled Wednesday - Sunday.
Tanzanian weekend holidays are Saturday and Sunday. Children were enrolled
between 8am and 6-8pm on the days of enrolment (the exact times depending on
staffing constraints).
Eligibility Criteria
Fever > 37.5°C or history of fever within 48hrs
Age 2months to 13 years
No known malignancy or severe congenital
abnormality
Not admitted for surgery or trauma
Not part of'MOMS birth cohort study'
Box 1. Study eligibility criteria.
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3.2 Clinical Data Collection
All patients were first assessed using ETAT criteria and where required were given
resuscitation prior to enrolment in the study. All parents or guardians received HIV
pre-test counseling as part of the consenting procedure, prior to the participation and
HIV testing of their children. Parents or guardians who were unable to write were
asked to provide a thumbprint.
Height and weight were recorded for all children using scales calibrated daily; a
check on inter-observer and intra-observer variability was within recommended
WHO limits. In addition to demographic details, medical history and examination
findings were recorded on a proforma (Appendix 1). Findings recorded were based
on the 1MCI referral care handbook, adapted for local conditions using other
guidelines or studies. 1 65
3.3 Methods for the comparison of reproducibility of clinical
signs between different grades of staff
This part of the study was conducted in the third and fourth month of the 1-year
study. Staff consisted of clinical officers and hospital nurses (with 3-4 years of
training in nursing). Clinical officers were either those specifically employed to
gather research data (RCOs) for the 1-year study or were employed by the hospital to
provide routine care (HCOs). Hospital nurses (HNs) were all regular hospital staff.
Both HNs and HCOs regularly worked on the paediatric wards.
RCOs had received didactic teaching supported by video clips that demonstrated the
signs in the study; these were assembled from recordings that had been used for
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IMCI training or had been recorded by experienced paediatricians to demonstrate
specific signs. In addition RCOs received bedside supervision on clinical
examination for 3 months before the start of the study (the piloting period) and their
assessments of children in the main study were regularly checked by me and the
second study physician (GM) when he joined.
HCOs and HNs had a 1-hour training session on clinical examination using the same
training materials as had been used for RCOs followed by an interactive teaching
session. In addition, each staff member received a 30-minute individual training
session where they examined children on the ward under supervision. Definitions of
clinical signs were consistent throughout and are shown in Box 2.
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3.3.1 Repea t examina tion procedure
On arrival at the ward all children were triaged and resuscitated as needed before the
first examination. Following consenting procedures, children were examined initially
by a research clinical officer (RCO) followed within 1 hour by a second examiner
(RCO, HCO or HN according to a duty roster). Examinations were performed with
no other staff present in a well-lit, quiet part of the ward, with results recorded on a
standardised form listing the 17 clinical signs defined in Box 2. All examiners were
blind to any clinical information (previous clinical examination, investigations or
treatment) at the time of examination.
3.4 Bedside tests and laboratory methods
Blood was taken for blood culture (BactAlert, Biomerieux), full blood count (Coulter
Act/Dif, Beckman-Coulter) and acute serology/serum save and research malaria
slide. All children were tested for HIV antibodies using two rapid tests (Capillus
HIV-1, HIV-2 Test, Trinity Biotech PLC, County Wicklow, Ireland & Determine
HIV-1/2 Test, Abbott Laboratories, Abbott Park, IL, USA). Discordant samples in
children aged over 18 months were resolved by ELISA (Vironistika UniForm II Plus
O Test, bioMerieux, Durham, NC.). Plasma from children aged less than 18 months,
positive by either Capillus or Determine tests were also analysed for HIV-1 RNA
using the Abbott Real-Time m2000 System (Abbott Molecular Inc., Des Plaines, IL,
USA). Patients also had bedside tests for haemoglobin and blood glucose
(Hemocue™, Anglholm, Sweden), lactate (Lactate-Pro™, Arkray Inc, Kyoto, Japan)
and a rapid test for P falciparum (Paracheck™, Orchid Biomedical, Mumbai, India).
The research protocol did not include lumbar puncture or radiography, both of which
were available at the site. Lumbar puncture was performed as indicated based on
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regional guidelines (NETSPEAR - The Network for Surveillance of Pneumococcal
Disease in the East African Region). Where performed, lumbar punctures were
processed by the research lab and results were recorded for research purposes. Chest
radiography (CXR) was performed where indicated in children who were stable.
CXR results were not available for the purposes of this thesis.
3.4.1 Microbiology
Venous blood was taken from all patients after cleaning the skin first with a
methylated spirit/alcohol mix then with iodine. A sample was first inoculated into
BactAlert Paediatric blood culture vials before being used for other tests. Bottle tops
were cleaned with iodine prior to inoculation and the original needle was discarded
into a sharps bin and replaced with a sterile one prior to inoculation. Staff were
encouraged to obtain 4-5ml of blood for the purpose of culture. Staff indicated their
name on samples that they had drawn and inoculated, a procedure that allowed staff
who began to run a high contamination rate to be identified and the problem
discussed with them. Blood culture bottles were weighed before and after sampling
to determine inoculum volume. Samples were cultured for 5 days in an automated
system. Samples that flagged positive were sub-cultured onto commercially sourced
chocolate, horse blood and CLED agar (Oxoid Ltd, UK). Samples that flagged
positive but showed no subsequent growth were noted and reincubated. Positive
specimens were identified by standard laboratory methods including API test kits
where appropriate (bioMerieux, France). Antimicrobial resistance patterns were
determined by NCCLS procedures. Initial typing and antibiotic sensitivity was
performed on site. Laboratory work was carried out by a Tanzanian team of research
lab technicians, trained and supervised by an accredited microbiologist (BA).
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CSF was examined microscopically for determination of cell count, gram stain and
Indian ink stain. Biochemical tests for determination of glucose and protein were also
performed. In addition latex agglutination for Haemophilus influenza type b and
Streptococcus pneumoniae was performed if the results of microscopy, glucose or
protein were abnormal. Acid fast staining for Mycobacteria was performed when
clinically indicated/suspected. Samples were then plated onto chocolate and horse
blood agar and positive results identified as above.
Blood or cerebrospinal fluid (CSF) samples positive for coagulase negative
Staphylococcus, Micrococcus, Corynebacterium, Bacillus sp or viridans group
Streptococci were considered contaminants. If a known pathogen was amongst a
mixed growth of 2 organisms it was considered positive. Cultures with three or more
organisms were considered contaminated.
3.4.2 Malaria Slides
Blood slides were stained with Geimsa and double read. Parasites were counted by
experienced Tanzanian lab technicians. Parasites were counted against 200 white
blood cells on thick film microscopy. Slides were declared negative only after 100
high power fields had been viewed. Staining and first reads were supervised by me.
Slides that were positive/negative discordant between the two slides went for a third
readings, as did slides where there was a greater than twofold discrepancy in slide
density above 400 parasites/pL. Slide readings were geographically and temporally
apart to ensure independence. Blood slides were read after the study was over and
were therefore not available to assist in patient care.
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3.5 Quality control
The rapid test for malaria used in the study (Paracheck) and the Determine HIV rapid
tests both use internal control lines. Samples where the control line was not visible
were discarded and the test repeated. The Capillus rapid test utilizes positive and
negative control samples that were run daily and the results recorded. The Hemocue
Hb and glucose machines use an internal control that runs when the machine is
activated.
Control samples were run daily for the for the Coulter Act/Dif full blood count
machine and the machine recalibrated accordingly.
Bacterial isolates of S pneumoniae and Haemophilus were sent to a regional
reference laboratory (NETSPEAR, Kilifi, Kenya) where they were checked,
serotyped and sensitivities were repeated. Isolates of Salmonella (typhi or non-typhi)
were sent to the University of Queensland Centre for Clinical Research and
Pathology, Australia.
3.6 Outcome
At discharge a form detailing treatment provided and outcome (time of death or
discharge) was filled for all patients (Appendix 1). Where this form was missing the
information was obtained from hospital records.
3.7 Data Management
Data were scanned using Teleforms (Verity software Inc.) into an Access database
(Microsoft). Data for the sub-study looking at the reproducibility of clinical signs
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between different grades of staff were separately double entered into an Access
database.
3.8 Statistical Analyses
Data analysis was performed using Stata-10 (Stata Corp, College Rd, Tx).
Nutritional Z-scores were calculated from NCHS/WHO reference data in Epi-6.
(CDC, Atlanta) We used the %2 test for the comparison of proportions. We used the
t-test for comparison of normally distributed data (means) and the Wilcoxon rank
sum test for non-parametric data. Forward logistic regression was used to determine
associations between potential risk factors and outcomes; variables were added
sequentially to a model in order of those with the highest unadjusted OR first,
variables that became non-significantly associated with the outcome were dropped.
Correlation of findings between examiners for the reproducibility of clinical signs
analysis was assessed using Cohen's Kappa score and classified by categories
proposed by Landis and Koch.191
3.9 Ethics
The study was approved by the Ethics Committees of the National Institute for








Ability to breast feed/drink
Sunken eyes








Measured by digital thermometer in the axilla for 2 bleep
cycles.
Counted over 1 minute in a non feeding child who is not
crying.
A conscious child who takes no interest in its surroundings.
Ability to sit unsupported if aged 8 months or more.
Observed ability to breast feed or drink from a cup.
A subjective assessment of sunken eyes.
A full thickness pinch of skin taken in a longitudinal plane
midway between umbilicus and the side of the body. Longer
than two (2) seconds to return to normal is considered a
positive response.
Bluish tinge to the buccal mucosa.
Directed eye movements, score 1
Undirected or closed eyes, score 0
Movements to localise pain, score 2
Other movements without localisation, score 1
No movement or abnormal flexion/extension, score 0
Normal cry / speech, score, 2
Weak/high pitched cry. score 1
No vocal response' score 0
A subjective assessment based on inspection of the sclera or
palms.
Noted by examination of the conjunctiva and palms.
The anterior fontanelle is assessed by palpation.
Assessed by observing resistance to voluntary neck flexion
and passive flexion of the neck by the researcher
Inward movement of the lower chest wall on inspiration in a
non-crying child.
Assessed by depressing the fingernail or fingertip pulp for 3
seconds and counting the time it takes to re-perfuse. A count
of greater than 3 seconds is considered positive.
Detected by running the back of the hand down the limb.
Oedema of both feet Detected by pressing a thumb on the dorsum of the foot.
Box 2. Definitions of clinical signs used in the study of reproducibility of clinical signs
between different grades of staff.
Bulging fontanelle
Neck stiffness






During the one year of the study (June 2006 and May 2007) 6,470 children were
admitted, 4,334 (67%) during study hours, and 695 (16%) were ineligible or
excluded due to missing data or refusal to participate.
Breaking the non-enrolled patients down further; 529 children (12.2%) were not
eligible because they had no history of fever, were a trauma or surgical admission,
had severe congenital abnormality or malignancy, there were 30 deaths in this group
(CFR 5.7%); in 58 (1.5%) of the eligible children consent was withheld by parents or
guardians, 4 of these children died (CFR 6.9%). Review of the hospital death register
at the end of the study revealed a further 39 children who appeared to have been
admitted and died during study hours, but were not included in the study database;
these children have been considered as having missing screening data. There were
187 deaths amongst the 2,136 children admitted out of hours (CFR 8.8%).
In 69 (1.9%) enrolled children there was missing data on outcome (25 children), HIV
result (7 children), malaria blood slide result (33 children) or blood culture result (2
children); in two children the hard copy of their case record form had gone missing -
these children were excluded from the final data analysis; there were 2 deaths in this
group (CFR 2.9%). Amongst children enrolled into the study, with full data for
analysis, there were 184/3,639 deaths (CFR 5.1%). Of the deaths in study children
where the time of death was recorded 98/177 (55.4%) occurred in the first 24hrs of
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admission, with 84.2% of deaths occurring within 72 hours of admission. The
breakdown of admissions and exclusions over the year is shown in Fig 5.
There were 1,970 male children (54.1%). Male children had a lower mortality,
though this did not reach statistical significance (CFR 4.4% in male children
compared with 5.8%, p=0.056). The median age was 19 months. A graph of the
distribution of children by age, with associated case fatality rates, is shown in Fig 6.
4.1.1 Anaemia
The median (mean) haemoglobin in study children was 8.2g/dl (7.9g/dl). The
prevalence of severe anaemia (haemoglobin < 5g/dl) was 15.8%. Severe anaemia
was significantly more prevalent in children less than 5 years of age (543/3327,
16.3% compared with 33/312, 10.6% in those over 5 years, p<0.05). Mortality was
significantly higher in children with severe anaemia (53/576, 9.2%) than those
without (131/3,063, 4.3%, p < 0.001).
4.1.2 Malnutrition
Malnutrition was defined as a weight for height Z score of < -3 or visible severe
wasting or bilateral pitting oedema of the ankles. Case fatality amongst children with
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Referred from an inpatient facility
Fever for over 7 days
Diarrhoea
Vomiting
Cough or difficulty breathing
Convulsions
Taken oral antimalarial within 48hrs
Taken parenteral antimalarial within
48hrs














Signs of circulatory shock*
Signs of dehydration
Signs of malnutrition''
Hypoxia (Pa02 < 90%)
















Table 14. Characteristics of study children on admission.
*
Blantyre coma score <3
+
Neck stiffness or bulging fontanelle
* Chest indrawing or deep breathing
s Systolic blood pressure <70-mmHg, capillary refill <3 sec or cool peripheries
Sunken eyes or skin pinch > 2 seconds
,f
Weight for height Z score <-3, visible severe wasting or bilateral pedal oedema
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4.2 The aetiology of febrile disease & the implications of
infections - results
The blood cultures from 252/3639 (6.9%) children yielded organisms that were
considered contaminants or were polymicrobial (>3 organisms). The case fatality rate
in children with contaminated blood cultures was 6.7%, and did not differ
significantly from that in those with non-contaminated blood cultures (CFR 4.9%,
p=0.2). Children with contaminated blood cultures were considered to have a
negative culture result for further analysis. One child with a contaminated blood
culture had a significant growth from lumbar puncture (Haemophilus influenzae
group b), this child has been considered to have invasive bacterial disease (see
below). One child grew non-typhi salmonella from blood and Strep, pneumoniae
from CSF, this child has been considered as having invasive pneumococcal disease
for the purposes of analysis.
An infectious agent was identified in 2,507/3,639 (68.9%) of the study children. The
most commonly found pathogen was P.falciparum; asexual parasitaemia being found
in 2,195 (60.3%) children. Invasive bacterial disease (IBD), defined as a bacterial
pathogen cultured from blood (336, 9.3% of children) or CSF (25, 0.7% of children),
was found in 341 (9.4%) children and HIV in 142 (3.9%). Infections, coinfections
and associated mortality are summarised in Fig 7.
Children with invasive bacterial disease were significantly more likely to die than
those without bacterial disease (age adjusted OR 4.9; 95% confidence interval 3.5 -
6.9; p<0.001). This was true for children with positive blood slides for falciparum
malaria (AOR 3.5, 95% confidence interval 1.9 - 6.5, p<0.001) and also children
with negative malaria slides (AOR 6.2, 95% confidence interval 4.0 - 9.7). In
contrast the presence of falciparum malaria on a blood slide had no significant effect
on the risk of death in children with invasive bacterial disease, though there was a
trend to a reduced risk in children with positive blood slides (AOR 0.8, 95%
confidence interval 0.6 - 1.0, p=0.089). This trend disappeared if invasive bacterial
disease was adjusted for (AOR 1.05, p=0.770).
The importance of invasive bacterial disease as a cause of mortality appeared to be
greatest in children under 1 year of age, where it was associated with more deaths
than malaria. Table 15 describes the total number of deaths and case fatality rate by
infectious agent and age for falciparum malaria and invasive bacterial disease.
Although the numbers were small, children with falciparum malaria appeared to die
sooner after admission than children with IBD alone (Table 16). Although children
with malaria and IBD coinfection had a mortality rate dictated by the IBD, the time
to death was more similar to that of the children with malaria alone.
4.2.1 The spectrum of invasive bacteria
Overall, the most common bacterial isolates were non-typhi Salmonellae (46.9%),
followed by Strep, pneumoniae (16.4%) and Haemophilus influenzae (11.4%). The
only age group in which non-typhi salmonella (NTS) was not the most common
isolate was in children over 5 years age, where both Strep, pneumoniae and S. typhi
were more common. Non-typhi salmonella were also associated with more deaths
than any other organism. (Table 17) Salmonella enterica serovar Typhimurium
made up the bulk of the NTS isolates (137/161, 85.1%), with Salmonella enterica
serovar Enteritidis the next largest group (11/161, 6.8%).
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4.2.2 Children with negative blood slides for malaria
Mortality in children without malaria was significantly higher than in children with
malaria (89/1,444, 6.2% compared with 95/2,195, 4.3%, p=0.013). Children with
negative blood slides had a higher incidence of invasive bacterial disease (241/1,444,
16.7% compared with 100/2195, 4.6%, p<0.001), however the mortality of children
with invasive bacterial disease was no higher in children with malaria parasitaemia
(13/100, 13%) compared with children without malaria (45/241, 18.7%, p=0.204).
The most common bacterial pathogen isolated in slide negative children remained
non-typhi Salmonella (108/241, 44.8%) with Strep, pneumoniae and Haemophilus
influenzae accounting for 18.7% and 14.5% of positive isolates in children with
negative blood slides.
Children with a positive P. falciparum I IRP-2 based rapid diagnostic test and a
negative blood slide can be considered to have had recent malaria."8 Children with
recent malaria had a higher risk of invasive bacterial disease than other slide negative
children (AOR 1.4, p=0.028). In these children almost 1 in 5 children had invasive
bacterial disease (98/501, 19.6%); NTS was the most common bacterial pathogen,
accounting for 68.4% of isolates. In contrast only 28.7% of bacterial isolates in
children with negative slides and rapid diagnostic tests were NTS. (Table 18)
4.2.3 COINFECTION WITH P. FALCIPARUM.
Falciparum malaria was present in 100/341 (29.3%) children with invasive bacterial
disease. Co-infected children thus represented 100/2,195 (4.6%) of the total with
malaria. Invasive bacterial disease was more common in children at low densities of
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P. falciparum infection than at high density; in children with a P. falciparum parasite
density of between 1 and 5000 parasites/pl a bacterial pathogen was cultured in
33/405 (8.1%) as compared with 67/1,790 (3.7%) of children with over 5,000
parasites/ pi (p<0.001). However the rate of invasive bacterial disease observed in
children with parasite densities above 50,000/pl (31/917, 3.4%) did not differ
significantly from that in children with between 5000 and 50,000 parasites/pl
(36/873, 4.1%, p=0.408). There was a significant increase in mortality associated
with invasive bacterial disease in children with low (1-5000 parasites/pl) density
malaria (AOR of 5.0, 95% confidence interval 1.6 - 15.6, p=0.006) and in children
with a high (> 5000 parasites/pl) parasite density (AOR 3.2, 95% confidence interval
1.4-6.9, p=0.004). (Fig 8)
Gram negative organisms made up the bulk of the organisms isolated regardless of
the results of slide or rapid test results. However in children with neither current nor
recent malaria NTS made up 28.7% of the positive isolates as compared with 68.4%
in children with evidence of recent malaria and 52% of those with a current
parasitaemia. In children with no evidence of current or recent malaria Haemophilus
influenzae and Strep, pneumoniae caused a correspondingly larger share of invasive
bacterial disease. (Table 18) Analysis of the organisms isolated by parasite density
shows that NTS causes a smaller proportion of bacterial infections at higher densities
of falciparum malaria although Gram negative isolates still dominated with a wider
array of organisms in this group. (Fig 9)
Severe malaria
Children were retrospectively categorized as severe malaria cases according to a
number of definitions used in the published literature"7136-137 and the current WHO
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definition.1 It was then possible to assess the effect of changing definitions of severe
malaria on the prevalence of bacterial co-infection and its effect on mortality. Other
than for this comparison we have used the WHO definitions of severe malaria.1 One
25 month old child with lethargy, a stiff neck and hypoglycaemia grew Haemophilus
influenzae from blood and CSF and had a concurrent malarial parasitaemia of 20,000
parasites/pl. There were no other cases of meningitis amongst the severe malaria
patients.
Prevalence of invasive bacterial disease remained fairly constant across the
definitions, though some of the definitions for severe disease selected children with a
higher mortality. In all definitions, other than the 'Bronzan criteria' (defining severe
malaria as children in coma or with severe anaemia and asexual parasites on a blood
film), children with severe malaria and invasive bacterial disease had a case fatality
rate significantly higher than those with severe malaria alone (Table 19).
Gram negative organisms caused a similar proportion of the invasive bacterial
disease in children with severe malaria (35/47, 74.5%) as non-severe malaria (43/53,
81.1%, p=0.422). NTS made up the bulk of these (22/35, 63%). (Table 20)
The prevalence of invasive bacterial disease in children aged 2 months to 1 year was
6.5%, in children aged 1 to 2 years 6.8% and in children aged 2 to 5 years 5.1%.
There were no cases of invasive bacterial disease in children with severe malaria
aged 5 years and above.
Invasive bacterial disease in severe malaria was associated with severe anaemia, with
or without other clinical features, in 31/47 (66%) cases. (Fig 10) NTS comprised
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18/31 (58%) of the isolates in children with severe malaria and severe anaemia but
only 4/16 (25%) of those with severe malaria without severe anaemia.
4.2.4 HIV ASSOCIA TED INFECTION
There were 142/3,369 (3.9%) cases of confirmed HIV infection. In children over 5
years age HIV infection was confirmed in 30/312 (9.6%) as compared to 112/3,327
(3.4%) children under 5 years age (p<0.001). Invasive bacterial disease was more
common in children with HIV, occurring in 27/142 (19.0%) children with HIV
infection but only 314/3,497 (9.0%) of children without HIV (AOR 2.5, 95%
confidence interval 1.6 - 3.9, p<0.001). In contrast only 48/142 (33.8%) of children
admitted with HIV had a P.falciparum parasitaemia as compared to 2,147/3,497
(61.4%) of children without HIV (AOR 0.3, 95% confidence interval 0.2 - 0.5,
p<0.001). The caregivers of 15/142 children admitted with HIV told research staff
the child had been given cotrimoxazole prior to admission.
In children admitted with HIV infection the most common isolate was Strep
pneumoniae, with a prevalence of 9.2% in this population. NTS remained common in
this group with a prevalence of 5.6%, though this was not statistically different from
its prevalence in admissions without HIV (4.3%, p=0.463). (Table 21)
Children with HIV had a higher case fatality rate (18/142, 12.7%) than children
without HIV (166/3,497, 4.7%, p<0.001). Out of the 18 deaths in children with HIV
infection 6 children had a falciparum parasitaemia (3 with >50,000 parasites/pl, 2
with 5,000 - 50,000 parasites/pl and 1 with <5,000 parasites/pl); 6 children had
invasive bacterial disease (2 cases of NTS, 1 each of Strep, pneumoniae,
Haemophilus influenzae, Staph aureus and E. coli).
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4.2.5 Infections associated with malnutrition
Severe acute malnutrition (SAM), defined as a weight for height Z score less than -3,
severe wasting or bilateral pedal oedema, was found in 110 children. Children with
SAM were significantly more likely to have invasive bacterial disease than children
without SAM (AOR 3.1, 95% confidence interval 1.9 - 4.9, p<0.001). Although non-
typhi salmonellae (NTS) were the most common bacterial isolate in children with
SAM, the proportion of positive isolates in children with SAM that were NTS (8/25,
32%) was lower than in children without SAM (152/316, 48.1%), in contrast Strep,
pneumoniae was more common in children with SAM (7/25, 28%) than children
without SAM (49/316, 15.5%) although neither of these differences reached
statistical significance. (Table 22)
Children admitted with SAM had a higher prevalence of HIV infection (25/110,
22.7%) compared to those without SAM (117/3,529, 3.3%, p<0.001). There were
only 4 HIV positive children with SAM and proven invasive bacterial disease, in 3 of
these children NTS was isolated from blood, in one child Strep, pneumoniae was
isolated from blood.
Mortality in children with SAM was raised (18/1 10, 16.4%) compared with children
without SAM (166/3,529, 4.7%, p<0.001). Of the 18 children who died with SAM, 8
were associated with invasive bacterial disease (1 of whom had concurrent
falciparum parasitaemia), 4 had falciparum malaria alone, 2 had HIV infection with
no other pathogens found and in 4 children no pathogen was isolated.
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Deaths/Total cases (CFR %)



























25/782 5/53 3/29 4/270 37/1134





(3.2%) (24%) (2.3%) (4.5%)
Total
82/2095 45/241 13/100 44/1203 184/3639
(3.9%) (18.7%) (13%) (3.7%) (5.1%)
Table 15. Distribution of deaths and cases by infection with malaria and invasive bacterial disease
(IBD). Case fatality rates in parenthesis.
No. deaths Median time to death
P.falciparum only 73 11 hr 54min
P. falciparum & IBD 11 12 hr 20min
IBD only 39 21 hr25min
IBD & HIV 5 31 hr 58min
HIV alone 6 51hrs 25min
P.falciparum & HIV 6 59hr 9min
P.falciparum & HIV & IBD 0 N/A





































































































































Total (any IBD) 143 (100%) 98 (100%) 100 (100%)
Tabic 18. Bacterial isolates by blood slide and rapid diagnostic test results.
Considered as having 'recent malaria'
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OPrev. IBD(%) ■CFRIBD(%) QCFR no IBD (%)
25
20 -
Slide & RDT neg Slide neg, RDT 1-5,000 5,001-50,000 50,001+
pos*
RDT & slide result (pf/uL)
Figure 8. Prevalence of invasive bacterial disease and case fatality rate in children with
and without invasive bacterial disease by slide and malaria rapid diagnostic test result.
* Probable recent malaria
95
ENTS □ E. coli □ S. Typhi
□ H. influenzae □ Other Gram neg □ Strep pneumoniae












Slide &RDTNeg Slide neg, RDT 1-5,000 5,001-50,000 50,001+
pos*
RDT and slide result (parasites/uL)
Figure 9. Proportion of isolated bacterial organisms by P falciparum density and rapid
diagnostic test results.
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Strep, pneumoniae 6 2 5 1
Staphylococcus aureus 3 1 5 0
Group A Streptococcus 2 1 0 0
Group B Streptococcus 1 0 0 0
Gram negative
Non-typhi Salmonella 22 4 30 0
H. influenzae b 4 1 0 0
Escherichia coli 2 0 1 0
Salmonella typhi 1 0 1 0
Acinetobacter sp 1 0 3 0
Pantoea sp. 1 0 2 0
Citrobacter 1 0 1 0
Kingella kingii 1 1 0 0
Klebsiella pneumoniae 1 1 0 0
Pseu. aeruginosa 1 1 1 0
Campylobacter 0 0 1 0
Neisseria sp. 0 0 1 0
Other Gram neg orgs 0 0 2 0
Table 20. Bacterial isolates in children with severe & non-severe malaria (WHO criteria)
Altered Consciousness
Figure 10. Prevalence of invasive bacterial disease amongst childrenwith severe malaria, by syndrome.
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HIV Positive HIV negative
Bacterial Isolate No. isolates Deaths No. isolates Deaths
Gram positive
Strep. Pneumoniae 13 1 43 10
Staph, aureus 1 1 16 4
Other Gram pos. orgs - - 8 1
Gram negative
Non-typhi Salmonella 8 2 152 16
H. influenzae b 1 1 38 12
Escherichia coli 2 1 21 2
Salmonella typhi - - 11 2
Other Gram neg. orgs 2 0 25 5
Total 27 6 314 52














Strep. Pneumoniae 7 4 49 7
Staphylococcus aureus 2 1 15 4
Other Gram positive orgs 1 0 26 4
Gram negative
Non-typhi Salmonella 8 0 152 18
Haemophilus influenzae b 2 1 37 12
Escherichia coli 3 1 20 2
Salmonella typhi 1 0 10 2
Other Gram neg. orgs 1 1 7 1
Total 25 8 316 50
Table 22. Bacterial isolates in children with and without severe acute malnutrition.
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4.3 Can those children at risk of death be reliably predicted at
the bedside?
4.3.1 Missing Data
Supply problems resulted in a proportion of children not having glucose or lactate
measurement performed. For both blood lactate and glucose these children
represented a cohort defined by time rather than selected by the research team. In
391/3,639 (10.7%) children supply problems resulted in no blood lactate being
available, in these children acidosis was defined clinically. Mortality in children who
had no blood lactate measured (20/391, 5.1%) was not significantly different to
mortality in children in whom lactate was measured (164/3,248, 5.0%, p=0.955). In
412/3,639 (11.3%) children there was no record of blood glucose available. In
children in whom a blood glucose was not recorded mortality (17/412. 4.1%) did not
differ significantly from those in whom it was recorded (167/3,227, 5.2%, p=0.36).
4.3.2 Children with positive malaria slides
Of 184 deaths in study children 95 (51.6%) were in children with falciparum
parasitaemia. Girls had a higher mortality from malaria (54/1,009, 5.4%) than boys
(41/1,186, 3.5%, age adjusted OR 1.59, p=0.03). There were several clinical features
associated with death in age-adjusted analysis (Table 23). These features were added
sequentially to a logistic regression model in order of those with the highest OR first,
features that became non-significantly associated with death were dropped. The
resulting multivariate model showed that severe malnutrition and prostration or coma
were the clinical signs with the highest association with death (AOR 8.82 and 5.24
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respectively). Bedside laboratory tests showing hypoglycaemia (blood glucose
<2.5mmol/l), hyperlactataemia (blood lactate >5mmol/l) and hypoxia by oximetry
(oxygen saturations <90%) were all associated with increased mortality, whilst
children with severe anaemia had a significantly reduced risk of death in the
multivariate model (AOR 0.50, 95% confidence interval 0.26 - 0.98, p=0.044).
Female sex remained a significant risk factor for death from malaria in children
(AOR 1.89, p=0.026). (Table 24)
We retrospectively assigned children into severe and non-severe malaria categories
by WHO criteria1 as defined in Box 3; 823/2,195 (37.5%) parasitaemic children were
thus considered as having severe malaria. Equal proportions of male (435/1,186,
36.7%) and female (388/1,009, 38.5%, p=0.392) parasitaemic children were
considered to have severe malaria. Mortality in children with severe malaria was
87/823 (10.6%) compared with 8/1,372 (0.6%) in children with non-severe malaria
(OR 20.15, 95% confidence interval 9.72 - 41.81, p<0.001). Whilst there was no
difference between case fatality rates for non-severe malaria between boys (4/751,
0.5%) and girls (4/621, 0.6%, p=0.787), girls with severe malaria had a higher case
fatality rate (50/388, 12.9%) than boys (37/435, 8.5%, p=0.041). Severe malaria
identified 87/95 (91.6%) of deaths in children with a positive blood slide for malaria.
Of the 8 deaths not identified 2 had concomitant HIV infection and 1 had invasive
bacterial disease {Strep, pneumoniae), 6 died 3 days or more after admission. Of the
children that died with severe malaria, 75/87 (86.2%) had evidence of acidosis, 60/87
(69%) had altered consciousness and 36/87 (41.4%) had severe anaemia. Mortality in
children with severe anaemia alone was low (2/195, 1%) and one of these children
was admitted hypoxic with kwashiorkor and pneumococcal pneumonia in addition to
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severe anaemia and malaria. A larger proportion of boys with severe malaria had
severe anaemia alone (122/435, 28%) than girls (73/388, 18.8%, p=0.002). There
were no significant differences between the sexes in the proportions of children with
severe malaria that had either acidosis or altered consciousness. The mortality of
children with severe malaria by syndrome is depicted in Fig 11.
When the severe malaria definitions were altered to a set that involved clinical
findings only with maximal sensitivity (any of severe pallor, deep breathing, lower
chest wall or intercostal recession, nasal flaring, prostration, lethargy or coma and
jaundice) 859 children were identified including 84/95 (88.4%) deaths in children
with malaria parasitaemia and giving a group with a case fatality rate of 9.8%.
4.3.2.1 Children with malaria and altered consciousness
Of children with altered consciousness and malaria 92/235 (39.1%) had true
'cerebral' malaria (Blantyre coma score <2). Children with cerebral malaria had a
significantly higher case fatality rate (34/92, 37.0%) compared with children with
malaria and less severe altered consciousness (26/143, 18.2%, p=0.001). Factors
associated with mortality in children with malaria and altered consciousness included
acidosis (OR 6.38, 95% confidence interval 2.75- 14.81, p<0.001), hypoglycaemia
(OR 5.61, 95% confidence interval 1.83 - 11.12, p<0.001) and invasive bacterial
disease (OR 5.23, 95% confidence interval 1.64 - 16.68, p=0.005). Severe anaemia
was not associated with mortality in children with altered consciousness and malaria
(OR 1.07, 95% confidence interval 0.59 - 1.94, p=0.820).
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4.3.2.2 Children with malaria and acidosis
Acidosis was defined as respiratory distress (deep breathing and/or chest wall
indrawing) or a raised blood lactate (>5mmol/l). Of parasitaemic children with
clinical or laboratory signs of acidosis 400/434 (92.2%) had a blood lactate measured
and 338/434 (77.9%) of these children had a blood lactate over 5mmol/l. Both raised
lactate (>5mmol/l) and respiratory distress in parasitaemic children were associated
with mortality by univariate and multivariate analysis (Table 23 & 24). Higher values
for blood lactate were associated with increasing mortality; mortality in parasitaemic
children with a blood lactate between 5 and 10mmol/l was 26/230 (11.3%), rising to
22/91 (24.2%) of children with blood lactate between 10mmol/l and 15mmol/l and
9/17 (52.9%) in children with a blood lactate >15mmol/l (p<0.001).
4.3.2.3 Children with severe malaria anaemia
Of parasitaemic children with severe anaemia 36/413 (8.7%) died compared with
59/1,782 (3.3%) of parasitaemic children with haemoglobin results over 5g/dl at
admission (p<0.001). Mortality in parasitaemic children with lower haemoglobin had
a higher mortality (15/113, 13.3% for those with admission haemoglobin under
3.5g/dl died compared with 21/300, 7% of those with admission haemoglobin
between 3.5 and 5g/dl, p=0.044).
4.3.3 Children with negative malaria slides
Although there were fewer deaths in slide negative children, the mortality in slide
negative children was higher than in slide positive children (89/1,444, 6.2%
compared with 95/2,195, 4.3% in slide positive children, p=0.013). In contrast to
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children with positive slides, there was no difference in mortality between male
(46/784, 5.9%) and female children (43/660, 6.5%, p=0.61) with negative slides for
malaria. Most factors associated with death in slide positive children by age-adjusted
analysis were also associated with death in slide negative children. In addition, signs
of meningism (a bulging fontanelle or stiff neck) were associated with an increased
risk of death by age-adjusted analysis in slide negative children, but not in slide
positive children. (Table 25) A similar methodology to that performed in slide
positive children for creating a multivariate model for mortality was performed in
slide negative children. Hypoglycaemia and prostration or coma were the features
most strongly associated with death with odds ratios of 8.47 (95% confidence
interval 2.49 - 28.79, p=0.001) and 6.31 (95% confidence interval 3.18 - 12.52,
p<0.001) respectively. (Table 26)
Children with any one of the factors associated with mortality in the multivariate
model available at the bedside (hypoglycaemia, prostration/coma, hyperlactataemia,
severe malnutrition and respiratory distress) had a significantly higher risk of death
(OR 10.76, 95% confidence interval 6.53 - 17.71, p<0.001) but only accounted for
67/89 (75.3%) of deaths in aparasitaemic children.
When the clinical features of WHO-defined severe malaria were applied to slide
negative children the resulting group of children also included 67/89 (75.3%) of
deaths in aparasitaemic children. When the two definitions were combined, because
of significant overlap, 70/89 (78.7%) of deaths in aparasitaemic children were
identified.
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Female sex 54/1,009(5.4%) 1.59 1.05-2.41 0.030
Convulsions 36/329 (10.9%) 3.84 2.48-5.92 <0.001
Vomiting everything 3/40 (7.5%) 1.86 0.56-6.18 0.309
Unable to drink 53/180(29.4%) 21.96 13.92-34.66 <0.001


























65/308(21.1%) 19.13 11.97-30.57 <0.001
1.14 0.15-8.75 0.898






HIV positive 6/48 (12.5%) 3.85 1.57-9.47 0.003
Table 23. Clinical features with associated case fatality rates and age-adjusted odds ratios
for death in children with positive blood slides for malaria.
Lower chest wall indrawing or deep breathing
f Systolic blood pressure <70-mmHg, capillary refill <3 sec or cool peripheries
* Blantyre coma score <3 or unable to sit/drink
§Stiff neck or bulging fontanelle
**
Weight for height Z score <-3, visible severe wasting or bilateral pedal oedema
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Characteristic AOR 95% CI P
Signs of malnutrition* 9.32 2.62 --33.22 0.001
Prostration or coma+ 5.06 2.66 -9.63 <0.001
Hypoglycaemia
(glucose<2.5mmol/l)
4.59 2.22 -9.49 <0.001
Hyperlactataemia (Lactate
>5mmol/l)
3.98 2.10 -7.55 <0.001
Hypoxia (Pa02 < 90%) 3.96 1.55 -- 10.10 0.004
Invasive bacterial disease 3.83 1.61 -9.11 0.002
Respiratory distress* 3.55 1.91 -6.58 <0.001
Female sex 1.89 1.08 -3.32 0.026
Severe anaemia (Hb <5g/dl) 0.50 0.26 -0.98 0.044
Table 24. Multivariate model showing risk factors associated with death in slide positive
children.
*
Weight for height Z score <-3, visible severe wasting or bilateral pedal oedema
+
Blantyre coma score <3 or unable to sit/drink





AOR 95% CI P
Female sex 453/660 (6.5%) 1.11 0.72-1.72 0.623
Convulsions 18/115 (15.7%) 3.50 1.98-6.17 <0.001
Vomiting everything 2/48 (4.2%) 0.61 0.15-2.57 0.5
Unable to drink 31/77 (40.3%) 17.51 10.09 -30.38 <0.001
Lethargy 41/144 (28.5%) 10.82 6.75-17.34 <0.001
Respiratory distress 45/205 (22.0%) 6.95 4.39 - 10.99 <0.001
Signs of circulatory
shock+ 32/277 (11.6%) 2.73 1.68-4.45 <0.001
Prostration or coma® 37/102 (36.3%) 15.97 9.59-26.58 <0.001
Meningism5 7/35 (20%) 3.62 1.50-8.72 0.004
Signs of malnutrition" 13/80 (16.25%) 3.76 1.95-7.24 <0.001
Hypoxia
(Pa02 < 90%)
12/39 (30.8%) 2.91 3.74-16.21 <0.001
Severe anaemia
(Hb <5g/dl)
17/163 (10.4%) 2.18 1.24-3.82 0.007
Hypoglycaemia
(glucose<2.5mmol/l)
16/32 (50%) 26.45 11.95-58.55 <0.001
Hyperlactataemia
(Lactate >5mmol/l)
35/91 (38.5%) 4.57 10.02 -28.80 <0.001
Invasive bacterial disease 45/241 (18.7%) 6.19 3.96-9.67 <0.001
HIV positive 12/94 (6.2%) 2.60 1.34-5.01 0.005
Table 25. Clinical features with associated case fatality rates and age-adjusted odds ratios
for death in children with negative blood slides for malaria.
"Lower chest wall indrawing or deep breathing
+
Systolic blood pressure <70-mmHg, capillary refill <3 sec or cool peripheries
* Blantyre coma score <3 or unable to sit/drink
§Stiff neck or bulging fontanelle
**
Weight for height Z score <-3, visible severe wasting or bilateral pedal oedema
I 10
Characteristic AOR 95% CI
Hypoglycemia g 4? 2.49-28.79(glucose<2.5mmol/l) 0.001




Invasive bacterial disease 4.84 2.73-8.59 <0.001
Signs of malnutrition 3.38 1.49-7.65 0.004
Respiratory distress 3.18 1.72-5.88 <0.001
Tabic 26. Multivariate model showing risk factors associated with death in slide negative
children.
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4.4 Do CURRENT WHO GUIDELINES ACCURATELY PREDICT INVASIVE
BACTERIAL DISEASE AND THEREFORE REQUIRED TREATMENTS?
4.4.1 Diagnostic syndromes
Retrospectively applied, 1,767/3,639 (48.6%) children had clinical features that
would have led them to meet WHO criteria for antibiotic treatment. (Table 27) This
group included 224/341 (65.7%) cases of proven invasive bacterial disease and 47/58
(81.0%) of the deaths associated with invasive bacterial disease. Children with any of
the WHO criteria had a 2.2-fold increase in odds of actual invasive bacterial disease
(95% confidence interval 1.7 - 2.8, p<0.001) and a 4.3-fold increased risk of death
(95% confidence interval 3.0 - 6.3, p<0.001).
The organism most commonly isolated in children with a meningitis/encephalopathy
syndrome was Haemophilus influenzae, which accounted for 46% of the positive
isolates in children with this syndrome. In 69/255 children (27.1%) with a clinical
diagnosis of meningitis/encepahalopathy no lumbar puncture was performed. In
20/186 (10.8%) children with a clinical diagnosis of meningitis/encephalitis who had
a lumbar puncture meningitis was proven by the growth of a pathogenic bacteria
from CSF. There were 5 further cases of culture proven bacterial meningitis in
children without a clinical diagnosis of meningitis/encephalopathy (4 children with
very severe pneumonia and 1 child that was not assigned to a WHO clinical
diagnostic category).
Non-typhi salmonellae were the most common isolates in children with WHO
clinical pneumonia, accounting for 83/178 (46.6%) of isolates. In children with a
clinical diagnosis of severe or non-severe pneumonia 79/110 (71.8%) isolates were
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Gram negative and consequently likely to be resistant to recommended antibiotic
therapy. (Table 28)
Although there were 25 cases of invasive bacterial disease in the 110 children with
severe malnutrition (22.7%), 18 of these children had clinical features of other WHO
diagnoses (1 meningitis/encephalopathy, 11 very severe pneumonia, 6 pneumonia),
leaving 7/42 (16.7%) children with no other clinical signs suggesting a WHO
diagnosis that were culture positive for invasive bacterial disease. (Table 27)
4.4.2 DO CURRENT GUIDELINES ADEQUA TELY IDENTIFY CHILDREN WITH
INVASIVE BACTERIAL DISEASE AND MALARIA PARASITAEMIA?
The sensitivity of WHO-defined syndromes for identifying IBD in children with
P.falciparum parasitaemia was 56.0% (95% CI 53.9 - 58.1%) compared to 69.7%
(95% CI 67.3 - 72.1%) in aparasitaemic children. In identifying fatal cases, these
sensitivities rose to 69.2% (95%CI 67.3 - 71.2%) and 84.4% (95%CI 82.6 - 86.3%)
respectively, though numbers were small. The sensitivity of WHO guidelines to
detect IBD dropped as the parasitaemia rose; at over 50,000 parasites/pl sensitivity
was 47%, whilst the prevalence of IBD in this group was similar to that in lower
parasitaemias. (Table 29)
Amongst children with malaria, both children who were correctly identified as
having invasive bacterial disease by the WHO guidelines, and those in whom
bacterial disease was 'missed' by the guidelines, had an increased risk of death
associated with their bacterial disease (OR 2.7 and 6.0 respectively, p<0.05 for both).
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4.4.3 whatare the risk factors for IBD in children with and without
falciparum parasitaemia ?
Factors associated with invasive bacterial disease in an age-adjusted analysis of slide
negative children included a history of cough or difficulty breathing, respiratory
distress, prostration/coma, lethargy, meningism, hepato- or splenomegaly, severe
malnutrition, severe anaemia, hypoglycaemia, hyperlactataemia, leukocytosis,
positive HRP-2 falciparum malaria rapid diagnostic test and HIV infection. (Table
30)
In slide positive children there were fewer factors associated with invasive bacterial
disease; surprisingly neither meningism nor malnutrition were associated with
invasive disease, nor were a history of cough or difficulty breathing, respiratory
distress or hypoxia. Circulatory shock was associated with invasive bacterial disease
in slide positive (but not slide negative children). Whilst splenomegaly was
associated with invasive bacterial disease only in slide negative children,
hepatomegaly was associated with bacterial disease in both slide negative and slide
positive children. Factors relating to bedside laboratory tests (severe anaemia,
hypoglycaemia and hyperlactataemia) were associated with invasive bacterial disease
in both groups of children. HIV infection, associated with invasive bacterial disease
in slide negative children did not reach significance in slide positive children (AOR
2.72, p=0.066). (Table 31)
Factors significant in age-adjusted analysis were sequentially added to a multivariate
model, starting with those at the highest AOR. Factors were dropped when they no
longer showed significance. In slide negative children meningism, lethargy, hepato-
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or splenomegaly, severe malnutrition and chest crepitations were all independent
markers for invasive bacterial disease. In slide positive children jaundice, the clinical
feature associated with the highest OR in the age-adjusted analysis, when analysed
with any other positive features became non-significant. In view of this, factors were
sequentially added to hypoglycaemia. Only hypoglycaemia, leukocytosis and signs
of circulatory shock remained positively associated with invasive bacterial disease.
The final models with significant features are shown in Table 32.
4.4.4 HOW CAN WE IMPROVE THE GUIDELINES IN THE DETECTION OF IBD IN
CHILDREN WITH P. FALCIPARUMPARASITAEMIA?
The addition of clinical features found to be independently associated with invasive
bacterial disease in multivariate analysis (raised white blood cell count,
hypoglycaemia and signs of circulatory shock) to the WHO guidelines improved
sensitivity in the detection of invasive bacterial disease in slide positive children
from 56% to 78% (95% confidence interval 76.3 - 79.7%). However specificity was
poor (37.8%) which would have hypothetically resulted in treating 63% of slide
positive children with antibiotics. Additionally a white blood cell count is not
available in most district hospitals. In view of these constraints, the effect of adding
variables from another widely used set of clinical and basic laboratory indices (the
WHO criteria for severe malaria) was assessed.
In order to make the results more relevant the WHO severe malaria criteria were
adjusted by removing hyperlactataemia and hyperparasitaemia as both are unlikely to
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be accurately recorded in most African district hospitals (Box 3). The addition of
WHO criteria for severe malaria to the WHO criteria for presumptive use of
antibiotics improved sensitivity from 56.0% (95%CI 53.9 - 58.1%) to 70.0% (95%
CI 68.1 - 71.9%) in identifying children with IBD-P. falciparum coinfections, and
92.3% (95% CI 91.2 - 93.4%) when identifying fatal cases. However addition of
WHO criteria for severe malaria as an indication for antibiotic use would result in a
modest (0.7%) increase in the number of children that would be treated with
antibiotics per child treated with proven bacterial coinfection.
The contribution of the addition of individual components of the WHO definition of
severe malaria (prostration, anaemia, respiratory distress and hypoglycaemia ) to
increasing the sensitivity of current WHO guidelines for antibiotic use was then
assessed both individually and in combination. The addition of severe anaemia
resulted in the largest increase in sensitivity. There was a further increase in
sensitivity with the addition of severe anaemia or prostration, however there were no
further improvements in sensitivity with any further additions. (Table 33) The
improvement in sensitivity was gained with a small reduction in the number of
children that would have been treated with antibiotics to treat one with IBD (NNT),
as the prevalence of IBD in the children with malaria and severe anaemia or
prostration not otherwise identified by the WHO categories was 14/218 (6.4%) as
compared with 56/1000 (5.6%) in parasitaemic children meeting WHO criteria for
presumptive antibiotic treatment.
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4.4.5 Can we improve the sensitivity of the guidelines in
aparasitaemic children?
The sensitivity of the WHO guidelines for detecting IBD in slide-negative children
was 69.7% (95% CI 67.3 - 72.1) and 4.6 children would have been treated for each
case of IBD (NNT). The addition of severe anaemia or prostration to the WHO
criteria increased the sensitivity to 74.7% (95% CI 72.5 - 76.9%) with a slight
increase in the NNT to 4.7. (Table 33) Addition of axillary temperature over 38°C to
the standard WHO criteria increased sensitivity to 82.2% (95% CI 80.2 - 84.1) but
would have involved treating 68.1% of children with antibiotics.
The rise in sensitivity from the addition of severe anaemia and prostration was
largely due to the ability of these findings to pick up infection in children who may
have recently had malaria (positive HRP-2 based rapid test and negative blood slide);
9/12 (75%) of the additional cases identified for presumptive antibiotic use by the
addition of severe anaemia or prostration were in children in this group.
4.4.6 Are the differences in observed sensitivity of the WHO
guidelines in children with positive and nega t1ve blood slides
related to different pathogens or differing clinical
presentations?
For most bacterial pathogens the WHO guidelines missed a larger proportion of
cases of invasive disease in children with malaria parasitaemia than in aparasitaemic
children. This was most marked for NTS, where 52% of slide positive infections
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were missed compared with 38% of slide negative, but was also true for other Gram
negative organisms and Strep, pneumoniae. (Table 34)
Looking at differences between pathogens, the guidelines had low sensitivity in
identifying S typhi, NTS and Staph aureus compared with other organisms. Applied
to all children, 68/160 (42.5%) of invasive NTS were missed compared to 15/95
(15.8%) of infections due to Strep, pneumoniae or Haemophilus influenzae and 6/23
(26.1%) for E coli. This also contributed to the difference in the sensitivity of the
WHO guidelines between slide positive and slide negative children as the spectrum
of infecting organisms differed between the two. In slide negative children, Strep,
pneumoniae, Haemophilus influenza and E. coli, organisms detected well by the
guidelines, together accounted for 100/241(41.5%) of isolates, while NTS and other
Gram negative organisms accounted for 108/241 (44.8%) and 19/241 (7.9%)
respectively; in slide positive children Haemophilus influenza, Strep, pneumoniae
and E. coli were less common, accounting for only 18/100 (18%) of infections whilst
NTS were more common, accounting for 52/100 (52%) of invasive bacterial disease
as were other Gram negative organisms (19/100, 19%), both groups of organisms
that the guidelines identified poorly. Table 34 summarises the pathogens that were





















plus lower chest indrawing,










plus raised respiratory rate
for age
80/860 (9.3)
Table 27. Definitions of WHO diagnostic categories used in this study with prevalence of
invasive bacterial disease.
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AOR 95% CI P
Cough or difficulty
breathing
190 (18.2%) 1.51 1.08-2.11 0.016
Fever > 7days 24/122 (19.7%) 1.26 0.78-2.02 0.345
Respiratory distress* 47/205 (22.9%) 1.62 1.12-2.34 0.01
Signs of circulatory shock* 55/277(19.9%) 1.29 0.92-1.82 0.145
Prostration or coma* 30/102 (29.4%) 2.26 1.44-3.55 <0.001
Lethargic 52/144(36.1%) 3.32 2.28-4.82 <0.001
Meningism5 19/35 (54.3%) 6.66 3.34-13.26 <0.001
Crepitations in chest 79/343 (23.0%) 1.74 1.28-2.36 <0.001
Jaundice 5/23 (21.7%) 1.44 0.52-4.03 0.486
**
Hepatomegaly 36/109 (33.0%) 2.96 1.91-4.58 <0.001
Splenomegaly" 53/185 (28.6%) 2.38 1.65-3.41 <0.001
Signs of malnutrition** 24/80 (30.0%) 2.30 1.39-3.80 0.001
Hypoxia
(Pa02 < 90%)
13/39 (33.3%) 2.59 1.31-5.11 0.006
Severe anaemia
(Hb <5g/dl)
39/241 (23.9%) 1.69 1.14-2.50 0.009
Hypoglycaemia
(glucose<2.5mmol/l)
13/32 (40.6%) 3.60 1.75-7.41 0.001
Hyperlactataemia
(Lactate >5mmoi/l)
29/91 (31.9%) 2.50 1.57-4.00 <0.001
WBC > 15 99/491 (20.2%) 1.57 1.15-2.15 0.005
HIV positive 23/94 (24.5%) 1.70 1.04-2.78 0.036
Malaria RDT positive 98/501 (19.6%) 1.38 1.04-1.85 0.028
Tabic 29. Age adjusted odds ratios for invasive bacterial disease in slide negative
children.
Chest indrawing or deep breathing
t Systolic blood pressure <70-mmHg, capillary refill <3 sec or cool peripheries
* Blantyre coma score <3 or unable to sit/drink
§ Neck stiffness or bulging fontanelle
**
Liver edge >2cm below costal margin
^Splenic tip > 2cm below costal margin








Cough or difficulty breathing
Fever > 7days
Respiratory distress*













































































































Table 30. Age adjusted odds ratios for invasive bacterial disease in slide positive children.
Chest indrawing or deep breathing
*
Systolic blood pressure <70-mmHg, capillary refill <3 sec or cool peripheries
+ Blantyre coma score <3 or unable to sit/drink
§Neck stiffness or bulging fontanelle
Liver edge >2cm below costal margin
**
Splenic tip > 2cm below costal margin
++ Weight for height Z score <-3, visible severe wasting or bilateral pedal oedema
123
Characteristic AOR 95% CI P
Negative blood slide
Meningism 6.91 3.14-15.21 <0.001
Lethargic 2.79 1.77-4.38 <0.001
Splenomegaly 2.11 1.31-3.38 0.002
Signs of malnutrition 2.06 1.10-3.85 0.024
Hepatomegaly 1.92 1.11-3.32 0.02
Crepitations in chest 1.57 1.08-2.29 0.019
Positive blood slide
Hypoglycaemia 2.75 1.21-6.24 0.015
WBC > 15 2.52 1.51-4.19 <0.001
Signs of circulatory shock 1.73 1.05-2.85 0.032
Table 31. Multivariate analysis of risk factors for invasive bacterial disease in children
with and without malaria parasitaemia
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WHO severe malaria









hyper-parasitaemia (>20% of red cells infected)*
Box 3. WHO definition of severe malaria.1
Respiratory distress defined as chest indrawing and/or deep breathing
+
Prostration defined as inability to sit after the age of 9 months, inability to drink prior to that age
31 Hyperparasitaem ia excluded from definition of severe malaria syndrome in these studies as not
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NTSSPneumoniaeHi fl enzOtherGramn gp s
WHOCriteriaSlideNegative41/108(38. %)7/45(15.6%)5/3 ( 4.3 )1 /39(3 .9/14( 5.7%) SlidePositive27/52(51.9%)3/1 (27.3%)0/4(01045 54 11 36.4 ) P/usanaemiaSlideNegative34/108(31.5%)7 5(1 .6%)5/3 4 31 /39914(21.4 ) SlidePositive18/52(34.6%)3/11(27.3%)0/ (09/40.94/ 36.4 ) SlideNegative32/108( 9.6%)7/45(15.6%)5 3 4 31 /393 914 21 4 SlidePositive15/52(28.8%)3/11(27.3%)0/4(09/240 9Plusanaemiaor prostration Table33.Proportionfinvasivebacter alsolates'missed' yWHOguidel n sndv r oum ndm tsguidelif p r caltr tmen malariaslideresult.
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4.5 Are clinical signs in children reproducible between different
grades of staff?
A total of 439 children were examined by a RCO and then examined a second time
by a HN (189), HCO (129) or another RCO (121). Table 35 shows the numbers of
repeat examinations undertaken by individuals in each of the staff categories. The
median time between examinations was 14.2, 13.4 and 14.2 minutes for RCO-HN,
RCO-HCO or RCO-RCO respectively. The mean (median) age of children
examined was 25(18) months and 39% cried during the first or second examination;
neither age nor crying varied by category of examining staff (p=0.13 and p=0.11
respectively).
Overall, the agreement between RCOs on clinical signs was slightly higher than for
HCOs or HNs; the mean (median) Kappa scores for all signs examined were 0.54
(0.57) for RCO-RCO, 0.49 (0.49) for RCO-HCO and 0.50 (0.49) for RCO-HN pairs
of examiners, indicating moderate agreement in all groups. (Box 4, Figure 12).
Level of consciousness or prostration are important predictors of outcome in severely
ill children and all grades of staff reached 'moderate' or 'substantial' levels of
agreement for these. However, agreement on the presence of'chest wall indrawing'
between RCOs or HNs compared to the first RCO examination was 'poor'. (Table
36)
Agreement between examiners, particularly RCOs and HNs, for the presence of
'delayed capillary refill' and 'temperature difference' was 'poor'. Since the ability to
see capillary refill depends on a colour change in the nailbed we calculated the
overall agreement (irrespective of staff grade) on 'delayed refill' (Kappa=0.14, 95%
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CI 0.06-0.22) and then in the 159 children whose haemoglobin levels were <7g/dl
(Kappa=0.083, 95% CI -0.04-0.20) compared to repeatability in the 280 children
with haemoglobin>7g/dl (Kappa=0.21, 95% CI 0.15-0.29).
We tested the repeatability of a combination of signs that would indicate the need for
parenteral therapy according to IMCI criteria. These corresponded to the IMCI
definitions of severe or very severe pneumonia or severe dehydration. The agreement
between hospital nurses and research clinical officers for the presence or absence of
one of these combinations was 'moderate' (Kappa=0.51, 95% CI 0.39-0.57) for
severe or very severe pneumonia and substantial (Kappa=0.61, 95% CI 0.49-0.73)
for severe dehydration.
A composite sign of'severe disease' was constructed from a combination of
respiratory signs, reduced consciousness, severe pallor or jaundice. (Table 36) The
overall Kappa value (irrespective of staff grade) was 0.61 (95% CI 0.56-0.76) while
the weighted mean Kappa of its components was 0.56.
Forty percent of signs in children over 18 months of age reached 'substantial' or
better levels of agreement compared to only 10% in children under 18 months of age.
Similarly, 38% of elicited signs reached substantial or better agreement in children
who did not cry compared to only 25% in children who did cry. Most children (66%)
were examined within 15 minutes of the first examination and repeatability of
examination results was no better in these than the minority (34%) who were
examined with a delay of more than 15 minutes.
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Kappa Score Level of agreement






Box 4. Classification of Kappa scores according to Landis & Koch19'
No. No. No.
RCO examined HCO examined HN examined
1 20 1 44 1 46
2 25 2 28 2 41
3 42 3 27 3 31




Total 121 129 189
Table 34. Number of repeat examinations by individual staff and staff categories.















0-0.2 0.21-0.4 0.41-0.6 0.61-0.8 0.81-1.0
Kappa range
































































































































































































































These studies have demonstrated several important findings that will be expanded on
below but are summarised here.
The literature on the pattern of bacterial disease in sub-Saharan Africa has been
summarised earlier119 l22"126,28"134 (Table 1). Data from the studies contained in this
thesis differ from the published studies in that the prevalence of non-Typhi
Salmonella and the proportion of mortality attributable to this organism were much
higher in this study. This thesis also importantly 'adds to the map' of studies
describing the aetiology of infection in hospitalised children in sub-Saharan Africa.
There is little published data on the aetiology of disease in children whose
presentation is typical of malaria but who test negative for P falciparum. This thesis
has described a high prevalence of invasive bacterial disease in children that tested
negative for malaria (16.7%) with a high proportion of bacterial infections due to
non-Typhi Salmonella in this group.(Table 18, Figures 8, 9)
This is the first study to test WHO guidelines on the presumptive use of antibiotics in
children admitted to hospital with infection62 in a high malaria transmission setting.
The data show that the guidelines had poor sensitivity in detecting children with
invasive bacterial disease and positive blood slides for falciparum malaria. (Table
29)
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In children with severe malaria there remains debate as to whether a policy of
treating such children with antimalarials alone is safe."7136-137 Data from this thesis
would support a change of policy to treating all children with severe malaria with
broad spectrum antibiotics in addition to antimalarials. (Tables 19, 33)
Few of the studies described earlier are from district hospitals serving the rural
communities where most of the morbidity of childhood infection in East Africa lies.
Where studies do concern rural communities the hospitals involved in studies have
often been established research centers that may no longer represent the 'norm' in
terms of admissions. The data from these studies were generated from research
conducted in a hospital that had little experience of inpatient research and should be
more representative of the distribution of disease encountered in most hospitals in
high malaria transmission areas.
5.2 Aetiology of febrile disease
Infectious diseases are the most important cause of child mortality and morbidity in
sub-Saharan Africa. This series of studies have demonstrated that, even in a setting
with a high level of malaria transmission, invasive bacterial disease is a major cause
of mortality. Invasive bacterial disease was associated with almost a third (31.5%) of
all paediatric deaths and occurred in almost 1 in 10 children. As discussed previously
there have been few studies that have examined all febrile admissions to ascertain the
infections associated with death, but the data from this study are similar to that
described in studies from 'neighbouring' Kilifi (26%).'19 The prevalence ol invasive
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bacterial disease is also similar to that quoted from other hospitals serving malaria
endemic regions.131 133199 Further in keeping with data from Kilifi119 we found that
approximately 1 in 5 deaths in children with bacterial disease had positive blood
slides for malaria and 14% of deaths in children with malaria also had invasive
bacterial disease.
As discussed earlier both the prevalence of invasive bacterial disease found, and its
impact on mortality are likely to be under-estimates owing to the poor sensitivity of a
single blood culture,71"72 with some authors suggesting that the true prevalence of
invasive bacterial disease may be up to 50% higher than that predicted by blood
culture studies.116 Several diagnostic strategies would have improved the yield of
bacteria from cultures in children with febrile disease. Lung aspiration or sputum
culture in pneumonia, urine culture and multiple blood culture should all increase the
sensitivity for the detection of invasive bacterial disease.71"72 200 212 In one study from
West Africa percutaneous lung or pleural aspiration increased the yield of bacterial
pathogens in 100 children with pneumonia from 18 to 52.200 However it is an
invasive procedure that is operator dependent and requires specific training and
expertise.209 Sputum culture is difficult in children and samples are often more
representative of oro-pharyngeal colonization than lung parenchyma infection. Some
studies have found promising results using induced sputum,204 213"216 with one study
from Uganda detecting bacterial pathogens in two thirds of children admitted with
severe or very severe pneumonia using induced sputum and blood cultures.215 It can
be difficult to obtain multiple blood cultures and delaying treatment in a sick child is
not possible. More cultures would also increase the demands on labs that are already
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under pressure. Similarly the resources and personnel required to obtain sterile urine
samples on a large scale were prohibitive. However it is likely that a high proportion
of children sick enough to die from sepsis would have bacteraemia, reducing the
impact of restricting microbiological sampling to blood cultures on mortality studies.
An autopsy study from Zambia in 2002 showed a high rate of tuberculosis in HIV
negative children that died with respiratory illnesses and a high rate of tuberculosis,
Pneumocystis jiroveci and cytomegalovirus in HIV positive children.216 The absence
of any mycobacterial culture, virology, sputum cytology or chest radiography in this
study makes it difficult to produce data on these infections. It is worth noting that the
Zambian study involved autopsies on only 16% of the children that died and 68% of
these were HIV positive. One might expect that the care-givers of children in whom
a diagnosis was not apparent might be more likely to give consent to autopsy,
possibly biasing the results to diagnoses that are more difficult to make in a resource
poor environment.
There were also likely to have been benefits, in terms of antibiotic prescribing, in
having on site microbiological facilities. This allowed children who may not have
initially received the appropriate antimicrobials to be given them when results of
blood cultures became known, potentially reducing the mortality associated with the
infection.
The most common bacterial isolates were non-typhi Salmonella, found in almost half
of all admissions, followed by Strep, pneumoniae and Haemophilus influenzae b
(Table 17). There are substantial differences in the literature between sites in the
relative frequency of different bacterial species."9 122-126128-134 The data from this
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study are similar to the studies from Malawi,122"123 Mozambique133 and the
Democratic Republic of Congo131 in that non-Typhi Salmonella were the most
common invasive isolates and contrast with data from The Gambia,126 128 where
pneumococci appeared the most prevalent cause of invasive bacteria disease. Given
the data suggesting a link between recent malaria and non-typhi Salmonella sepsis118
217 it is tempting to postulate that the level of transmission of falciparum malaria may
account for the differences in the spectrum of bacterial isolates observed. However,
whilst the prevalence of malaria in hospitalised children was similar in the study by
Siguaque et al. in Mozambique133 to that in this study another study reporting similar
malaria prevalence, in Nigeria,129 reported only a few cases of invasive non-typhi
salmonellosis and many studies did not report on the prevalence of malaria amongst
children admitted. The paucity of data makes it difficult to ascertain a pattern;
without more data it is difficult to know to what degree the differences observed
represent temporal rather than geographical variation and additionally how much
variation there may be within countries as well as between them.
A further problem for those planning interventions is understanding to what extent
data from inpatients (admissions) to hospitals is representative of the distribution of
bacterial disease in the community. It is possible that more severe disease, perhaps
due to more virulent pathogens, may be underestimated in some hospital settings as
children living in remote areas may not survive to present to hospital. It has been
suggested that this is the reason for the absence of epiglottitis (usually associated
with Haemophilus influenzae b) in any of the reported literature despite Haemophilus
being a common cause of pneumonia and meningitis in areas where there is little or
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no vaccine coverage,119122 126133 Prior antibiotic use can also render cultures negative
underestimating the burden of bacterial disease.
Perhaps unsurprisingly in this setting malaria was the most common infection
associated with paediatric inpatient mortality in this hospital, being implicated in
around half of all paediatric deaths. (Fig 7) This is over twice the proportion that was
recorded by researchers in Kilifi, Kenya119 despite the two hospitals being less than
400km apart and at similar altitudes. The case fatality rates for malaria found in this
study (0.6% and 10.6% in non-severe and severe disease respectively) compare well
with data from other sites including Kenya65 67-68 70 152-157 (Table 6) and the high
proportion of deaths due to malaria may simply represent the high caseload of severe
malaria seen.
Malaria infection appears to have had an influence on the epidemiology of bacterial
disease. Children with co-infection had similar case fatalities to those with bacterial
disease alone, yet those with co-infection appeared to die at a speed that was more in
keeping with children with malaria alone than those with bacterial disease alone.
(Table 15, 16) Recent or current malaria also had a strong effect on the spectrum of
bacteria isolated with a higher proportion of non-typhi Salmonellae seen particularly
in children with recent, but not current malaria whilst those without any evidence for
malaria suffered a higher frequency of more traditional pathogens such as Strep
pneumoniae and Haemophilus influenzae b (Fig 9 & Table 18). Clinicians and policy
makers need to be aware that the majority (58%) of invasive bacterial disease was
found in children who had a positive rapid diagnostic test for malaria, indicating
current or recent falciparum malaria. (Table 18) Clearly in this region many young
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children will have a malaria parasitaemia, even when 'well'. However recent malaria
was associated with an increased risk of invasive bacterial disease over other slide
negative children (Table 30). Malaria transmission may thus be a major factor in the
differences observed in the spectra of invasive bacterial isolates described in this and
other studies (Tables 1 & 17) and be a major predisposing factor in invasive bacterial
disease. It will be enlightening to see the effect of malaria controls strategies on the
spectrum and incidence of invasive bacterial disease over the coming years. There is
also some operational significance to this finding. Should health centers and
hospitals move to using HRP-2 based rapid diagnostic tests for falciparum malaria,
many children with bacterial disease are likely to present with a positive malaria test
due to recent, but not current malaria. This may result in further misdiagnosis,
unnecessary malaria treatments and the potentially life threatening consequences of
missing invasive bacterial disease.
Although invasive non-typhi Salmonellae infections had the lowest case fatality rate
of any bacteria isolates, they were also the most common isolates associated with
inpatient death (Table 17). Despite an epidemiological link between invasive non-
typhi Salmonellae and malaria being known for over 20 years217, there is still no
clear pathological link. The high incidence of invasive non-typhi Salmonellosis in
1 R 11 Q
patients with sickle cell disease and some recent data in animal models point to
a possible role for haemolysis. Dendritic cell function has been found to be abnormal
in murine models following malaria infection with impairment of their oxidative
burst, delayed maturation of monocytes laden with haemozoin (a by-product of
haemoglobin found in malaria) and impaired T-cell activation by these dendritic
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cells 220 ^ remains unclear why such impairments should select for invasive
salmonellosis.
This study has also demonstrated that concomitant malaria may change the clinical
presentation of bacterial disease with more bacteraemic, parasite positive, children
presenting with symptoms and signs that are not typical of the recognized WHO
clinical syndromes (Tables 29 & 34). The reasons for this change in presentation are
not clear but may involve the changes in immune function associated with malaria
outlined above. These children may be presenting with primary septicaemia, with the
host unable to contain infection due to impaired immune function. This hypothesis
could be explored by a study looking at the proportion of children with radiographic
changes associated with pneumococcal bacteraemia in children with and without
concurrent or recent malaria. Nonetheless it is clear that children co-infected with
invasive bacteria and falciparum malaria are at an increased risk of dying compared
non-bacteraemic children.
Although neonates were not enrolled in the studies described in this thesis, the
incidence and case fatality rate of invasive bacterial disease among hospitalised
children was highest in children under 1 year of age, as in studies from elsewhere119
133 (Tables 15 & 17), indicating that infants and not just neonates were at increased
risk. This is unlikely to relate to vaccination as none of the pathogens identified were
being vaccinated for at the time of the study. There were no cases of malaria-
bacterial co-infection in children over 5 years age, though there were relatively few
children in this category (Table 15).
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The prevalence of HIV in children admitted to hospital was 3.9%, in children that
died in hospital it was 9.8%. In contrast to HIV negative children the most common
bacterial isolate in HIV positive children was Strep, pneumoniae, accounting for 48%
ofisolates. (Table21) In in contrast with data from Kenya and Malawi ll8"119 137 221
invasive non-typhi salmonellosis was not associated with positive HIV status,
possibly due to any effect being swamped by the impact of malaria. Invasive
bacterial disease was more common and falciparum malaria less common in children
that were HIV positive compared with HIV negative children. Study children with
previously diagnosed HIV may have had access to interventions that would have
reduced the risk of malaria (such as insecticide treated nets) though other
interventions available would have reduced the risk of both bacterial disease and
malaria (such as cotrimoxazole).222"223 A minority (11%) of children's care givers
reported that the child had been given cotrimoxazole in the 48hrs prior to admission,
though we did not record whether children were known to have HIV prior to
admission.
5.3 Severe Malaria
The issue of whether children with severe malaria should be prescribed broad
spectrum antibiotics is a contentious one. In this study children aged less than 5 years
with severe malaria by WHO criteria1 had around a 1 in 20 chance of invasive
bacterial disease, with a threefold increase in their risk of dying despite a hospital
policy of broad-spectrum antibiotics in this group. This is a similar prevalence as
found in studies on severe malaria in Kenya,117 Malawi137 and Ghana136 discussed
earlier. Despite showing similar rates of bacterial co-infection, these other studies
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have found varying statistical significance for its impact on mortality. (Table3) The
finding that by changing the case definition of severe malaria the magnitude and
statistical significance of the effect of invasive bacterial disease on mortality can be
altered is important (Table 19). There are many possible reasons for this discrepancy.
The role of invasive bacterial disease in severe malaria may differ according to local
factors, such as the intensity of malaria transmission, the prevalence of HIV
infection, local conditions affecting the epidemiology of bacterial disease itself (such
as vaccination, provision of water and sanitation etc.) It is also possible that other
studies may have inadvertently selected for a group of children with severe malaria
in whom bacterial disease has less impact. Additionally the authors of the study from
Ghana136 commented that Strep, pneumoniae was difficult to culture in their lab and
postulated a high level of antibiotic use prior to admission as a cause for this. This
may have blunted the effect of bacteraemia on mortality which together with the
small number of children involved (182 children with slide proven severe malaria)
may account for the findings.
The finding that the prevalence of invasive bacterial disease appeared highest in
children with severe malarial anaemia (Fig 10) is consistent with at least one other
study,137 though the mortality in children with severe malarial anaemia alone is low
in this (Fig 11) and other studies.65 70 152 158 In research settings it is likely that these
children are picked up and treated for their infections quickly, however bloodstream
infection could give rise to significant mortality in this group if not promptly
managed.
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These data would support the assertion by others116"117 that all young children with
severe malaria should be treated with broad spectrum antibiotics. Doing so increased
the proportion of bacterial disease treated in slide-positive children from 56% to 71%
(Table 33) with no change in the number of children being given antibiotics for each
child with invasive bacterial disease captured. Where malaria is being over-
diagnosed, or if HRP-2 based rapid diagnostic tests are being used in severely ill
inpatients, such an approach is even more important if the burden of invasive
bacterial disease is to be effectively treated. Ideally questions concerning the
management of severe malaria would be addressed by a randomised clinical trial but
given the data outlined in this thesis it seems likely that it would be unethical to
recruit children into the placebo arm of such a trial. A large proportion of inpatient
deaths in febrile children occur within hours of admission and it is possible that these
outcomes will not be altered by antibiotic therapy.
5.4 Identifying children at risk of invasive bacterial disease and
death
In settings where resources and personnel are few it is clearly important to target
those children in most need. In keeping with earlier studies65 67 70157-158 (Table 6), we
found that WHO criteria of severe disease1 predicted over 90% of inpatient deaths in
children with malaria. Children who had non-severe malaria had a low (<1%) risk of
dying in this setting. Mortality in children with severe anaemia without evidence of
acidosis also had a low mortality (Fig 19). It has been suggested that a short stay
ward would help in the management of children in a resource poor setting.224 Such a
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unit with a slimmed down staffing might help save resources whilst allowing
children with non-severe malaria to be reassessed for signs of developing severe
disease.
It was more difficult to identify children with negative slides at increased risk of
death. The WHO severe malaria criteria, applied to slide negative children, selected
children at risk of death with similar sensitivity to a set of criteria set up de-novo.
However both criteria missed a quarter of deaths. Clinicians need to be aware of the
difficulties in predicting children at risk of death who have negative malaria slides
and act with extra caution in these admissions. As in a previous study from East
Africa,120 the sensitivity of WHO guidelines for detecting invasive bacterial disease
were greater in slide negative than slide positive children (Table 29), but in this study
could be improved by the addition of severe anaemia or prostration to the criteria for
antibiotic therapy (Table 33). Other signs that might cause clinicians to consider
antibiotic therapy were splenomegaly or hepatomegaly and crepitations audible on
auscultation of the chest - all associated with invasive bacterial disease on
multivariate analysis (Table 32). Both prostration and severe anaemia are fairly
straight forward signs to elicit. Prostration had a 'near perfect' Kappa score for
agreement between observers when repeat examinations were conducted as part of
these studies (Table 36) and 'substantial' in another study from Tanzania.193
Prostration is also well validated as a predictor of mortality in other studies of severe
malaria65147 and was associated with death in both children with and without malaria
in this study (Table 24, Table 25). Severe anaemia requires some means to measure
blood haemoglobin or haematocrit, but this is usually available in most district
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hospitals. Where it is not, severe pallor, a clinical sign, picked up 79% of the children
with a blood hemoglobin of less than 5g/dl and 85% of the invasive bacterial disease
associated with severe anaemia. Agreement on severe pallor was 'moderate' in this
study and 'moderate' or better in two other East African studies.193 225 Clearly any
such new criteria should be tested prospectively and in different settings if they are to
be deployed more widely.
The data on the reproducibility of clinical data showed adequate agreement, and were
similar to those obtained by other studies.193 195-196 Yet in some areas, such as
capillary refill and temperature gradient, the agreement was only slight. The reasons
for this are not clear, but they may reflect the little attention given to emergency fluid
resuscitation in this setting.226 There is some evidence that the interpretation of
clinical signs can differ substantial if the signs are subtle.1 ^ It would then be
expected that disagreement would be less pronounced in the more severely ill
children where clinical signs are more likely to be exaggerated. Unfortunately there
is no data to support this assertion. Most clinicians would agree that some objective
data, such as blood lactate and oxygen saturation, is useful to help triage children.
These data support this, with improved sensitivities and specificities of algorithms
for the detection of life threatening illness and bacterial disease when such test
results were incorporated into the models. Unfortunately these laboratory or bedside
tests are not available to most clinicians practicing in this setting. The results of these
studies would support the more widespread distribution of such technology to enable
more accurate triage and more appropriate use of scarce resources.
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5.5 Critique of methodology & Limitations
5.5.1 Overview
These studies are limited in that they are of an observational nature and from a single
site in Tanzania, indeed these data have shown important differences from data from
other centers. However no study data can automatically be generalized to other sites,
and it is important to have a range of sites providing data to allow an understanding
of the variation in findings. Similarly these data only describe what was found at the
time of the study. Emerging infectious diseases, changes to vaccination programmes
and developments in vector control, education, housing and sanitation may all have
influences on these data over time.
An observational study such as this can only provide evidence of association rather
than cause. Whilst it may be a fair assumption that the finding of pathogenic bacteria
in the cerebrospinal fluid of a febrile child are likely to be the cause of death if that
child goes on to die in the next few hours or days the same cannot be said of finding
malaria parasites in the blood of children in an area endemic for this infection.
Some infections, including most viral infections but also mycobacterial infections,
were not looked for in these studies. Although this may have limited the findings the
treatment of most viral infections are out-with the capability of most East African
district hospitals; whilst these data would have been important for discussion on the
provision and need for vaccines they are less so for the clinical management of
admissions. It is worth noting that at the time of these studies human influenza A
H1N1 ('Swine 'flu') had not been described. Infections that were uncommon at the
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time of the study may also not have been picked up due to the limited number of
cases described.
5.5.2 Enrolmentand un-enrolled patients
The level of refusal of consent for the study (1.3%) was extremely low, as was the
loss of enrolled children due to incomplete data (1.9%); both a reflection of the hard
work and diligence of the research team. However some criticism of the enrolment
procedures can be made. Due to staffing constraints, relating to funding and
providing a clinical service, we were unable to recruit patients 24 hours a days, 7
days a week. Consequently the selection of study children was incomplete, and only
67% of children admitted over the year were assessed for inclusion in the study. The
most scientifically robust response to the staffing constraints would have been to
randomly select days over which the study would recruit (randomly selecting patients
would have required staff being present at all times). Although this approach might
have been taken, I considered that it was important to have a degree of permanence
about the opening times of the assessment unit, to avoid confusion amongst hospital
staff. This allowed the unit to become a recognized element of hospital care, ensuring
that all children being admitted were sent directly to the assessment unit. Sampling
of 'out of hours' admissions was achieved by changing the enrollment times to
recruit children admitted over weekend for part of the study period. There is some
evidence that children admitted outside of working times have a poorer prognosis, 7
though there is no reason for such children to have a different spectrum of infections
to those admitted within working times. In this study mortality in children admitted
out of study hours (187/2136, 8.8; 95% CI 7.6 - 10.0%) was significantly higher than
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that of those admitted within study hours (259/4334, 6.0%; 95% CI 5.3 - 6.7%) (Fig
5).
However it is important to mention several issues regarding the out of study hours
data. Children admitted into the study had accurate tracking of their progress and
discharge (or death). However the data was reliant on standard hospital records for
the outcomes of children not admitted into the study. These records were very poor.
The 39 children who died with 'incomplete screening data' are an example of this
(Fig 5). These children were recorded in the hospital records as being admitted
during hospital hours, yet there was no record of them having been seen by study
staff. It seems unlikely that children admitted severely ill would have bypassed what
had become the hospitals resuscitation service (though it is possible that these
children were already dead on arrival at the hospital). The quality of the out of hours
data could have been improved by a closer monitoring of the hospital data during the
study period. There was an attempt to establish which of the 'out of hours'
admissions would have been eligible for admission and to collect improve data on
them. This was dependent on hospital staff (as opposed to research staff) filling out
forms on all out of study hours admissions and was poorly taken up and
consequently abandoned. The quality of routine hospital data was improved towards
the end of the study as part of other ongoing attempts to improve paediatric care in
the region.
Another group of children worthy of consideration are children that may have had
infection but presented without fever or history of fever. Although it is usual for both
bacterial disease and malaria to present with fever certain groups of children,
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particularly those with malnutrition, may present without fever despite severe and
life threatening infection. These children may not have met the inclusion criteria and
thus our study may not represent a complete picture of the role of infection or
malnutrition in inpatient mortality.
5.5.3 The aetiology of infections
The study was limited by cost and scope to a single blood culture taken at admission.
More intensive investigation using multiple blood cultures, mycobacterial culture,
urine and sputum culture and systematic radiological examination could have
improved the sensitivity of study investigations to detect invasive bacterial disease as
discussed previously. Acute and convalescent serology samples were taken from
children with severe febrile disease, but these have not yet been analysed for cost
reasons. Clearly autopsy data, if complete, would have been the gold standard test for
the aetiology of terminal cases. This was not available.
5.5.4 Predicting invasive bacterial disease
The improved sensitivity in algorithms for the detection of children with invasive
bacterial disease obtained by making hypothetical changes to the antibiotic
prescribing guidelines were tested on the same group of patients that they were
developed in. This is flawed and a preferable approach would be to apply the revised
guidelines suggested (treating all children with severe malaria and all children with
negative slides but severe anaemia or prostration with antibiotics) to a new cohort of
children (for example the subsequent years hospital admissions) and seeing how they
performed. Unfortunately other commitments prevented me from collecting this data
and analyzing it.
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5.5.5 Medical management of study children
Common sense, and some data, suggest that outcomes of paediatric admissions are
improved by ensuring guidelines are followed.228 As cited above the mortality of
children admitted during study hours was significantly lower than that for children
admitted when the study was not running. This may be in part due to improved early
management. It is impossible to say what interventions by study staff were
responsible and how they affected the course of different infections. I strongly
suspect that the study children received more aggressive fluid resuscitation and
antibiotic therapy than children admitted outside of the study. This may have
disproportionately lessened the impact of invasive bacterial disease.
Additionally, as a result of the study, there were considerable improvements in the
provision of supplies, from oxygen through to antibiotics and anticonvulsants. As
part of running the assessment unit stocks of oxygen essential drugs and other
important consumables were always checked and replaced through a system
independent of the hospital supply chain. Again common sense and some evidence
suggest that ensuring supplies of essentials, such as oxygen for the treatment of
pneumonia,229 improves outcomes. Consequently diseases associated with hypoxia,
such as pneumonia, bronchiolitis and Pneumocystis may have had an improvement
in their outcomes due to this greater availability of oxygen, potentially downplaying
their importance as a cause of death and enhancing that of other illnesses where
hypoxia is less commonly a feature (such as malaria). My feeling is that such an
effect would have been small.
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It should be emphasised that none of the treatments or management provided to study
children were outside of what could, and indeed should, be available to children
admitted to any district hospital in East Africa.
5.6 The impact of ethical considerations
The aim of this section is to draw attention to certain areas of study design and
practice that were strongly influenced by perceived ethical considerations (largely by
the author). However this section is not intended to be a review of the ethical
considerations of research in the developing world. Ensuring that research involving
patients is of the highest possible quality is an essential component in maintaining
high ethical standards, yet I found that in several areas what I felt was our duty as
clinicians to ensure the best possible care for patients conflicted with the research
agenda to collect valid and complete research data.
5.6.1 The acute assessment unit & research staff roles.
At conception of the study it was planned that the research staff would examine
children and obtain research samples, but not contribute to the care of children other
than by providing results to the hospital clinicians. In the intervening time between
initial study design and study start-up there had been a sustained drop in hospital
staff numbers, probably as a result of uncompetitive wages, expansion of the state
healthcare system (drawing staff away from Mission Hospitals) and dissatisfaction
with hospital management. This had adversely affected the clinical care provided.
Children were not adequately assessed in outpatients and there were not the staff to
assess children again on admission. It was not uncommon to find children in septic
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shock, suffering from hypoglycaemic coma or with clear meningitis without an
appropriate management plan. This situation was not unique to this hospital, and
indeed may be the norm throughout the region.31 Although all new admissions were
reviewed by the on call physician in an evening round, this left many children
waiting, severely ill, for up to 12 hours. With upwards of 50 children to review on
occasion, and other duties in the hospital, the on call physician would struggle.
The Declaration of Helsinki suggests that in interventional studies even the control
arm should be given "the best universal standard of care",230 this has been interpreted
by some to mean that the best care available anywhere in the world for that condition
must be provided.231 Others have argued that this is unreasonable and potentially
harmful given that the 'best universal standard' for many severe illnesses that afflict
those in the developing world would involve supportive treatments (intubation,
• • • 232 233
ventilation renal and cardiovascular support for example) that is not available.
However the ethical requirements of an observational study in this situation are not
clear, though the General Medical Council of Great Britain advises that doctors
involved in clinical research should have the patient's priorities uppermost in their
considerations.234
In view of the above I changed the study protocol such that all admissions should
come to one ward for assessment, resuscitation and initial doses of treatments. These
duties would be primarily performed by the research staff recruited and trained
specifically for the study. Hospital staff would be encouraged to come to the ward for
education and skills training. An Acute Assessment Unit (AAU) was constructed at
the entrance to one of the wards, next to the paediatric high dependency unit (a room
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with provision of oxygen via oxygen concentrators). This unit was fitted with extra
equipment to provide urgent resuscitation to severely unwell children (short of
intubation and ventilation). Staff were trained by myself and colleagues in paediatric
resuscitation in addition to data collecting and consent procedures. A triage system
according to WHO emergency triage and assessment guidelines (ETAT) was
established at the outpatients department. Staff there gave red or orange cards to
children who had emergency or priority signs (Appendix 3). Children were
encouraged to go to the AAU urgently and present the cards. Sick children were thus
readily identified by the research staff and prioritized for resuscitation, consent and
ongoing management.
These changes did result in a more comfortable and calm space for the standardised
examinations than would otherwise have been possible but the changes in hospital
care may have had an impact on mortality and even risk factors for death as
considered above. In addition the increased workload, due to involvement of research
staff in the resuscitation and treatment of children, resulted in more staff being
needed on each shift. This limited the ability to recruit children as described below.
5.6.2 Enrolment hours
As discussed above, to avoid any possibility of bias, it would be desirable to screen
every child that was admitted and enroll children around the clock, seven days per
week. However as a direct consequence of providing sufficient staff to resuscitate
and treat children, whilst collecting data, we were unable to collect data over the full
week, 24 hours a day. Faced with this an ideal alternative would be to select days
that the unit would be operating at random and work for 24 hours on those days. I
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considered this option but rejected it as I considered that both the hospital and
research staff would have difficulty coping with such a provision of service. A
compromise solution that involved splitting the study enrollment days such that for 5
months children were recruited at weekends was instituted to enable some
representation of children admitted outside of working hours.
5.6.3 TREA TMENT DECISIONS
As a result of the new admissions process, research staff became involved in making
treatment and management decisions concerning children. National and international
guidelines on treatment of severe malaria do not mandate the use of broad spectrum
antibiotics in children with severe malaria. Hospital policy on my arrival did not
stipulate this either, nor were antibiotics commonly prescribed for that syndrome.
Data from a nearby research centre in Kenya suggested that there were significant
rates of bacteraemia in children with severe malaria and a significant mortality
associated with bacterial co-infection.117 These data had informed their policy which
was to give broad spectrum antibiotics to all young children with severe malaria. 1
decided that we should adopt a similar policy for the children being treated in the
Assessment Unit, as to do otherwise would not be providing the best available care
that was known to me at the time. Clearly this may have resulted in this study
underestimating the real mortality risk of bacterial disease in these children as they
will have been given early antibiotics that children in other units would not. Data
from these studies must be interpreted in this context.
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5.6.4 Exclusions & non-consenting children
Setting up a resuscitation service as part of the study creates some issues concerning
those that refuse consent or are considered ineligible. It is clear that all children
should be entitled to the resuscitation facilities that were available as a result of the
study and did not discriminate between those consenting and those preferring not to
be involved. This also increased the workload for the research staff, but thankfully
the low rate of refusal of consent meant this was not a major problem.
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6 Conclusions
This series of studies have shown that a large part of the burden of infectious disease
in East Africa is due to invasive bacterial disease, in addition to falciparum malaria
and that current guidelines do not adequately predict, nor adequately treat invasive
bacterial disease. These data are supported by published studies from several centers.
The key bacterial organisms involved are Gram negative organisms, in particular
non-typhi Salmonellae and Haemophilus influenzae b, and also Strep, pneumoniae.
(Table 1 and this study)
There are two important ramifications of this. Firstly, given that effective vaccines
are available against Haemophilus influenzae b and Strep, pneumoniae it is
imperative that these are deployed rapidly.138 235"243 Data from this study was
presented to the Tanzanian Ministry for Health in 2007 and undoubtedly had a role in
the decision to adopt Hib vaccination into the EPI programme for Tanzania.244
Secondly current guidelines for treatment of febrile disease in children62161 advise
the use of inadequate antibiotics in many situations. Penicillin - considered the
antibiotic of choice in severe pneumonia - has no activity against most Gram
negative organisms.245 Additionally non-typhi Salmonellae are often resistant to
commonly available antibiotics such as ampicillin, chloramphenicol and
cotrimoxazole.124 127139246-247 [t has been suggested that there should be greater use
of third generation cephalosporins, such as ceftriaxone, in severely ill children in this
setting,139 The optimum antibiotic choice must take into account local sensitivities,
cost and potential effect on resistance. Clearly there is a need to expand the network
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for bacterial surveillance across Africa to cater for this need. It is unlikely that there
would be a dramatic effect on resistance from the use of a third generation
cephalosporin in a select group of children with severe febrile disease however such
a change in policy should ideally be supported by randomized control trial evidence
and enhanced surveillance.
These studies have shown that current guidelines on the criteria for antibiotic use in
children with febrile disease are insufficiently sensitive at identifying invasive
bacterial disease in areas of high malaria transmission. These data would suggest that
all children under 5 years of age with severe malaria should receive broad spectrum
antibiotics. In addition children with severe anaemia or prostration without malaria
should also be treated with broad spectrum antibiotics. Ideally these revised criteria
should be prospectively evaluated in other high transmission settings.
Clinical examination, in this research setting, was adequate at predicting poor
outcome. However abnormalities in bedside laboratory tests for oxygen saturation,
blood haemoglobin, lactate and glucose were all significantly associated with death
and improved the sensitivity for the prediction of death in children admitted with
febrile disease. Further work to explore the use of these tests in other resource poor
settings is indicated.
158
Appendix 1 - Consent, eligibility & case record
forms
(Actual eligibility forms and case record forms were in a format for scanning, precise
layout therefore differed from these reproductions).
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Consent form - Swahili version
Watafiti STUDY IDNO: | | | | | |
Utafiti htm unafanywa chini ya Daktari Rajabu Malahiyo wa Hospitali ya Teule,
Prof. Raimos Olomi wa Kilimanjaro Christian Medical College (KCMC) na Daktari
Hugh reybum wa London School of Hygiene and Tropical Medicine kama sehemu
ya Joint Malaria Programme hapa Tanzania.
Sababu ya utafiti
Thumuni ya kufanya utafiti huu ni kufahamu mengi kuhusu magonjwa ambayo
yanatokea mara kwa mara katika eneo hili na kutafuta sababu zinazowafanya
wagonjwa wengine kuugua magonjwa makali na wakati wengine hawaugui. Taarifa
hii itasaidia kuwatibu watoto walio na magonjwa makali hapo baadaye.
Utaratibu wa utafiti
Kama utakubali kushiriki kwenye utafiti huu utaulizwa maswali kadhaa kuhusu
ugonjwa ambao mwanao anaugua hivi sasa. Mwanao atafanyiwa uchunguzi na
sampuli ya damu itachukuliwa (kiasi kisichozidi kijiko kimoja na nusu cha chai).
Damu hiyo itatumwa kwenye uchunguzi wa kuotesha ili kuchunguza maambukizi ya
vijimea, damu ya malaria, kiasi cha damu, kipimo cha sukari na acidi kwenye damu,
na vipimo vya kinga kwenye magonjwa ya maambukizi. Kipimo cha mkojo
kinaweza kuchukuliwa kama dalili za maambukizi. Majibu haya yatapewa daktari
arnbaye anakuhudumia wakati tu zitakapokuwa tayari. Pia, timu ya wauguzi wa
hospitali wanaweza kupendekeza kama wewe na mwanao mnahitaji kupigwa picha
ya kifua au kutolewa maji ya uti wa mgongo; kama itakuwa hivyo, tungependa
kunakili/recodi majibu ya matokeo.
Kama sehemu ya utafiti huu tungependa kukupatia inawaidha kabla ya kufanyiwa
uchunguzi halafu tumpime mwanao kama ana virusi vya ukiinwi. Hii
inapendekezwa kama desturi ya huduina Hospitali ya Teule; majibu yatapewa daktari
anayemhudumia mwanao kwa njia ya siri. Kama itahitajika, mawaidha ya namna
mbalimbali, vipimo vya maaabara na matibabu ya virusi vya ukimwi yanapatikana
sasa bure katika hospital hii.
Kiwango kidogo cha damu ambayo imechukuliwa itahifadhiwa kwa vipimo vya
baadaye ili kuchunguza maambukizi mengine na hatari ya magonjwa ya
maambukizi; baadhi ya hivi vipimo vitafanyiwa maabara nje ya Tanzania. Majibu
hayatapatikana kwa muda ufaao ili kuchangia kwenye huduma ya mwanao na kwa
hiyo hautapewa majibu hayo.
Huenda tukamwangalia mwanao hapa Hospitali ya Teule mwezi mmoja baada ya
yeye kuruhusiwa kutoka hospitali hii ili kuona kama amepona vizuri, na
kumwangalia kama ana upungufu wa damu na pia kuchukua damu takriban kijiko
kimoja cha chai ili kuangalia kinga yake kwenye maambukizi.
Hatari na faida
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Consent form - Swahili version
Kuchukua kipimo cha damu kinaweza kusababisha kidonda au maumivu lakini
madhhara mengine huenda yasitokee na tutatoa matibabu kama itahitajika. Kama
taarifa ya siri ya mwanao itagundulika, haya yanaweza kuleta majonzi lakini taarifa
yote itakayokusanywa kwenye utafiti huu yatawekwa kwa siri na kwa njia dhabiti.
Uchunguzi wote ambao utafanywa kwa watoto kwenye utafiti huu utakuwa bure
lakini huduma ya matibabu na uangalizi utalipiwa kwa njia ya kawaida. Matokeo ya
uchunguzi ama taarifa nyingine ambayo tumekusanya hayatashirikishwa na mtu
yeyote isipokuwa wahudumu wa hospitali wanaomuuguza mwanao na timu ya
watafiti. Faili za compyuta zitapewa namba ya siri na faili za karatasi zitafungiwa na
kuhifadhiwa kwa usalama na wafanyakazi wanaoruhusiwa tu ndio watakao kuwa na
idhini ya kuziangalia.
Uhuru wa kukataa au kijiondoa
Kama utaamua kutoshiriki kwenye utafiti huu vipimo hivi vitapatikana kama
utaomba timu ya wauguzi na matibabu yako hayataadhirika kwa njia yeyote. Uko
huru kukataa kushiriki kwenye utafiti huu au anaweza kuondoa idhini yako wakati
wowote, bila kutoa sababu, na hii haitaadhiri matibabu na huduma ambayo utapatiwa
Karatasi ya taarifa " Utafiti wa sababu za homa kali" nimesomewa/nimesoma na
nimeelewa karatasi ya taarifa. Nimejibiwa maswali kuhusu utafiti huu na
mfanyakazi wa utafiti.
Ninakubali mwanangu ashirikishwe kwenye utafiti huu
Jina la Mzazi
Jina la Mtoto




Nimemsomea/namemuelezea mzazi aliyetajwa hapa chini kuhusu utafiti huu kwa
kutumia lugha ambayo anaelewa na ameelewa taarifa hii na anaruhusu kiwango
kidogo cha damu kutolewa kwa hisani yake mwenyewe.
Jina la mtafiti msaidizi
Sahihi ya mtafiti msaidizi Tarehe / /20
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Consent form - English version
This study is being conducted under Dr Rajabu Malahiyo of Teuie Hospital, Prof.
Raimos Olomi of Kilimanjaro Christian Medical College (KCMC) and Dr Hugh
Reyburn of the London School of Hygiene and Tropical Medicine as part of the Joint
Malaria Programme in Tanzania.
The reason for doing the study is to find out more about what diseases are common
in this area and to find the reasons that some children suffer from severe illness while
others do not. This information will help to treat children will severe illness in the
future.
If you agree to take part you will be asked some questions about your social situation
and your child's current illness. Your child will then be examined and a venous
blood sample will be taken (about one tea-spoon). Blood will be sent for culture (to
test for bacterial infection), a blood slide for malaria, a full blood count, and testing
for sugar and acid in the blood. These results will be given to the doctors looking
after your child as soon as they are available. In addition the medical team looking
after your child may recommend that your child needs a chest x-ray or lumbar
puncture; if so we would like to record the result.
As part of this study we would like to provide you with pre-test counselling and then
to test your child for HIV. This is now recommended as part of routine care in Teule
hospital; the result will allow better treatment of your child both now and during
his/her recovery. If needed HIV treatment is now available free in Teule Hospital.
Some blood will be stored for future tests to look for other infections and risk factors
for illness in children, including genetic (DNA) studies; some of these tests will be
done in laboratories outside Tanzania. These results will not be available in time to
contribute to the care of your child so will not be given back to you.
All the investigations done for children in the study will be free but hospital care and
treatments will be paid for in the usual way. Results of investigations or other
information that we collect will not be shared with anyone other than the medical
staff looking after your child and authorised members of the research team.
We would like to check your child 1 month after their discharge from hospital to see
if they have made a good recovery, to check them for anaemia and to take
For further information or if you have any complaint relating to your involvement in
this study you may contact:
Dr Andrew Kitua, Director, National Institute for Medical Research,
Ocean Road, Dar es Salaam.
Consent form - Swahili version
approximately 1 teaspoon of blood for evidence of your child's immune response to
infection.
If you decide not to allow your child to be included in the study the same tests will
be available on the request of the medical team and your treatment will not be
affected in any way. You are free to withdraw your consent at any time, without
giving reasons and this will not affect the care and treatment that is provided.
The purpose of this study and its procedures and risks and benefits have been
explained to me by
I agree for my child to participate in this study
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Eligibility form
Child's first name Child's last name
Hospita number Subject ID
Date of admission / / Reported age (yr/mm) /
Sex O Male O Female
1.0 SCREENING QUESTIONS FOR EL1GIBITY
1.1 Has this child had a fever in the last 48 hours or does the child have an axillary
temperature of >37.5 °C or a rectal temperature of >38 °C ?
No Do not collect this patient's data
Yes
1.2 Is the patient aged between 2 months and 13 years?
]vj0 Do not collect this patient's data
Yes
1.3 Was the patient admitted with known malignancy, renal failure, hepatic failure,
marrow aplasia, congenital abnormality, or for trauma or surgery?
yes Do not collect this patient's data
No
1.4 Is the child part of the MOMS cohort study?
Yes Do not collect this patient's data
No
The child is eligible to participate in the SFI study. If he or she is willing to provide assent
and her or his parent/guardian/legal representative is willing to provide consent, please
document consent according to the study SOP and proceed. Keep the screening form for all
subjects consented. Record aM subjects screened for the study in the screening log book.
164






Date of admission / /
Date of study recruitment
Time of study recruitment
Date of birth / /
Or (if month or year missing from DOB)
Reported age (yr/mm) /
Village name
Time of admission (24hr clock)
village code (JMP village list)
Sex (choose only one) O Male O Female
O Pare O MsambaraTribe- Mother O Chagga
Other (spec)
Tribe- Father O Chagga
Other(spec)
Mother education level O None
Higher




O standard 7 O
Referred from Mawenzi O Yes O
3.0 MEDICAL HISTORY
Referred from other inpatient facility O Yes O No
No
Number of days days
ill
Diarrhoea 3 or more times in the last 24hrs O Yes O No
Fever in last 48hrs O Yes O No Diarrhoea lasting more than 14day O Yes O No
Fever lasting more than 7 days OYesONo Diarrhoea with blood O Yes O No
Cough O Yes O No Vomit 3 or more times in the last 24hrs O Yes O No
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Case Record Form (CRF)
Breathing difficulty O Yes O No
Convulsion in the last 48hrs O Yes O No
General
Convulsion in the last lhr O Yes O No
ONo
Vomit everything O Yes O No
Type of convulsion O Focal O
Anticonvulsant in the last 6hrs O Yes
Number of convulsions last 24hrs
Medications
Oral antimalarial in last 48 hrs O Yes O No Antibiotic in last 48 hrs O Yes O No
Parenteral antimalarial in the last 48 hrs O Yes O No If So: O Amoxcillin O Cotrimox
O Other
(Spec)
Birth weight • □ K-gs
Severe congenital abnormality (inc. ss) O Yes O No Known Chronic renal or liver
disease O Yes O No
Specify congenital abnormality
Specify other relevant
Information (inc. known HIV status
code congenital abnormality
code other relevant information
4.0 PHYSICAL EXAMINATION
Weight of child | | |.| |
I I l-l I Kg
Kg OR Weight of child + adult
Kg
Weight of adult alone | |_
Rectal temperature
MUAC | | |.|_
Severe pallor
OR Axillary temperature °C
cm
O Yes O No
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Case Record Form (CRF)
Lymphadenopathy: >lcm in >2 areas O Yes O No
Pitting oedema of both feet O Yes O No
Visible severe wasting OYesONo Jaundice
No
Oral candidiasis O Yes O No
Temp, different between hand and chest? O Yes O No
Skin pinch > 2secs OYesONo Sunken eyes
No









Low chest in-drawing OYes ONo







Sustained nasal flaring O Yes O No





Liver cm below costal margin Spleen
Able to sit if>9months (observed) O Yes O No
Able to breastfeed or drink OYes ONo




cm below costal margin
Stiff neck O Yes O No
O Directed O Not Directed
Verbal: O Normal O Abnormal O None
Motor: O Location O No location O None
Indication to repeat Blantyre O Yes O No
(Blantyre score < 5 and: Blood sugar < 2.5 mmol/L or conv<lhr or anticonv<6hr)
Repeat Blantyre score Eyes: O Directed O Not Directed
Verbal: O Normal O Abnormal ONone
Motor: O Location O No location O None




. | | mmol/L Admission Hb
Paracheck: O Positive O Negative
• □ g/dL
O Unsure
Paracheck Control line O Present O Not present
5.0 ADMISSION SUMMARY
Admission diagnosis code 1
Admission diagnosis code 2









Did the patient die during admission? O Yes O No
Date of discharge or death
Time of death (24hr clock)
Treatment during admission
Quinine O Convulsion after admission O Yes O No
Any anticonvulsant during admission O Yes O No
Glucose given for hypoglycaemia O Yes O No
If so, did glucose resolve coma OYes ONo







O Blood transfusion Code other
O Other Specify other
Record additional information (i.e. not already on the form), including results of ultrasound or
Xray performed after admission and give details if it was not possible to measure Blantyre. It is
not necessary to give results of lab tests.
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Appendix 2 - Clinical Standard Operating
Procedures (SOPs)
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SFI STUDY, TEULE HOSPITAL
Standard Operating Procedure for study eligibility and consent.
Pre-eligibility procedure: registration on arrival for admission.
Pre-registration and recruitment times
Patients are seen in the MCH clinic where admission decisions are made. Children
waiting to be seen are triaged according to IMC1 guidelines and those with priority or
danger signs will be given essential treatment, where required and available, and then
sent to the ward with either a yellow (priority) or red (danger) card indicating the
need for prompt attention on arrival at the ward.
Patients will be identified on arrival to the registration at the entrance to Hills ward
during study recruitment times.
These times are: 8am to 6pm Monday to Friday inclusive.
During certain months these times will be 8am-6pm Thursday to Monday inclusive.
At other times patients will be dealt with in the usual way by Teule Hospital staff.
MCH and Outpatient staff will be kept aware as to the recruiting times of the study
by verbal instruction and posted rostas.
The following SOP refers to the procedure to be followed during study recruitment
times and does not apply to admissions outside these times.
Secondary triage
Patients arriving will be identified by the SFI research assistant. If they have a red
('danger sign') card, medical staff will be alerted immediately to assess the need for
immediate treatment. Once this is provided, study recruitment can be followed.
Registration
All patients presenting for admission will be recorded in the study register. Details to
be recorded are the name, age, date and time. This record constitutes the 'Eligibility
log' for the study and also provides registration details for routine Teule hospital use.
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SFI STUDY, TEULE HOSPITAL
Standard Operating Procedure for study eligibility and consent.
Eligibility
Following registration of all new patients the Eligibility Form will be completed.
This includes
A pre-printed study IDN, Name, age, and date.
A reported history of fever within the previous 48 hours
> Answer Yes = eligible
The child is aged between 2 months and 13 years (i.e. including children who are
exactly 2months or 13 years of age).
> Answer Yes = eligible
Absence of a known diagnosis of severe chronic or severe congenital disease. If there
is any doubt about whether a reported condition qualifies in this category the patient
should be judged eligible and details of the condition will later be recorded on the
CRF. Sickle cell and known HIV positive patients ARE eligible. The details of there
disease (CD4 count etc) will be noted on the CRF after consent.
> Answer No = eligible
Prior recruitment into the MOMS cohort study, either as reported by the
parent/guardian or through inspection of a MOMS study ID card. Enrolment in the
Diana Centre for HIV care does NOT constitute a barrier to eligibility, however
treatment from the Diana Centre for malignancy (Burkitts, lymphoma etc) is an
exclusion (under the question above).
> Answer No = eligible
In order to be eligible for the study the parent must have given the 'eligible' response
to ALL questions.
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Standard Operating Procedure for study eligibility and consent.
Children who are not eligible.
Children will have their heights/lengths determined by measuring against a cm scale
either standing or lying, with feet flat to the foot-stop and head looking straight
ahead. They will be weighed on specified scales situated in the admission area; the
child with minimal clothing will be lifted by the caretaker and weight calculated by
subtracting the holders own weight. Older children who are able to stand may be
weighed on their own. The scales shall be calibrated daily against a standard weight.
The child and parent/guardian should then be conducted to the ward nursing station.
The eligibility form should be placed in the appropriate box file in the data-entry area
of the ward.
Children who are not eligible but require emergency resuscitation should still be
managed by the admission team.
Children who are eligible.
A study CRF should be part-completed to include the date and time, the child's name
and age, and the child's weight and height (or length). The study 1DN on the
eligibility form should be transcribed onto all pages of the CRF, the severe disease
checklist (along with the patient's name), and onto the consent form.
Children's heights/lengths and weights will be recorded as described above onto the
CRF.
The village name and code should be established and entered.
The consent form should be part-completed to include the name of the mother or
guardian and the date.
Eligible patients will be asked to wait and the forms for study recruitment placed in
the 'Awaiting consent slot' for study consenting and completion of the CRF in the
assessment area of the ward.
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Standard Operating Procedure for study eligibility and consent.
The forms to be place in the 'Awaiting consent slot' consist of:
> The completed Eligibility form
> The consent form with name of parent/guardian, date and study IDN
> The SFI CRF with name of the child, age or d.o.b. of the child, the height and
weight of the child and village name and code.
> The severe disease checklist with name and study No.
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Standard Operating Procedure for study eligibility and consent.
Informed consent procedure
The consent form is to be completed by staff who have undergone training in
medical ethics as applied to children and who are have also undergone training in
'Voluntary Counselling and Testing' for HIV.
Consenting should take place in a pre-defined area that is screened for privacy. If the
child is over 12 years of age and conscious he/she must accompany the
parent/guardian. If not, the presence of the child is optional.
The consent form should be shown and given to the parent/guardian who should be
asked if they would prefer to read it themselves or have it read to them. As much
time as the parent/guardian requires should then be allowed for this to happen. The
parent/guardian should then be asked if they have understood the content of the form
and if they have any additional questions, and these should then be answered. The
parent/guardian should then be offered additional time to discuss with any other adult
of their choice (spouse, friend etc).
If the child is aged 12 years or more the content of the consent form should be
explained to them and they should be given the opportunity to ask questions. They
should then be asked if they assent to be included in the study. If they do not assent
they should not be included.
If the parent/guardian is willing to provide consent the consent form should be signed
first by the research assistant and then by the parent/guardian. Where the
parent/guardian is unable to provide a signature they may provide a thumb-print.
Following informed consent the CRF should be filled; CRF SOP
The Consent form, completed eligibility form and CRF should be stored in the
relevant box fde in the data area after inputing of the CRF by the Data Entry
staff.
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The completion of the admission form will be undertaken when 5 preconditions are
met:
1. That the child has been assessed for his/her need for emergency treatment
according to hospital guidelines for ETAT and that, if needed, such treatment
has been provided.
2. That the parent or guardian has provided verbal consent to provide
information to determine eligibility for the study.
3. That the child is eligible for inclusion in the study.
4. That the parent or guardian has undergone consenting procedures and has
provided written consent to participate.
5. That the completion of the form will not compromise the provision of
essential treatment or the completion of routine hospital procedures.






5. Black fine-tipped roller-ball pen
6. Digital axillary thermometer..
7. Oxygen saturation meter
8. Automated (electronic) sphygmomanometer
9. Stethoscope
10. Measuring tape marked in centimetres
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The following notes specify definitions or give a brief explanation of each question
in the form. If it is not possible to fill a question in, it should be left blank and an
attempt should be made later to fill in that category. If it is not possible at a later
stage the reason should be written in the free text box and '99' should be inserted if
the question has a number box or the circle should be left blank for yes/no questions.
Where a correction is made the correct answer must be written clearly in pen,
the entry initialled and dated.
Q No. PATIENT IDENTIFICATION
Name The patients name will conform to the name given for hospital
admission.
Study Id This will run sequentially from 0001. The IDN should have been




This will be transcribed from the hospital case file.
1 Date admitted in European format (dd/mm/yyyy)
2 Time admitted will be according to the 24 hour clock (not Swahili
time), East African local time. There will be a wall mounted clock in
the ward.
3 Date of recruitment will be recorded to detect delays between
admission and recruitment.
4 Time of recruitment will be recorded for the same reason.
5 Date of birth will be asked for all subjects. If only month or year are
available these will recorded with date or month left blank.
6 If either month or year of birth is unknown, the age in years and
months reported by the caretaker will be recorded.
7 The caretaker will be asked their village of normal residence. This
will be checked against a list of villages that conform to the
Tanzanian National Census 2003, most of which have been geo-
positioned.
8 Unique codes will be filled from a list that conforms to the Tanzanian
Census 2003 that will be kept in the admission area.
9 Sex will be asked, not assumed
10 The caretaker will be asked the tribe of the child's mother. Tribe can
be confirmed by language group if there is doubt.
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11 The caretaker will be asked the tribe of the child's father
12 SOCIO-ECONOMIC INDICATORS
13 The Child's mother's education level is asked of the caretaker defined
as completion and certification of Standard 7.
MEDICAL HISTORY
14 Referral from any other health facility will be noted.
15 The caretaker's estimate of the number of days ill will be noted; the
response of the caretaker will be accepted but the interviewer will ask
if this was the same illness and there had not been recovery during the
reported time.
16 Diarrhoea is defined as loose or watery stools at least 3 times per day
17 Fever in the last 48 hours; the caretaker response will be accepted as
long as the child felt hot (i.e. the potential confusion in Kiswahili that
'homa' can mean fever and illness will be clarified at the time of data
collection).
18 Diarrhoea for 14 days is defined as diarrhoea that has been present on
every day for the last 14 days.Fever for more than 7 days is defined as
a palpable fever for some part of every day for the last 7 days.
19 Fever for more than 7 days is defined as a palpable fever for some
part of every day for the last 7 days .
20 Diarrhoea with blood in stool will be asked
21 Presence of coughing in the last 48 hours will include a cough
sufficient to concern the caretaker but exclude an occasional or
unsustained cough
22 Vomiting 3 or more times in the last 24 hours will be taken as a guide
for potential dehydration and electrolyte imbalance
23 Breathing difficulty includes any breathing problem sufficient to
concern the caretaker
24 'Vomiting everything' is defined as vomiting within 30 minutes of
any feed (solid food or fluid) over the last 24 hours. This is a general
danger sign in IMCI
25 A convulsion in the study is defined as abnormal movements with
altered consciousness. Research assistants will ask the respondent to
mimic the abnormal movement.
The WHO training video defines categories of convulsion.
26 Evidence of focal convulsions (a potential indication for lumbar
puncture) will be sought as above, i.e. whether all limbs were
involved from the description of the respondent. This question should
be left blank if there is no history of convulsions.
27 A convulsion less than 1 hour prior to the interview.
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28 Anticonvulsant medication within the last 6 hours will be used to
exclude a post-ictal state or medication as a cause of altered
consciousness and thus the Blantyre Coma Scale (BCS). If either of
these is positive the examination for coma will be repeated after one
hour if the BCS is <5 (<4 if age <9Mo). If BC=5 (or 4 if age <9 Mo)
it will not be repeated.
29 The number of convulsions as described above, in the last 24 hours
will be recorded. If the response to question 24 was no then this
question can be left blank. If the answer was yes but there have been
no convulsions in the last 24hrs then this question should be fdled
'00'.
29, 30 Reported use of medication in the previous 48 hours. If the answer to
question 29 is no then questions 30-34 can be left blank.
Traditional and non-traditional medicines will be accepted as 'yes'
and oral rehydration solution (ORS); these should be specified under
'other'
31 Reported use of antimalarial therapy will be used as a possible
explanation for malaria with a negative blood slide for malaria
parasites. The name of the antimalarial will not be recorded.
32 Reported use of antimicrobial therapy will be used as a possible risk
factor for negative blood culture results. The name of the antibiotic
will be recorded in Q 43.
33 The use of parenteral (injection) antimalarial within the last 48hrs will
be noted here.
34 The name of antibiotic will be recorded here. The question should be
left blank if no antibiotic has been taken.
35. Reported birth weight will be recorded in Kg. The birth weight will
be checked against the child health card if available and this source
preferred to the caretaker report. If it is not known this question
should be marked 'X' in all 3 boxes.
36 The presence of a severe congenital abnormality as reported by the
caretaker will be recorded as a check against inclusion of children
with severe birth defects. Wherever possible this report will be
validated by reference to the medical notes. Birth defects associated
with poor childhood survival (egg. cardiac or neurological defects,
biliary atresia, sickle cell disease) will be included in severe
congenital abnormality. Congenital defects not associated with poor
childhood survival will be eligible for the study, (egg. Most
dermatological disorders, squint etc). If research assistants are in
doubt, children with congenital defects will be included and the
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details of the defect noted.
37 The presence of chronic disease such as malignancy or marrow
aplasia will be excluded from the study. If in doubt these children will
be included and a note made of the specific disease. Children with
known HIV-AIDS will be included.
38 The details of any reported congenital or chronic illness will be
recorded and later verified by reference to the case notes.
39 Any additional details available at the time of interview about the
current illness or pre-existing conditions likely to affect the outcome
will be noted. Known HIV disease should be noted here.
EXAMINATION
40 Children's weights will be recorded on a scale situated in a fixed
position on concrete flooring in the ward. The child with minimal
clothing will be lifted by the research assistant or caretaker and
weight calculated by subtraction of the holder's own weight. Scales
will be checked for calibration using a standard weight daily.
Alternatively the child may be weighed on it's own (for older
children)
41 Height/length will be measured by placing the child against the
measuring board with feet flat to the base, heels against the back
board and knees straight. The length from the base to the top of the
child's head in cm while looking forward will be recorded.
42 Axillary temperature will be measured in degrees centigrade with a
digital thermometer, leaving the bulb in the axilla for 2 bleep cycles.
43 Mid-upper arm circumference. The circumference in cm around the
mid-point of the child's left arm will be measured using a soft
measuring tape pulled tight to the arm.
44 Pallor is noted by examination of the conjunctiva and palms. Only
severe pallor need be noted.
45 The neck (anterior and posterior), both axillae and groins should be
examined for adenopathy. Significantly enlarged lymph nodes in 3 or
more sites should be noted.
46 The dorsum of the feet should be examined for pitting oedema. A
finger should be pressed firmly on the surface of each foot for 3
seconds. If an imprint is made the swelling is defined as pitting
oedema. It must be present in both feet for this question to be marked
'yes', oedema in one foot should be marked 'no'.
47 The child should be inspected for severe wasting over the buttocks
and scapulae.
48 Whilst examining for pallor (q 44) the sclera should be examined for
179
SFI Study in Teule Hospital. SOP for completion of Case record form
signs ofjaundice (yellow discolouration).
49 The oral cavity will be examined for the presence of Candida (white
plaques
50 One of the forearms will be felt and its temperature compared to the
temperature felt on laying the hand flat on the chest wall. This is best
done with the back of the hand. Any palpable difference will be
recorded as a sign of reduced peripheral circulation
51 Hydration status will be assessed using the skin pinch test. A full
thickness of skin midway between the umbilicus and the side of the
body in the vertical plane (i.e. up and down the body) will be held
firmly and then released. A return to normal in 3 seconds or more
indicates significant dehydration.
52 A subjective assessent of the presence of sunken eyes will be made
and recorded.
53 Capillary refill is assessed by pressing the nail for 3 seconds to
blanche (make white) the area, when the pressure is released the time
taken until the area becomes pink is measured. If this is over 3
seconds the result is noted as 'yes'
54 Lethargy is defined as a child who does not take any interest in
his/her surroundings or does not respond normally to sound or
movement. It is an IMCI danger sign. A child who is not awake is
considered to show lethargy.
Respiratory function - This should be examined when the child is
calm and undisturbed. This will often be at the beginning of the
examination. A crying child, a child that has just been crying, or is
about to cry will not have a valid respiratory examination. If the child
is crying it can often be calmed by the mother breastfeeding but the
respiratory rate must be measured in a non-feeding child.
55 Intercostal indrawing will be assessed by inspection of the chest for
inward movement of the area between adjacent ribs.
56 Lower chest wall in-drawing will be assessed by inspection of the
chest for an inward movement of the lower chest wall on inspiration.
The WHO training video defines this.
57 Central cyanosis will be assessed by inspection of oral mucosa.
58 Deep breathing will be assessed by close observation of the child
lying flat. A subjective judgement will be made of abnormally deep
respiration, sometimes referred to as 'air hunger' or 'Kusmaul
respiration'. The WHO training video defines this.
59 The inspiratory sound of stridor will be listened for and recorded.
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60 Nasal flaring should be assessed by inspection whilst counting the
respiratory rate. It should be sustained throughout the minute.
61 The chest should be auscultated with a stethoscope to listen for
wheeze (an expiratory, musical noise).
62 Respiratory grunting can be heard with each breath at expiration.
63 The chest should be auscultated with a stethoscope for crepitations
(also known as crackles). The chest should be auscultated in 3 sites at
on each side of the back, 2 sites (including the apices) on each side of
the front of the chest and both axilla. Crackles in any of these
positions qualifies as 'yes'.
64 The respiratory rate will be measured by counting respirations at the
lower chest over the course of 1 minute in a non-feeding child at rest
and who is not crying.
65 The heart rate and blood pressure will be simultaneously measured
using an appropriately sized cuff and digital sphygmomanometer. The
heart rate should be inserted as displayed on the sphygmomanometer.
If this does not display a pulse it can be read from the nonin portable
meter (see q 66) or recorded manually from the femoral artery
n(counted over 30 seconds and multiplied by 2) in that order of
preference. If it is not possible to record a blood pressure after 2
attempts the field should be entered 'XXX/XX'
66 Oxygen saturation will be measured using a Nonin 9550 portable
meter placed over the finger tip, toe or ear lobe. The result will be
interpreted in conjunction with a palpable difference in temperature
between a hand and the chest. The appropriately sized attachment
should be left in place for at least 10 seconds. The reading should
include a pulse AND saturation, it should be repeated at another site if
one is missing. The result should be looked at carefully and in the
context of the clinical situation. If no good trace (signified by regular
rhythmic flashing of the LED with a saturation and pulse rate) can be
obtained the field should be marked XXX. The heart rate obtained
should be ignored unless the heart rate cannot be obtained from the
sphygmomanometer (see q 65).
67 The edge of the liver will be sought by moving the leading edge of
the hand progressively up from the abdomen to the right costal
margin. When the edge is felt it will be marked with a ball point pen
and the distance between this and the costal margin in the mid¬
clavicular line recorded in centimetres using the ruler/tape-measure.
68 The spleen will be palpated by moving the leading edge of the hand
from the umbilicus towards the left costal margin. When the edge of
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the spleen is felt its lowest tip will be marked with a ball point pen
mark on the skin and the distance between this mark and the nearest
point on the costal margin will be recorded in centimetres using the
ruler/tape-measure.
69 Ability to sit will be assessed in children aged 9 months or more by
supporting the child from behind to sit and then letting go while
keeping the hands close to catch a child unable to sit. Inability to sit
defines prostration in this age range. Children aged under 9 months
do not need this documented and it can be left blank.
70 Ability to drink will be assessed by the caretaker offering a drink or
the breast in the way that is usual for the child. The research assistant
should observe that the child actually drinks rather than just accepting
fluid or the nipple in his/her mouth. Inability to drink defines
prostration in a child <9 months old. In children older than 9
months this can be left blank.
71 The anterior fontanelle in children less than 1 year old will be
assessed by close inspection for evidence that the skin over the
fontanelle bulges forward compared to nearby skin over the bony
cranium. If the fontanelle is closed this should be left blank.
72 Neck stiffness will be assessed by cradling the head of a prone child
in one hand and gently flexing the neck. As the neck Ilexes reflex
stiffness (positive neck stiffness) prevents the chin touching the chest.
In some children it may be necessary to observe for neck stiffness. A
child that voluntarily flexes/extends its neck to look up/down does not
have a stiff neck.
CNS
Blantyre Score - much of this can be gathered from observing the
child during the preceding examination. For example a child that
grabs for the stethoscope as it is put on its chest is localising pain. A
child that tracks the examiner as he/she moves around them is
showing normal eye movements. The following descriptions are
given for children whose behaviour is not easily classified.
73 Eye movements will be assessed by holding the child's face at 12
inches from the interviewers face and observing if eye movements
follow movements of the face (directed) or not.
74 The verbal response will be assessed to be normal or abnormal by the
nature of the child's cry (subjectively judged to be high-pitched or
feeble) or, in a child over the age of 2 years, incoherent or moaning
speech. Absence of verbal response is coded as 0.
75 The response to pain will be assessed from the response to firm
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rubbing over the sternum with the knuckles. A normal (score 2)
response is to attempt to push the pressurising hand away, an
impaired response (score 1) is to flex any limb, lack of motor
response is scored 0. A child aged less than 9 months may not have
developed the ability to localise pain (i.e. a 'normal' score in this
group is 1 or 2.
76 The indications to repeat the Blantyre scale are shown on the form. If
a repeat is needed the CRF should be placed in the 'Repeat Blantyre '
tray and the timer set for 1 hour. The examination should be repeated
at that time.
77 If it is not possible to repeat the Blantyre score this should be noted
and the reason given in the 'additional comments' text box.
78 Blood glucose (Hemocue) will measured on admission on a
fingerprick or venous sample on all children. See bedside tests SOP
79 Haemoglobin (Hemocue) will measured on admission on a
fingerprick or venous sample on all children. See bedside tests SOP
80 Blood lactate will be measured on admission on a fingerprick or
venous sample in all children. See bedside tests SOP
81 Blood for HRP-2 (Paracheck) will measured on admission on a
fingerprick or venous sample on all children. See bedside tests SOP
82 Admission diagnoses based on the examination findings and bedside
tests will be entered.
83 Second admission diagnosis
84 Third admission diagnosis
85 The responsible staff for each form will record their initials clearly.
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Venepuncture will be undertaken as soon as possible after the study admission form
is completed. The child will have been weighed in filling the questionnaire and this
will be used to calculate the target volume of blood. (2ml/kg to a maximum of 8ml)
Hand washing
Before starting, the blood-taker will wash her/his hands thoroughly with
chlorhexidine hand washing solution using a scrubbing brush as for theatre
procedures.
Latex gloves should be used.
The following equipment should be laid out:
23 and 25 g Butterfly cannulae- at least 4 of each
19 gauge needle
10ml disposable syringe




Bactalert blood culture bottles, paediatric aerobic
2 ml heparinised tube
2m 1 EDTA tube
2ml plain tube
The above will be place on a stainless steel-topped clinical trolley. The
surface will be cleaned with chlorhexidine after and again immediately
before use.
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Staff required
1 qualified staff and an assistant should undertake the procedure with the caretaker.
Positioning the child
The child will be prone and in a bed accompanied by his/her caretaker, preferable
mother, who should sit with the child's head in her lap or lying across her lap
(depending on preference and size of child) and the assistant should restrain the
child.
Venepuncture
A suitable vein will be found in the arm or dorsum of the hand. If a vein is not
available in the upper limbs, the lower limbs and then the scalp will be inspected in
that order. The skin should be well cleaned with iodine followed by alcohol. A 23-
25g 'Butterfly' canula will be unsheathed immediately before insertion and inserted
into the vein.
If more than one attempt is made to gain access to the vein the needle should be
changed between attempts. Canulae contacting any other surface before
venepuncture will be discarded and replaced.
When blood is seen to flow back, the plastic hub will be replaced by a 10 ml syringe
and the target volume of blood collected.
On withdrawing the canula the hub will be changed for a 19g needle and the
Butterfly discarded into the sharps container.
Filling sample tubes.
Sample tubes will be filled in the following order:
BC, EDTA, heparinised, clotted, drop on a slide for ward tests and malaria slide.
5ml BC, lml EDTA, 1-2 ml plain, 0.5ml heparinised + 1 drop on microscope slide
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Where less than 8ml blood is obtained an attempt should be made to get at least 2ml
of blood for BC in addition to the other samples.
EDTA and heparinised tubes should be rolled slowly between the hands to ensure
good mixing.
Labelling and transport of specimens to the lab




A blood sample form should be completed with the same information as
above and with the time the samples were taken.
The tubes and the form should be placed in a lidded plastic container and kept in the
specified tray (room temperature) for collection. One patient per plastic container.
This should be transported to the lab reception by the study assistant as soon as
possible and within 2 hrs as a maximum delay.
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This SOP refers to bedside measures and testing but excludes taking of samples for
lab analysis
The following tests are done at the bedside:
1. Hemocue measurement of blood haemoglobin (Hb)
2. Hemocue measurement of blood glucose
3. Measurement of blood lactate
4. Paracheck for P falciparum
5. HIV tests -
a. Capillus
b. Determine
6. Generation of 'Hospital slide' for malaria
The above may be tested on venous blood obtained at venepuncture (see Blood
Taking SOP) or capillary blood obtained by finger prick with a lancet. The above
order is the order in which it is preferable to use venous blood over finger prick
blood - that is if there is limited venous blood it should be used for Hb rather than
paracheck (and finger prick blood used for the latter).
For venous blood bedside tests the blood should be put onto a hydrophobic (water
repelling) surface such as the wrapper of the syringe or butterfly. Blood that has
clotted should not be used for any of these tests.
For finger prick blood it is always important to squeeze out a sufficiently large drop
that the test device (Paracheck loop or Hemocue cuvette) is able to be completely
filled. It is also important that the first drop of blood is wiped away as this drop will
be diluted by alcohol/interstitial fluid.
Be aware that the Hemocue Haemoglobin analyser and its microcuvettes looks
very similar to the Hemocue glucose analyser and its microcuvettes. Always
ensure that you are using the correct cuvettes and machine for your test.
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1/ Hemocue haemoglobin measurement
Equipment needed
1. Hemocue Haemoglobin analyser model no.
2. Hemocue haemoglobin cuvettes
3. Blood on hydrophobic surface or
4. Droplet of blood on skin of finger/toe/heel.
5. A pen and study form
6. Approved sharps disposal container
Procedure
1. Turn on the Hemocue analyser
2. Open the cuvette holder to the loading position, the display should show
three flashing dashes.
3. Remove a Hemocue microcuvette from the container and close
immediately.
4. Touch the tip of the Hemocue cuvette to the blood, filling it completely in
one continuous process- do not refill cuvettes.
5. Ensure that there is no excess blood on the outside of the cuvette, wiping
blood off if necessary. Make sure that no blood is drawn out from the
cuvette sample in this process.
6. Look for bubbles in the filled cuvette, if present discard into the sharps bin
and take a new sample. Small bubbles around the edge of the cuvette
(outside the marked circle) can be ignored.
7. Place the cuvette in the holder - this should be done immediately.
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8. Push the cuvette to the measuring position.
9. During measurement the '1' symbol will be displayed.
10. After 15 - 60 seconds the haemoglobin (Hb) result will be displayed
11. Write the result down on the patient case record sheet (using '0' as the first
digit if the result is <10)
12. Open the cuvette holder and dispose of the cuvette in the sharps bin.
Calibration and maintenance
1. Every morning Nurse 1 should ensure that the Hemocue Hb machine is
working and that there are spare batteries in the cabinet.
2. The cuvette holder should be cleaned every morning with an alcohol swab.
3. If the cuvette holder becomes dirty (with blood) it should be cleaned at that
time by Nurse 1 using an alcohol swab.
4. If the machine shows an error consult the manual. The most common errors
are E01- E05. The machine can be cleaned by following the guidance in the
manual and substituting a 'cotton bud' wetted with alcohol for the 'Hemocue
cleaner'. Full description on page 28 of the manual.
5. Every Monday the accuracy should be checked with the first sample drawn.
For this sample the EDTA sample should be used and the resulting hemocue
HB measurement written on the form with the letters QC. The lab will then
compare this result to their own.
189
SFI Study. Bedside procedures SOP
2/ Blood glucose measurement
Equipment needed
1. Hemocue blood sugar analyser.
2. Hemocue blood sugar cuvettes (stored in refrigerator)
3. Blood on hydrophobic surface or
4. Droplet of blood on skin of finger/toe/heel.
5. A pen and study form
6. Approved sharps disposal container
Procedure
1. Turn on the Hemocue analyser
2. Open the cuvette holder to the loading position, the display should show three
flashing dashes.
3. Remove the Hemocue microcuvette container from the fridge.
4. Remove a Hemocue microcuvette from the container and close immediately.
5. Replace the Hemocue microcuvette container in the refrigerator.
6. Touch the tip of the Hemocue cuvette to the blood, fdling it completely in
one continuous process- do not refill cuvettes.
7. Ensure that there is no excess blood on the outside of the cuvette, wiping
blood off if necessary. Make sure that no blood is drawn out from the
cuvette sample in this process.
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8. Look for bubbles in the tilled cuvette, if present discard into the sharps bin
and take a new sample. Small bubbles around the edge of the cuvette (outside
the marked circle) can be ignored.
9. Place the cuvette in the holder - this should be done immediately.
10. Push the cuvette to the measuring position.
11. During measurement the '§' symbol will be displayed.
12. After 15-60 seconds the glucose result will be displayed
13. Write the result down on the patient case record sheet (using '0' as the first
digit if the result is <10)
14. Open the cuvette holder and dispose of the cuvette in the sharps bin.
Calibration and maintenance
1. Every morning Nurse 1 should ensure that the Hemocue Hb machine is
working and that there are spare batteries in the cabinet.
2. The cuvette holder should be cleaned every morning with an alcohol swab.
3. If the cuvette holder becomes dirty (with blood) it should be cleaned at that
time by Nurse 1 using an alcohol swab.
4. If the machine shows an error consult the manual. The most common errors
are E01- E05. The machine can be cleaned by following the guidance in the
manual and substituting a 'cotton bud' wetted with alcohol for the 'Hemocue
cleaner'. Full description on page 28 of the manual.
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3/ Blood Lactate Measurement
Equipment needed
1. Lactate Pro blood lactate analyser.
2. Lactate Pro test strips
3. Blood on hydrophobic surface or
4. Droplet of blood on skin of finger/toe/heel.
5. A pen and study form
6. Approved sharps disposal container
Procedure
1. If you are opening a new box of lactate test strips the meter must be
calibrated using the calibration strip contained in each box. To do this insert
the strip into the inlet. The function no (F-0 to F-12) will flash on the display.
This should match the number on the box (and on all the test strips).
2. Peel back the foil packet of the test strip to the line and insert the strip into the
inlet.
3. The function number and last measured result will blink alternately. The
displayed function number should match that on the test strip.
4. Touch the tip of the test strip to the blood and hold there until the machine
'bleeps'.
5. The readout will show a countdown from 60 seconds. After 60 seconds the
blood lactate result will be shown.
6. Having recorded the lactate measurement in the CRF remove the strip and
discard it.
192
SFI Study. Bedside procedures SOP
Calibration and maintenance
1. Every morning Nurse 1 should ensure that the ProLactate machine is working
and that there are spare batteries in the cabinet.
2. Every morning the machine should be tested with the control test strip. If the
reading is outside the range given for the control strip the meter should not be
used and the fault reported to the Project Leader.
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4/ Rapid test for P.falciparum (Paracheck)
Equipment needed
1. Paracheck individual test packet.
2. Paracheck buffer bottle.
3. Anticoagulated blood (EDTA) or
4. Blood on hydrophobic surface or
5. Drop of blood on skin of finger/toe/heel.
6. Timer with alarm.
7. A pen and study form
8. Approved sharps disposal container
Procedure
1. Open Paracheck packet and remove contents.
2. Check silicagel is blue, if not discard and open new paracheck packet.
3. Touch the loop of the blood collector to the blood.
4. Check that a full drop of blood has been picked up (5p.L)
"i
5. HHHi
6. Apply the loop to the filter paper in the sample well of the paracheck device
by holding it vertically straight with the loop parallel to the side of the device:
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8. Blood will then be released into the sample well pad
•wir.
10. Ensure that the entire specimen is released to the test pad.
11. Discard the loop into the sharps container
12. Deliver 6 drops of buffer into the buffer well with the bottle held vertically
2cm above the well.
13. Label the Paracheck device with the patient's name and the time.
14. Set the timer for 15 minutes and place it with the paracheck device.
15. When the alarm sounds examine the device under good light.
16. If there is no control line discard the test and repeat.
17. If there is only a control line the test is negative - record this in the patient's
case record form
18. If there are two lines (control and test) the test is positive - record this in the
patient's case record form.
19. It is acceptable to record a positive result before 15 minutes if both lines are
clearly visible
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20. It is never acceptable to record a result as negative before 15 minutes.
21. If it is not possible to read the Paracheck, record unsure. The child should be
treated according to the clinical scenario - if severely unwell treat for
malaria, if not await B/S result.
22. Always record whether the control line is seen.
23. Dispose of the paracheck device into the sharps container.
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5/ HIV Test
a) Capillus
The Capillus test is a test for antibodies to HIV 1 and 2. It is the screening test to be
used on all patients who consent after councelling. Patients who wish to have
anonymous testing will not be tested at the bedside, but rather blood will be sent for
testing there (see anonymous testing SOP).
The test employs latex beads coated with proteins that are the targets of HIV
antibodies. When these a solution of these beads is mixed with antibody the beads
clump together; this is the basis of a positive test.
Positive and negative control samples should be run at least once every day. The
results should be documented at the top of every day sheet in the HIV/VCT book. If
a new box is started during the day, the controls should be repeated for that box. If
controls do not give the required result the box should be discarded and a new set
used. This should be reported to the project supervisor.
Materials required:
1. Blood (may be EDTA or blood on hydrophobic surface NOT direct from
fingerprick) or control.
2. lOpL pipette and disposable tip (both supplied in capillus boxed set)
3. Latex reagent
4. Capillus test slides
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Procedure:
1. Remove the capillus tests from the fridge. It is permitted to have the box out
of the fridge during the day for testing. It should be returned to the fridge at
the end of the day.
2. Remove test slide and lay flat.
3. Allow to come to room temperature.
4. Check patient has consented for VCT.
5. Label with name on specimen bottle.
6. Ensure that you are wearing disposable gloves throughout the procedure.
7. Invert capped reagent bottle to mix latex particles.
8. Draw latex up and down into dropper a few times to further mix.
9. Draw up latex reagent into dropper up to the marked line.
10. Dispense latex reagent into mixing well of slide, away from the capillary
channel.
11. Using the pipette dispense lOpL of blood/control into the mixing well.
Dispense directly into the latex reagent. Using the pipette mix the sample by
pumping the mixture in and out of the tip three times and stirring in a circular
motion at least 5 times.
12. Continue to use the pipette to move the sample to the opening of the channel
until capillary flow down the channel occurs.
13. Dispose of the pipette tip in an approved sharps container.
14. Allow the mixture to flow through the entire capillary channel into the
viewing chamber before interpreting the result.
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15. Do not tip the slide upright - this will cause the solution to flow more quickly
and may result in false negative tests.
16. Read the slide against a black background.
17. A positive or reactive test is indicated by aggregation of latex particles. All
positive tests should be confirmed using a determine test (see 7b in this SOP).
The result should be documented in the H1V/VCT log book and entered on
the lab request form.
18. Negative tests should be recorded in the HIV/VCT log book and on the
laboratory request form. The result should also be entered into the patient
hospital notes and post test counselling performed.
19. The slide should be disposed of in an approved sharps container.
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b) Determine
The Determine test is a test for antibodies for HIV 1 and 2. The test is used in the
study to confirm a positive Capillus test. The test should therefore be done only on
patients who have tested positive by Capillus unless there is other good reason
(discussed with Project Supervisor).
Materials required:
1. Blood (may be EDTA or blood on hydrophobic surface NOT direct from
fingerprick).
2. 50pL pipette and disposable tip.






1. Remove one Determine test strip from the packaging and immediately reseal
the bag.
2. Peel away the strip cover and lay test strip flat.
3. Label with the name on the sample bottle.
4. Transfer 50pL of blood using the pipette to the end of the test strip.
5. Set the timer for 15 minutes.
6. Dispose of pipette tip in sharps container.
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7. If the blood stops moving up the strip, add a single drop of chaser buffer.
8. Read the strip at 15 minutes.
9. The strip must have a control line to be valid, if there is no control line and
the blood has not progressed fully up the strip add a drop of chaser buffer and
leave for a further 15 minutes (use timer). If the blood has progressed up the
strip, but there is no control line, the test should be discarded and repeated.
10. If there is a line in test window the test is positive. If there is no line in this
window the test is negative.
11. It is often possible to read a positive before this time if both lines are clearly
present.
12. Record both the test result and the presence of a control line in the HIV/VCT
book.
13. Record the test result and the presence of a control line on the lab request
form.
14. Dispose of the strip in the sharps bin.
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Blood slide blood specimen collection
Definition
This SOP describes how to collect a thick blood film. Malaria blood
smears are best prepared using finger/heel prick capillary blood and can
also be made from blood collected in EDTA tubes or on a hydrophobic
surface.
Thick blood film is about 30 times more sensitive compared to thin film
(detecting about 20 parasites/pl) a thick film is therefore the most
suitable for the rapid detection of malaria parasites, particularly when
they are few. In thick films the blood is not fixed. The red cells are
lyzed during staining, allowing parasites and white blood cells to be
seen in much larger volume of blood.
For the study two slides will be stored. One will be prepared from the EDTA sample
in the lab. The other is prepared on the ward - the procedure is outlined here.
Procedure for collecting blood slide from finger/heel prick
Materials required:
* Dry and wet swabs soaked in methylated spirit (70% Ethanol)
* Swab containers
* Disposable sterile blood lancet
* Glass slide
* Permanent marker pen or pencil
* Sharps box
* Clean plastic disposable gloves
Procedure:
Prepare the equipment making sure sharps are safe.
Using a maker pen/pencil, label the microscope slide with the patient
name, study identification number and date on the (e.g. 90012, Juma
Athumani, 18/08/06). Explaining the slide of patient called Juma
Athumani collected on 18th August 2004, from Teule site with study
number 90012 - this is for the 'hospital' slide.
Explain to the parent/carer the procedure you are about to do and
reason why.
Wear a clean pair of disposable gloves
Disinfect thumb, finger or heel with a swab moistened with methylated
spirit and blot dry using a dry swab
Using a sterile blood lancet, prick the finger or heel.
202
SFI Study. Bedside procedures SOP
Wipe away the first few drops of blood.
Squeeze gently to obtain drop of blood.
Discard used lancets directly into the sharps disposal container
Using a completely clean grease-free microscope slide collect blood
directly onto slide (a large drop in the centre of microscope slide).
Procedure for making blood slide from venous blood
* Dry and wet swabs soaked in methylated spirit (70% Ethanol)
* Swab containers
* Sterile syringe containing patients blood (see Blood taking SOP)
* Glass slide
* Slide box
* Permanent marker pen or pencil
* Sharps box
* Clean plastic disposable gloves
Procedure:
Prepare the equipment making sure sharps are safe
Using a completely clean grease-free microscope slide collect blood
directly onto slide (a large drop in the centre of microscope slide).
Using a maker pen/pencil, label the microscope slide with the patient
name, study identification number and date on the (e.g. 90012, Jurna
Athumani, 18/08/06). Explaining the slide of patient called Juma
Athumani collected on 18th August 2004, from Teule site with study
number 90012 - this is for the 'hospitaP slide.
Discard syringe unless blood is required for other tests.
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• Severe respiratory distress




• Diarrhoea and 2 of
■ Lethargy
■ Sunken eyes
■ Very slow skin pinch
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PRIORITY PATIENT
• Any respiratory Distress
• Visible severe wasting
• Oedema of both feet
• Severe Palmar Pallor
• Lethargy
• Continually restless and irritable
• Less than 2 months old
• Major Burn
• Urgent Referral from another facility
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Appendix 5 - Alternative analysis - Do current
guidelines accurately predict invasive
bacterial disease?
INTRODUCTION
The analysis presented in chapter XXXX regarding the sensitivity of WHO guidelines for the
detection of bacterial disease in this cohort was based on the principle of defining the
clinical criteria that might define "septicaemia" (bacterial disease without clear focus). A
definition for septicaemia exists in the WHO guidelines, but it performed poorly. An
alternative analysis, based on incorporating this definition into the WHO hierarchical
classification (Table Al), is presented below and forms the basis of further publication.248
Antimicrobial sensitivity data was also available at the time of this later analysis and has
been incorporated.
RESULTS
Overall, the sensitivity of WHO criteria to detect IBD was little changed at 67.4% (95%CI
65.9 to 69.0) with a specificity of 51.5% (95%CI 49.9 to 53.1); sensitivity was higher among
slide-negative (70.5%, 95%CI 68.2 to 72.9) compared to slide-positive children (60.0%,
95%CI 58.0 to 62.1) and specificity was slightly higher among slide-positives (53.5%, 95%CI
51.4 to 55.6) compared to slide-negatives (48.1%, 95%CI 45.6 to 50.7). The sensitivity of
WHO criteria declined with increasing P. falciparum parasite density and in children with >
50,000 parasites/pl only 19/36 (52.8%, 95%CI 49.5 to 56.1) children with IBD were correctly
identified. The organisms associated with different clinical syndromes are shown in Table
A2. The new "septicaemia " criterion only identified 28 children with 3/28 (10.7%).
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RISK FACTORS FOR IBD
Clinical and laboratory features associated with IBD were assessed using bivariate odds
ratios and a multivariate logistic regression model (Table A2). There was a significant
association between IBD and axillary temperature >38 "C, severe anaemia (Hb<5g/dl), and
hypoglycaemia (blood sugar<2.5mmol/l) after controlling for the presence of any 'WHO
criteria, HIV infection, and current or recent malaria. Prostration was also associated with
increased odds of IBD among children without current or recent malaria (OR 2.70, 95%CI
1.47 to 4.97, p=0.001).
ANTIMICROBIAL SUSCEPTIBILITY
In vitro susceptibilities of isolates associated with WHO syndromes are shown in Table A3.
Just over half (112/211, 53.1%) of isolates were resistant to the recommended antibiotic.
The use of co-trimoxazole for non-severe pneumonia and parenteral penicillin for severe
pneumonia were associated with the lowest in vitro susceptibilities (31.8% and 33.3%
respectively). (Table A3)
CONCLUSION
This further analysis also demonstrated the poor sensitivity of WHO guidelines in the
detection of invasive bacterial disease. In addition it highlighted the poor coverage of the
currently recommended empirical antibiotic therapy in this setting. The clinical correlate of
these antimicrobial sensitivity data is not clear. Observational data from Malawi failed to
show an improvement in mortality following a change to broader empirical antibiotic
therapy. Ideally alternative antibiotic choices should be explored through clinical trials with
careful surveillance to address concerns regarding the impact of the use of broader
spectrum antibiotics on bacterial resistance patterns.
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Footnotes to Table Al.
Where these categories were used in the analysis, children were assigned to one diagnostic
category with priority to those higher in the list. Categories in italics were not used in this
analysis.
* Blantyre Coma Score
t Malaria with shock or signs of meningitis defined in WHO guidelines.62 Children with
malaria & signs of meningitis will already be included in the category above.
*Shock defined as capillary refill>3sec or cool peripheries or systolic BP<50 mm Hg (WHO
Pocket Book of Hospital Care for Children 6.2.1,142)
§ Severe respiratory distress was defined as oxygen saturation <90% or respiratory rate =70
breaths/minute
"Recommended if chloramphenicol is not available
^Amoxycillin plus gentamicin is recommended if there is hypoglycaemia or hypothermia or
if the child appears lethargic or 'sickly'
234
'Guidelines for care at first-referral Recommended antimicrobial Chapter, page of
level' criteria for presumptive use of Guidelines for care at
antimicrobials first-referral level
manual
Sick young infant Ampicillin plus gentamicin 6.1, 75
Any hospitalised infant age<2months IV/IM Or
(not included in this study) Penicillin plus gentamicin
IV/IM
Meningoencephalopathy Chloramphenicol plus 5.2, 62
BCS*<3 or stiff neck or bulging ampicillin IV/IM Or
fontanelle or >2 convulsions in Chloramphenicol plus
preceding 24hrs penicillin IV/IM
Malaria with shock1 Chloramphenicol plus 5.1.1, 59+
Positive slide for malaria plus penicillin IV/IM
Shock* or BCS*<3 or bulging fontanelle
or >2 convulsions in preceding 24hrs
Very severe pneumonia Chloramphenicol IV/IM 3.1.1, 30
Cough/difficulty breathing plus Or Gentamicin plus penicillin
Multiple convulsions or coma or IV/IM"
lethargy or vomiting everything or
inability to drink or cyanosis or severe
respiratory distress5
Severe pneumonia Benzyl penicillin IV/IM 3.1.2, 32
Cough/difficulty breathing plus
Lower chest indrawing or nasal flaring
or grunting
IMon-severe pneumonia Amoxycillin PO 3.1.3, 32
Cough/difficulty breathing plus Or
Raised respiratory rate for age Co-trimoxazole PO
Septicaemia Chloramphenicol plus 5.4, 67
Negative slide for malaria plus penicillin IV/IM
Axillary temperature = 37.5°C plus
Inability to drink/feed or lethargy or 2
convulsions in preceding 24hrs or
vomiting everything
Severe acute malnutrition Co-trimoxazole PO 7.2.5, 84
Bilateral oedema or severe wasting or Or ^Amoxycillin plus
weight-for-height z-score <-3 gentamicin IM/IV













































































Unadjusted OR (95%CI) Adjusted OR (95%CI)
WHO criteria 2.202 (1.738 - 2.789)** 1.669 (1.284 - 2.170)**
Meningo-encephalopathy 1.843 (1.284-2.643)**
Malaria with Shock 0.586 (0.344 - 1.000)
Very severe pneumonia 2.163(1.668 - 2.805)**
Severe pneumonia 1.848(1.246-2.742)**
Non-severe pneumonia 0.981(0.754- 1.276)
Septicaemia 5.581 (3.915 -7.956)**
Severe acute malnutrition 1.719 (0.717-4.125)
HIV-positive 2.38(1.541-3.677)** 1.465 (0.914 - 2.347)
Axillary temperature>38°C 1.339(1.070- 1.674)* 1.441 (1.131 -1.837)**
Prostration + 1.417(1.029 - 1.951)* 1.007 (0.652 - 1.554)
Hb<5g/dL 1.425 (1.078 - 1.885)* 1.558 (1.134 - 2.141)**
Glucose <2.5mmol/L 2.325 (1.442-3.749)** 2.458 (1.390 -4.347)**
Lactate >5mmol/l 1.459 (1.072 - 1.986)*
Shock 1.138 (0.689 - 1.879) 0.897 (0.503 - 1.600)
Slide-positive 0.238 (0.187-0.304)**
RDT-pos., slide-neg. * 2.897 (2.241 -3.745)** 1.293 (0.954 - 1.752)
Slide-pos.<5,000/pl 0.843 (0.579 - 1.226) 0.548 (0.359 -0.836)**
Slide-pos. 5000-50,000/p.l 0.272 (0.187-0.397)** 0.204(0.132 -0.314)**
Slide-pos.>50,000/pl 0.347 (0.244-0.495)** 0.241 (0.159 -0.367)**





Inability to sit unsupported or, if age<8months, inability to drink.
*
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Use of an HRP2-based rapid diagnostic test to guide treatment
of children admitted to hospital in a malaria-endemic area of
north-east Tanzania
George Mtove', Behzad Nadjm2, Ben Amos3, Use C. E. Hendriksen4, Florida Muro5 and Hugh Reyburn2
1 National Institute for Medical Research, Amani Centre, Muheza, Tanzania
2 London School of Hygiene and Tropical Medicine, London, UK
3 Teule Hospital, Muheza, Tanga, Tanzania
4 Mahidol-Oxford Research Unit, Bangkok, Thailand
5 Kilimanjaro Christian Medical Centre, Moshi, Tanzania
Summary objective To compare the performance of the Paracheck™ rapid diagnostic test (RDT) with
microscopy for diagnosing malaria in hospitalised children.
methods Children aged between 2 months and 13 years with fever were enrolled in the study over
1 year. A standard clinical history and examination were recorded and blood drawn for culture,
complete blood count, Paracheck™ RDT and double-read blood slide.
results Of 3639 children enrolled, 2195 (60.3%) were slide positive. The sensitivity and specificity
of Paracheck were 97.5% (95% CI 96.9-98.0) and 65.3% (95% CI 63.8-66.9), respectively. There was
an inverse relationship between age-specific prevalence of parasitaemia and Paracheck specificity. In
logistic regression model, false-positive Paracheck results were significantly associated with pre¬
admission use of antimalarial drug (OR 1.44, 95% CI 1.16-1.78), absence of current fever (OR 0.64,
95% CI 0.52-0.79) and non-typhi Salmonella bacteraemia (OR 3.89. 95% CI 2.27-6.63). In spite of
high sensitivity, 56/2195 (2.6%) of true infections were Paracheck negative and 8/56 (14.3%) were in
patients with >50 000 parasites//d.
conclusions Paracheck had poor specificity in diagnosing malaria in severely ill children; this was
likely to be due to HRP2 persistence following recent parasite clearance. The combination of positive
Paracheck and negative blood slide results identified a group of children at high risk of non-typhi
Salmonella infection. While Paracheck was highly sensitive, some high-density infections were missed.
For children with severe febrile illness, at least two reliable negative parasitological test results should be
available to justify withholding antimalarial treatment; the optimal choice of these has yet to be
identified.
keywords malaria, severe, rapid diagnostic test, hospital
Introduction
The use of rapid immunochromatographic tests for malaria
(RDTs) in primary care facilities has been studied over a
number of years, and these tests are now being rolled out
on a large scale in Africa as a means to restrict antimalarial
drug use to parasitologically confirmed cases, a policy now
supported by WHO (WHO 2010). However, the WHO
criteria for malaria diagnosis apply irrespective of severity,
and it is therefore surprising that as far as we are aware,
only one small study has so far been published on the use of
RDTs in patients admitted to hospital (Birku et al. 1999).
The wider use of RDTs in patients hospitalised with
severe febrile illness seems inevitable given the increasing
availability of RDTs. Given current evidence of the low
accuracy of routinely read slide results, this may represent
an improvement over current practice (Reyburn et al.
2004; Zurovac et al. 2006). However, the performance of
HRP2-based RDTs may differ when used for severely ill
children compared to use in non-severe illness. First,
specificity may be reduced by the persistence of HRP2 for
up to 5 weeks following clearance of parasites and this
may be a particular concern in patients who are frequently
infected or who have recently taken antimalarial drugs,
© 201 I Blackwell Publishing Ltd 545
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both of which may be more likely in hospitalised children
in malaria-endemic areas (Wongsrichanalai et al. 1999;
Swarthout et al. 2007). Secondly, it has been suggested
that test sensitivity may paradoxically decline at very high
parasite densities (more common in severe than non-severe
malaria) because of flooding of RDT capture sites (Rey-
burn et al. 2007). Thirdly, antibodies to HRP2 that are
acquired with increasing exposure to malaria might result
in age-dependent test performance (Biswas et al. 2005).
And finally, the interpretation of a combination of a
positive RDT result and negative blood slide may indicate
'recent malaria' and this has been associated with certain
bacterial infections in severely ill children that may provide
added diagnostic value if both RDT and blood slide results
are available (Brent et al. 2006; Nadjm et al. 2010).
In this study, we compared results of a commonly used
HRP2-based RDT (Paracheck™) with those from double-
read research slides in guiding the care of children enrolled
in a 1-year study of children admitted to a district hospital
for febrile illness in an area of intense malaria transmission.
We compare the technical performance of Paracheck with
research-quality blood slide results and suggest how HRP-
2-based RDT results might contribute to clinical care in
African district hospitals.
Methods
Study site and data collection
The study was conducted in a district hospital in north¬
eastern Tanzania serving a predominantly rural population
with childhood mortality that is typical for Tanzania (165
deaths/1000 person years under the age of 5 years). The
area is highly endemic for Plasmodium falciparum
(P. falciparum) malaria.
Details of the study have been published elsewhere
(Nadjm et al. 2010). Briefly, over the course of 1 year, all
daytime paediatric admissions were screened for inclusion
and were eligible if aged 2 months to 13 years with axillary
temperature >37.5 °C or a history of fever within the
previous 48 h. Children with chronic illness except HIV or
admitted with trauma or a surgical condition were
excluded.
After consenting procedures, a standard clinical history
and examination based on IMCI guidelines were recorded
by a study clinician (WHO 2000a). Pulse oximetry was
used on a finger or toe and height and weight were
measured. Lumbar puncture was undertaken on suspicion
of meningitis according to WHO criteria. Venous blood
was drawn for point of care (POC) tests of haemoglobin
concentration, blood glucose (Hemocue™, Anglholm,
Sweden), blood lactate (Lactate-Pro™; Arkray Inc, Kyoto,
Japan), HRP-2-based RDT for P. falciparum (Paracheck™;
Orchid Biomedical, Mumbai, India) and HIV antibody
tests (Capillus HIV-1, HIV-2 Test; Trinity Biotech, Ireland
and Determine HIV-1/2 Test; Abbott Laboratories, IL,
USA). Blood was sent to the laboratory for full blood count
(Act/Dif™; Beckman-Coulter) and aerobic blood culture
(BactAlert™; Biomerieux, France) with identification of
organisms by standard means. Blood slides were stained
with Giemsa and independently double-read with discor¬
dant results resolved by a third reader. Paracheck tests
were stored in a ventilated room out of direct sunlight with
temperature documented not to exceed 40 °C as recom¬
mended by the manufacturer.
Data management and analysis
Data were scanned using Teleforms (Verity software Inc.)
into MS-Access (Microsoft Corp, Redmond, VA, USA) and
analysed using Stata-10 (Stata Corp, College Rd, TX,
USA). Final blood slide results are considered as the
'reference standard' result in making comparisons with
Paracheck results throughout the paper.
Statistical tests used chi-squared for comparison of
proportions and t-test (for parametric variable) or rank-
sum (for non-parametric variable) for comparison of
normally or non-normally distributed data, respectively.
The logistic model was constructed with 'positive RDT and
negative blood slide' as the dependent variable and factors
in Table 3 as independent variables. All of the initially
chosen independent variables were retained in the final
model.
Ethics
The study was approved by the Ethics Committees of the
National Institute for Medical Research, Tanzania
(NIMR/HQ/R.8a/Vol.IX/392), and the London School of
Hygiene and Tropical Medicine, UK (LSHTM Ethics
# 2087). Witten informed consent to participate was
obtained from the parent or guardian of each child in the
study.
Results
After exclusions for missing data, 3639 children were
included in the analysis, all of whom had a blood slide and
Paracheck result. Overall, 2139 (58.8%) were both
P. falciparum slide positive and Paracheck positive, and
943 (25.9%) were negative to both tests. Of the 557
discordant results, 501/557 (90%) were Paracheck posi¬
tive but slide negative and 56/557 (10%) were Paracheck
negative and slide positive. Using the blood slide result as
the reference standard, there was an inverse relationship
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Figure I Age-specific sensitivity and specificity of rapid diagnostic
test results by prevalence of a positive blood slide of children in the
study.
between age-specific prevalence of parasitaemia and the
specificity of Paracheck (Table 1, Figure 1).
The sensitivity of Paracheck was above 95% in detecting
P. falciparum infections with >2000 parasites//(l with no
consistent trend with increasing density above this level.
The sensitivity of Paracheck was lower in detecting
infections with <2000 parasites//il and especially infections
with <200 parasites//tl compared to infections with
>2000//(l (Table 2). However, low-density infections were
relatively uncommon; only 20/2139 (0.9%) and 240/2,
139 (11.2%) of positive blood slide results were at
densities of <200 and <2000 parasites//tl, respectively.
More than half of all false-negative Paracheck results
(30/56, 53.6%) were in children with a parasite density of
>2000 parasites//d and 8/56 (14.3%) were in children
with parasite densities greater than 50 000//d.
An invasive bacterial infection was isolated in 341/3639
(9.4%) children in the study and these were more common
in slide-negative (241/1444, 16.7%) compared to slide-
positive children (100/2195, 4.6%, P < 0.001). Similarly,
bacterial infection was more common in RDT-negatives
than in RDT-positives; 194/2640 (7.4%) of RDT-positive
and 147/999 (14.7%) of RDT-negative children had
invasive bacterial disease (P < 0.001). However, of the 501
children who were slide negative but Paracheck positive,
98 (19.6%) had invasive bacterial disease and 67 (69.1%)
of these were caused by non-typhi Salmonella (NTS)
infections (Table 3).
Overall, 597/1850 (32.3%) of children with a true-
positive Paracheck result were reported to have taken an
antimalarial drug in the 2 days prior to admission com¬
pared to 188/443 (42.4%) of children with a false-positive
Paracheck result (P < 0.001). Factors judged likely to be
associated with false-positive Paracheck results were
assessed in the logistic regression model in Table 4.
Discussion
The main finding of the study was the low specificity of
Paracheck compared to reference blood slides; the overall
Table 2 Sensitivity of Paracheck results by
parasite density of reference blood slide
results
RDT RDT Sensitivity
Parasite density//d Prevalence positive negative (95% CI)
1-199 20/1464 (1.4%) 16 4 80.0 (78.0-82.1)
200-1999 220/1664 (13.2%) 198 22 90.0 (88.6-91.4)
2000-4999 165/1609 (10.3%) 159 6 96.4 (95.5-97.3)
5000-49 999 917/2361 (38.8%) 901 16 98.3 (97.7-98.8)
50 000-200 000 693/2137 (32.4%) 689 4 99.4 (99.1-99.7)
>200 000 180/1624 (11.1%) 176 4 97.8 (97.1-98.5)
RDT, rapid diagnostic test.
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NTS Other organism Total
Slide negative and RDT negative 41 (4%) 102 (11%) 943
Slide negative and RDT positive 67 (13%) 31 (6%) 501
Slide positive, P.f. density <5000//d 23 (6%) 10 (2%) 405
Slide positive, P.f. density 5000-50 000 13 (1%) 18 (2%) 917
Slide positive, P.f. density 50 000+ 16 (2%) 20 (2%) 873
Total 160 (4%) 181 (5%) 3639
NTS, non-typhi Salmonella; RDT, rapid diagnostic test.
Table 3 Pathogenic bacteria isolated from
blood or CSF by category of Paracheck and
blood slide results






Age 12-23 months 1073 (29.5)
Age 24-59 months 2254 (61.9)
Age 60+ months 312 (8.6)
Days ill, OR per day
Antimalarial in last 2 days 1102 (34.8)
Non-typhi Salmonella 169 (4.4)
Any invasive bacterial disease 341 (9.4)









































figure was among the lowest recorded for Paracheck and in
children aged between 2 and 5 years, specificity dropped
below 50%. The proportion of Paracheck results that were
false-positives correlated closely with age-specific parasite
prevalence and recent antimalarial drug use but was not
independently associated with age.
The rate of false-positive Paracheck results is at least
partly a function of the time between parasite clearance
and disappearance of HRP2 from blood and this can last
for more than 5 weeks (Swarthout et al. 2007) and is likely
to be associated with recent antimalarial treatment. One
would expect this to be particularly common in children
who are admitted to a district hospital because this
constitutes the first referral level of care, and in our study,
we found that over one-third of all children in the study
and almost half of the children with a false-positive
Paracheck were reported to have taken an antimalarial
drug in the 2 days prior to admission. In addition, apparent
low specificity may be the result of Paracheck or other
RDTs exceeding blood slide results in sensitivity; studies by
both Bell et al. (2005) and Hopkins et al. (2008) have
found that a substantial proportion of results that were
negative to expert slide reading but positive to Paracheck
were positive when tested by polymerase chain reaction
(PCIl). Without recourse to PGR, we are unable to
replicate this result but it seems likely that at least some of
the apparent low specificity of Paracheck that we observed
was the result of Paracheck detecting submicroscopic
parasitaemia.
The influence of antibodies to HRP2 on the accuracy of
RDTs is not clear. On the assumption that HRP antibodies
accelerate the disappearance of reactive HRP2, one would
expect RDT sensitivity and specificity to increase with
increasing exposure, for which age is a reasonable proxy in
a stable population such as that in our study area. This is
supported by the findings of (Fryauff et al. 1997) who
found a marked difference in sensitivity over and under the
age of 10 years among residents of a malaria-endemic area
of Irian Jaya, although in our study population, with a
much narrower age range, we did not observe age-specific
trends in sensitivity. Biswas et al. (2005) studied HRP2
levels and antibody titres to HRP2 in 45 subjects in a low-
transmission area for up to 6 weeks following infection
with P. falciparum and found that HRP2 antigen remained
elevated for at least 7 days post-treatment, despite the
development of HRP2-specific immune responses. Our
findings were thus consistent with the conclusions of
Biswas et al., that antibody levels to HRP2 are unlikely to
exert an important effect on test results in children with
severe febrile illness.
The relatively low specificity of Paracheck in our study
suggests that its use in a hospital setting will result in
significant overuse of antimalarial drugs with the possible
neglect of alternative diagnoses. Brent et al. (2006) previ¬
ously described the strong association between a false-
positive RDT result and blood stream bacterial infections
caused by NTS and other Gram-negative organisms and
thus the combination of a negative blood slide result and
548 © 201 I Blackwell Publishing Ltd
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positive Paracheck result should alert clinicians to the
possibility of these infections. Given the currently unsat¬
isfactory clinical predictors of bacterial infection in chil¬
dren admitted to hospital in resource-poor settings, this
could be a useful diagnostic aid, and a positive HRP2 RDT
result should not deter clinicians from providing pre¬
sumptive treatment with antimicrobials, especially if the
blood slide is negative.
By contrast, Paracheck reached very high levels of
sensitivity and negative predictive values approached
100%, a finding consistent with other studies (Hopkins
et al. 2007; Laurent et al. 2010). As expected from results
of the recent WHO-sponsored evaluation of RDTs, sensi¬
tivity dropped below 90% for the detection of low-density
infections but otherwise was consistently above the min¬
imum level of recommended level of 95% (WHO 2000a,
2008). The relative importance of low-density infections
varies by their prevalence, and low-density infections are
more common in low-transmission areas and in asymp¬
tomatic individuals; in a community survey in a low-
transmission area of the Solomon Islands, Harris et al.
(2010) found that almost half of all P. falciparum infec¬
tions were with <100 parasites//d. This is in contrast to
hospitalised children in our study where <1% of infections
were in this category. Thus, in spite of the high sensitivity
of Paracheck in detecting infections above 2000 para¬
sites/^, more than half of the false-negative Paracheck
results in our study were in children with >2000 para¬
sites/^ and almost one in six of the false-negative results
was in children with high-density (>50 000 parasites//d)
infections. False-negative RDT results at high density have
been described by at least two other studies although the
explanation is still not clear (Reyburn et al. 2007; Laurent
et al. 2010). The lack of association with increasing
parasite density in our study suggests that flooding of RDT
capture sites with excess antigen is an unlikely explanation.
Other explanations include mutations in the HRP locus
similar to those that have been found in South America
(Gamboa et al. 2010).
In practice, the small number of false-negative RDT
results that we observed suggests that it would be unwise to
withhold antimalarial treatment on the basis of a single
negative Paracheck result in a severely ill child. Ideally, at
least one other parasitological Lest result should be used
and results should ideally be available before starting
treatment. This could be a second RDT, preferably based
on the detection of alternative antigen to HRP2 such as
lactate dehydrogenase (LDH) or a rapidly read quality-
controlled blood slide; while the latter is clearly preferable,
the limitations on laboratory quality in Africa create
serious challenges. More research is needed on what is
sufficient evidence to justify withholding antimalarial
treatment in a severely ill child admitted to hospital in
malaria-endemic areas.
In conclusion, HRP-2 devices in hospitalised children in
high-transmission settings suffer from low specificity that is
largely dependent on the risk of recently cleared P. falci¬
parum infection. Thus, in areas of intense transmission of
P. falciparum, patients may be overtreated with antima¬
larial drugs and a positive HRP2 test result should not
discourage presumptive treatment with antimicrobial
drugs. The combination of a positive HRP2 test with a
negative blood slide result may suggest an increased risk of
invasive Gram-negative septicaemia. While the Paracheck
results in this study reached high levels of sensitivity, a
small number of high-density P. falciparum infections were
recorded as Paracheck-negative, suggesting that at least
one more quality-controlled parasitological test should be
used before withholding antimalarial treatment in patients
with suspected severe malaria. The choice of test or
combination of tests to guide treatment of children
admitted to hospital with suspected malaria has not so far
been defined.
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ABSTRACT
Objectives To assess the performance of WHO's
"Guidelines for care at the first-referral level in developing
countries" in an area of intense malaria transmission and
identify bacterial infections in children with and without
malaria.
Design Prospective study.
Setting District hospital in Muheza, northeast Tanzania.
Participants Children aged 2 months to 13 years admitted
to hospital for febrile illness.
Main outcome measures Sensitivity and specificity of
WHO guidelines in diagnosing invasive bacterial disease;
susceptibility of isolated organisms to recommended
antimicrobials.
Results Ovor one year, 3639 children were enrolled and
184 (5.1%) died; 2195 (60.3%) were blood slide positive
for Plasmodium falciparum, 341 (9.4%) had invasive
bacterial disease, and 142 (3.9%) were seropositive for
HIV. The prevalence of invasive bacterial disease was
lower in slide positive children (100/2195, 4.6%) than in
slide negative children (241/1444,16.7%). Non-typhi
Salmonella was the most frequently isolated organism
(52/100 (52%) of organisms in slide positive children and
108/241 (45%) in slide negative children). Mortality
among children with invasive bacterial disease was
significantly higher (58/341,17%) than in children
without invasive bacterial disease (126/3298, 3.8%)
(P<0.001), and this was true regardless of the presence of
P falciparum parasitaemia. The sensitivity and specificity
of WHO criteria in identifying invasive bacterial disease in
slide positive children were 60.0% (95% confidence
interval 58.0% to 62.1%) and 53.5% (51.4% to 55.6%),
compared with 70.5% (68.2% to 72.9%) and 48.1%
(45.6% to 50.7%) in slide negative children. In children
with WHO criteria for invasive bacterial disease, only 99/
211(47%) of isolated organisms were susceptible to the
first recommended antimicrobial agent.
Conclusions In an area exposed to high transmission of
malaria, current WHO guidelines failed to identify almost
a third of children with invasive bacterial disease, and
more than half of the organisms isolated were not
susceptible to currently recommended antimicrobials.
Improved diagnosis and treatment of invasive bacterial
disease are needed to reduce childhood mortality.
INTRODUCTION
Acute febrile illness is the most common cause of hos¬
pital admission and death in African children.1 The
large majority of these illnesses are due to malaria or
invasive bacterial disease, but differentiating between
these causes is often difficult and can result in missed
diagnoses and inappropriate treatment.2 7 Although
Plasmodium parasitaemia can be confirmed or
excluded by microscopy or rapid diagnostic tests, the
diagnosis of invasive bacterial disease is more proble¬
matic as blood culture is rarely available and is never in
time to guide crucial first treatment decisions. Clini¬
cians therefore often have to rely on the World Health
Organization's manual "Management of the child with
severe infection or severe malnutrition; guidelines for
care at first-referral level in developing countries"
(WHO criteria) to guide the presumptive use of anti
microbials.8
The use of the WHO criteria in an area of moderate
transmission of malaria has been shown to identify a
high proportion of fatalities due to invasive bacterial
disease among children admitted to hospital." How¬
ever, the criteria have not so far been systematically
assessed in an area of intense transmission of Plasmo¬
dium falciparum where infection with Gram negative
organisms, especially non-typhi Salmonella, is rela¬
tively common and has been associated with severe
anaemia, HIV infection, and non-specific clinical fea¬
tures that are not included in the WHO criteria for anti¬
microbial treatment.351014 In these areas, which
include much of rural Africa, clinicians remain uncer¬
tain as to which patients to treat and which anti¬
microbial to use.
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We report here the results of a one year prospective
study of febrile illness in children admitted to a Tanza-
nian district hospital serving a population exposed to
intense Pfalciparum transmission to assess the ability of




This was a one year observational study in Teule Hos¬
pital, Muheza, northeast Tanzania, a district hospital
serving a rural population of approximately 277 000
people with a mortality in children under 5 of 165 per
1000 (Tanzanian census 2002). Transmission oiPfalci¬
parum is intense (50-700 infected bites/person/year)
and perennial, with two seasonal peaks.lo The commu¬
nity prevalence of P falciparum in children aged
2-5 years in the study area was recorded as 88.2% in
2002.15 At the time of the study, routine immunisation
did not include vaccination against either Haemophilus
influenzae or Streptococcus pneumoniae. HIV seropreva-
lence among women attending antenatal clinics was
7.2% in 2007."' In 2002 only 5% of paediatric admis¬
sions were referred for admission from a primary care
facility; the remainer were brought directly to the hos¬
pital outpatients department by a parent or caregiver.
Eligibility and enrolment
Consecutive children admitted during the day were
given emergency treatment ifneeded, and then all chil¬
dren were screened for eligibility. Eligible children
were aged 2 months to 13 years with a current fever
or history of fever within the previous 48 hours. We
excluded children with an obvious non-infectious
cause for admission such as trauma, surgery, or
known malignancy. Children were enrolled over five
consecutive days each week. To include children pre¬
senting outside normal working hours, we recruited
children from Monday to Friday for the first seven
months and from Wednesday to Sunday for the next
five months. The caregiver of each child in the study
gave written informed consent, and pre-test counsel¬
ling was provided before HIV testing.
Clinical data collection
After consent procedures, clinical officers (a grade of
non-physician clinician in Tanzania) assessed children
by using a standard medical history and examination
based on the WHO criteria (table l)."1' Two study
physicians (BN and GM) supervised the collection of
clinical data throughout the study. Case management
was consistent with WHO guidelines, with the addition
that all children with severe malaria were treated with
broad spectrum antibiotics consistent with the recom¬
mendations of previous studies.18 Admission out¬
comes were recorded at discharge or death.
Blood testing and laboratory procedures
After cleaning of the skin, venous blood was drawn for
culture (2-5 ml), haemoglobin and glucose concentra¬
tions (Hemocue, Angelholm, Sweden), serum lactate
(Lactate-Pro, Arkray, Kyoto, Japan), HRP-2 based
rapid diagnostic test for P falciparum (Paracheck,
Orchid Biomedical, Mumbai, India), and a full blood
count (Coulter Act/Dif, Beckman-Coulter). We used
two rapid tests (Capillus HIV-1, HIV-2 Test, Trinity
Biotech, Ireland and Determine HIV-1/2 Test, Abbott
Laboratories, IL, USA) in all children to test for HIV
antibodies; discordant results were resolved by HIV-1
enzyme linked immunosorbent assay (ELISA) (Viro-
nistika UniForm II Plus-O Test, bioMerieux, NC,
USA).19 Children aged under 18 months with positive
Table 11 WHO criteria for presumptive antimicrobial treatment in children admitted to hospital
Chapter, page of guidelines for
WHO criteria Recommended antimicrobial carc at first referral levelo
Sick young infant—any infant aged <2 months admitted to hospital (not included in this Ampicillin plus gentamicin IV/IM or penicillin plus 6.1, 75
study) gentamicin IV/IM
Meningo-encephalopathy—BCS<3 or stiff neck or bulging fontanelle or >2 convulsions in
preceding 24 hours
Chloramphenicol plus ampicillin IV/IM or
chloramphenicol plus penicillin IV/IM
5.2,62
Malaria with shock*—positive slide for malaria plus shockj or BCS<3 or bulging fontanelle
or >2 convulsions in preceding 24 hours
Chloramphenicol plus penicillin IV/IM 5.1.1, 59f
Very severe pneumonia—cough/difficulty breathing plus multiple convulsions or coma or
lethargy or vomiting everything or inability to drink or cyanosis or severe respiratory
distress}:
Chloramphenicol IV/IM or gentamicin plus penicillin
IV/IM§
3.1.1,30
Severe pneumonia—cough/difficulty breathing plus lower chest indrawing or nasal flaring
or grunting
Benzyl penicillin IV/IM 3.1.2, 32
Non-severe pneumonia—cough/difficulty breathing plus raised respiratory rate for age Amoxycillin PO or co-trimoxazole PO 3.1.3,32
Septicaemia—negative slide for malaria plus axillary temperature ^37.5°C plus inability to
drink/feed or lethargy or >2 convulsions in preceding 24 hours or vomiting everything
Chloramphenicol plus penicillin IV/IM 5.4, 67
Severe acute malnutrition—bilateral oedema or severe wasting or weight for heightz-score Co-trimoxazole PO or amoxycillin plus gentamicinU 7.2.5, 84
<-3 IM/IV
Where categories were used in analysis, children were assigned to one diagnostic category with priority to those higher in list.
8CS=Blantyre coma score; IM=°intramuscular; IV=intravenous; POoral.
-"Malaria with shock or signs of meningitis" defined in WHO guidelines8; however, children with malaria and signs of meningitis will already be included in category above.
■fShock defined as capillary refill >3 seconds or cool peripheries or systolic blood pressure <50 mm Hg (WHO Pocket Book of Hospital Care for Children 6.2.1, 142).
^Defined as oxygen saturation <90% or respiratory rate £70 breaths/minute.
§Recommended if chloramphenicol is not available.
TjRecommended if hypoglycaemia or hypothermia present or if child seems lethargic or "sickly."
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All admissions 1 lune 2006 to 31 May 2007
(n=6470, 446 (6.9%) died)
Admitted in study hours Admitted out of study hours
(n-4334, 259 (6.0%) died) I (n-2136,187 (8.8%) died)
Eligible but refused consent
(n=58, 4 (7%) died)
in
Not eligible or screening
<- data incomplete
(n=568,69 (12.1%) died)
Eligible and enrolled (n-3708)
Excluded owing to missing data I
(n-69, 2 (3%) died) ■
Included in analysis (n=3639,184 (5.1%) died)
Fig 11 Admissions, deaths, inclusions, and exclusions during
study. 2383/3639 (65.5%) had an axillary temperature £37.5
on admission, 1234/3639 (33.9%) were afebrile with a
history of fever, and 22/3639 (0.6%) gave a history of fever
with no temperature recorded
results were tested for HIV-1 RNA (Abbott Real-Time
m2000 System, Abbott Molecular, 1L, USA).
Giemsa-stained blood slides were prepared from
venous blood and independently double read; discor¬
dant results (either positive/negative discordance or
greater than twofold density difference above 400
parasites/pi) were resolved by an independent third
reading. We calculated parasite densities from the geo¬
metric mean of the two closest counts of asexual para¬
sites/200 white blood cells and the actual white blood
count or, if missing, 8000 cells/pl. We classified chil¬
dren negative for Pfalciparum on microscopy and with
a positive rapid diagnostic test as "recent malaria"
because of the persistence of detectable HRP-2 for up
to one month after clearance of parasites.3
Blood for culture was inoculated into a BactALERT
Pacdiatric-fan bottle (bioMerieux, France) and incu¬
bated in the BacT/ALERT 3D automated microbial
detection system. We used standard methods to
identify cultures that flagged positive. We determined
antimicrobial resistance patterns by disc diffusion and
E-test by using the interpretive criteria of the Clinical
Laboratory Standards Institute.20 We considered cul¬
tures positive for non-cryptococcal yeasts, coagulase
negative Staphylococcus, Micrococcus, Corynebacterium,
Bacillus op, or viridans group Streptococci to be contami
nants and classified them as "negative culture" unless a
pathogenic organism was also isolated. We considered
the following as indications for lumbar puncture,
regardless of malaria test result: history of multiple or
partial seizures, history of seizures in children aged
under 6 months or over 6 years, confusion or reduction
in conscious level, bulging fontanelle, or neck stiffness.
We examined cerebrospinal fluid by microscopy and
cultured it. Bacterial identifications were indepen¬
dently confirmed for Salmonella (Queensland Health
Forensic and Scientific Services, Brisbane, Australia),
Strep pneumoniae, or Haemophilus influenzae b isolates
(Netspear, Kilifi, Kenya). The laboratory participated
in a bacteriology external quality assurance pro¬
gramme coordinated by a reference laboratory in
Moshi, Tanzania, which participates successfully in
external quality assurance programmes of the College
of American Pathologists and is monitored regularly
by the US National Institutes of Health and its contrac¬
tors.
Data management and analysis
We used the Cardiff Teleform system (Cardiff, Vista,
CA, USA) to scan data into a Microsoft Access data¬
base and analysed them in Stata-10. We calculated
nutritional z scores from NCHS/WHO reference
data in Epi-6 (CDC, Atlanta, USA). We used the f
test to compare proportions.
Table 1 shows the WHO criteria for antimicrobial
treatment used in the analysis; these are consistent with
the pocket book version of the guideline produced in
2005.821 The guideline has been interpreted to apply
irrespective of Pfalciparum parasitaemia; this is consis¬
tent with a previous study and justified by the finding
that Pfalciparum parasitaemia is common in asympto¬
matic children.9152223 We used logistic regression
models to determine bivariable and multivariable
Table 2 j Sensitivity and specificity of WHO "guidelines for care at first-referral level" criteria for antimicrobial treatment in identifying children with invasive
bacterial disease (IBD) by rapid diagnostic test (RDT) and blood slide results
1
Total cases(No;
% died) No (%) with IBD Sensitivity—% (95% CI) Specificity—% (95% CI) PPV (%) NPV (%) NNT*
% fatal cases with IBD
treated!
RDT and slide negative:) 943 (56; 5.9) 143 (15.2) 72.7 (69.9 to 75.6) 47.3 (44.1 to 50.4) 19.8 90.6 5.1 88.9
RDT positive, slide
negative§
501 (33; 6.6) 98 (19.6) 67.3 (63.2 to 71.5) 49.9 (45.5 to 54.3) 24.6 86.3 4.1 83.3
Slide positive <5000/pl 405 (19; 4.7) 33 (8.1) 60.6 (55.9 to 65.4) 51.9(47.0 to 56.8) 10.1 93.7 10.1 80.0
Slide positive 5000-50
000/pl
917 (33; 3.6) 31 (3.4) 67.7 (64.7 to 70.8) 55.9 (52.7 to 59.1) 5.1 98.0 19.6 66.7
Slide positive >50 000/pl 873 (43; 4.9) 36 (4.1) 52.8 (49.5 to 56.1) 51.6 (48.3 to 54.9) 4.5 96.2 22.3 60.0
NPV=negative predictive value; PPV=positive predictive value.
*Number needed to treat presumptively with antimicrobials to correctly treat one child with IBD.
tProportion of all IBD associated fatalities with "guidelines for care at first-referral level" indication for antimicrobial treatment.
£56 children were RDT negative and blood slide positive and are included in slide positive data (sensitivity of RDT compared with slide reading was 97.4%).
§Assumed to indicate recent infection with P falciparum.
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Fig 21 Numbers and deaths of children infected with P falciparum by blood slide, invasive
bacterial disease (IBD), or HIV. Areas in Venn diagram approximately to scale. *IBD consisted
of 336 children with a positive blood culture, of whom 20 also had a positive cerebrospinal
fluid (CSF) culture, and an additional five with a pathogenic organism isolated from CSF and a
negative or contaminated blood culture. fBlood cultures classified as negative included 251
(6.9%) from which contaminant organisms only were cultured. fThree negative HIV results
were based on Capillus testing only (negative predictive value 99.5%, detail not shown); all
other HIV results were based on at least two concordant test results
No P falciparum, IBDt, or HIVt
.(n-1132, 38 (3.4%) died)
n-23, 6 (26%) died
HIV
(n-71, 6 (8%) died)
Figure 2 summarises the prevalence ofand mortality
associated with invasive bacterial disease, Pfalciparum
by blood slide, and HIV. Invasive bacterial disease was
identified in 341 (9.4%) of3639 cases and in 58 (32%) of
184 deaths. Non-typhi Salmonella was the most fre¬
quently isolated bacterial pathogen, accounting for 52
(52%) of 100 organisms in slide positive children and
108 (45%) of 241 in slide negative children. Mortality
among children with invasive bacterial disease (58/
341,17%) was significantly higher than that in children
without invasive bacterial disease (126/3298, 3.8%)
(P<0.001), and this was true regardless of the presence
of P falciparum parasitaemia. The median duration of
admission was one day for fatal admissions and three
days for non-fatal admissions.
associations of invasive bacterial disease with WHO
criteria, HIV infection, fever, severe anaemia, hypo-
glycaemia, prostration, raised blood lactate, and recent
or current malaria.
RESULTS
During the one year of the study (June 2006 to May
2007) 6470 children were admitted; 4334 (67%) were
screened for inclusion; 3708 of these were eligible and
enrolled, ofwhom 3639 had sufficient data for analysis
(fig 1). The median age of children in the study was
1.6 years; 1054 (2.9.0%) were aged 2-11 months, 2273
(62.5%) were aged 12-59 months, and 312 (8.6%) were
aged 5-13 years.
Performance of WHO criteria to target antimicrobial
treatment
Overall, the sensitivity of the WHO criteria to detect
invasive bacterial disease was 67.4% (95% confidence
interval 65.9% to 69.0%), with a specificity of 51.5%
(49.9% to 53.1%). Sensitivity was higher among slide
negative children (70.5%, 68.2% to 72.9%) than among
slide positive children (60.0%, 58.0% to 62.1%), and
specificity was slightly higher among slide positive
children (53.5%, 51.4% to 55.6%) than among slide
negative children (48.1%, 45.6% to 50.7%). The sensi¬
tivity of the WHO criteria declined with increasing P
falciparum parasite density (P<0.05, y2 test for trend);
among children with more than 50000 parasites/pl,
only 19/36 (53%, 50% to 56%) children with invasive
bacterial disease were correctly identified (table 2).
WHO criteria were significantly more sensitive in
identifying invasive bacterial disease associated fatal¬
ities (82.8%, 77.3% to 88.2%) than non-fatal invasive
bacterial disease (64.3%, 62.7% to 65.9%), yet 10
(17%) of 58 deaths among children with invasive bac¬
terial disease remained unidentified by WHO criteria
as needing antimicrobials.
Table 3 shows the prevalence of infecting organisms
by WHO criteria of syndromic diagnosis. More than
three quarters (96/120, 80%) of children with Gram
Table 31 Number (%) of children with and without one of WHO indications for antimicrobial treatment by organism isolated
from blood or cerebrospinal fluid














Meningo-encephalopathy 7(3) 18(7) 5(2) 5(2) 4(2) 216 (85) 255
Malaria with shock 4(5) 0 2(2) 0 0 76 (93) 82
Very severe pneumonia 31 (8) 6(2) 10(3) 15(4) 5(3) 311 (82) 378
Severe pneumonia 13(7) 5(3) 2(1) 9(5) 1(5) 171 (85) 201
Non-severe pneumonia 39(5) 4(1) 15(2) 15(2) 6(1) 766 (91) 845
Septicaemia 1(4) 0 1(4) 1(4) 0 25 (89) 28
Severe acute malnutrition 2(5) 1(3) 2(5) 1(3) 0 34 (85) 40
No WHO indication! 63 (3.5) 5 (0.3) 24 (1.3) 10(0.6) 9(0.5) 1699 (93.9) 1810
One child in whom Strep pneumoniae was isolated from cerebrospinal fluid and non-typhi Salmonella was isolated from blood was classified as
infected with Strep pneumoniae alone,
included 23 E coli and 11 Salmonella typhi.
tlncluded 17 Staph aureus.
±225/1810 (12.4%) of children who did not meet an existing WHO indication for antimicrobial treatment had severe anaemia (haemoglobin <5 g/dl).
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positive or H influenzae infections presented with clin¬
ical features that met one of the WHO criteria, whereas
just over half (134/221, 61%) of children with non-H
influenzae Gram negative infections met one of these
criteria (P<0.001). Non-/f influenzae Gram negative
infections accounted for more than three quarters
(151/198, 76%) of organisms isolated in children with
recent or current malaria but less than half (70/143,
49%) of organisms isolated from children who were
both slide negative and rapid diagnostic test negative
(P<0.001) (fig 3).
Risk factors for invasive bacterial disease
We assessed clinical and laboratory features associated
with invasive bacterial disease by using bivariate odds
ratios and a multivariable logistic regression model
(table 4). After control for the presence of any WHO
criteria, HIV infection, and current or recent malaria, a
significant association remained between invasive bac¬
terial disease and axillary temperature above 38°C,
severe anaemia (haemoglobin <5 g/dl), and hypogly-
caemia (blood sugar <2.5 mmol/1) (table 4). Prostra¬
tion was also associated with increased odds of invasive
bacterial disease among children without current or
recent malaria (odds ratio 2.54, 95% confidence inter¬
val 1.37 to 4.70, P=0.003).
Additions to WHO criteria to improve sensitivity
To evaluate potential candidates for addition to the
WHO criteria, we identified factors from those asso¬
ciated with invasive bacterial disease (table 4). We
t? 100
I Other Gram positive
I H influenzae
I Strep pneumoniae
IIS Other Gram negative
□ Non-typhi Salmonella
Table A | Logistic regression model of factors associated with invasive bacterial disease in all
children in study
Factors Unadjusted odds ratio (95% CI) Adjusted odds ratio (95% CI)
WHO criteria 2.20 (1.74 to 2.79)** 1.67 (1.28 to 2.17)**
Meningo-encephatopathy 1.84 (1.28 to 2.64)**
Malaria with shock 0.59 (0.34 to 1.00)
Very severe pneumonia 2.16(1.67 to 2.81)**
Severe pneumonia 1.85 (1.25 to 2.74)**
Non-severe pneumonia 0.98 (0.75 to 1.28)
Septicaemia 5.58 (3.92 to 7.96)**
Severe acute malnutrition 1.72 (0.72 to 4.13)
HIV positive 2.38 (1.54 to 3.68)** 1.47 (0.91 to 2.35)
Axillary temperature >38°C 1.34 (1.07 to 1.67)* 1.44 (1.13 to 1.84)**
Prostration! 1.42 (1.03 to 1.95)* 1.01 (0.65 to 1.55)
Shock 1.14(0.69 to 1.88) 0.90 (0.50 to 1.60)
Haemoglobin <5 g/dl 1.43 (1.08 to 1.89)* 1.56 (1.13 to 2.14)**
Glucose <2.5 mmol/l 2.33 (1.44 to 3.75)** 2.46 (1.39 to 4.35)**
Lactate >5 mmol/l 1.46(1.07 to 1.99)*
Slide positive 0.24 (0.19 to 0.30)**
RDT positive, slide negative! 2.90 (2.24 to 3.75)** 1.29 (0.95 to 1.75)
Slide positive <5000/pl 0.84 (0.58 to 1.23) 0.55 (0.36 to 0.84)**
Slide positive 5000-50 000/pl 0.27 (0.19 to 0.40)** 0.20 (0.13 to 0.31)**




tlnability to sit unsupported or, if age <8 months, inability to drink.
LRDT positive and slide negative assumed to indicate recent infection with P falciparum.
Fig 31 Proportion of organisms isolated from children with
invasive bacterial disease by P falciparum infection status.
RDT=rapid diagnostic test
added HIV first on the assumption that this would be
incorporated if WHO guidelines included care of chil¬
dren with HIV in the "Fever" chapter. The further cri¬
teria of "severe anaemia (Hb <5 g/dl)," "prostration,"
and "current fever >38°C" increased the sensitivity of
the WHO criteria to 86.2% (85.1% to 87.3%), with a
specificity of 24.8% (23.4% to 26.2%). Table 5 shows
these results by malaria slide results.
In slide positive children, the prevalence of invasive
bacterial disease was 60/1035 (5.8%) if one of the
WHO criteria was present compared with 26/679
(3.8%) if none was present but the child had any of
severe anaemia, prostration, HIV infection, or "cur¬
rent fever >38°C." This contrasts with slide negative
children, among whom the prevalence of invasive bac¬
terial disease was 170/794 (21.4%) if one of the WHO
criteria was present compared with 38/265 (14%) if
none was present but the child had any of severe anae¬
mia, prostration, HIV infection, or current fever >38°
C. Hypoglycaemia, although strongly associated with
invasive bacterial disease, applied to only 22 children
with such disease; all but three of these already met
WHO criteria, and all but two of them met one of the
criteria classified as D in table 5.
Antimicrobial susceptibility
In children with invasive bacterial disease, the isolated
organism was susceptible in vitro to the WHO recom¬
mended antibiotic in 33% to 100% of cases, with a
weighted mean of 99/211 (47%). Co-trimoxazole for
non-severe pneumonia and parenteral penicillin for
severe pneumonia were associated with the lowest in
vitro susceptibilities (32% and 33%) (table 6). Table 7
shows susceptibilities of common isolates to routinely
available antibiotics.
DISCUSSION
Our findings show that, in a typical district hospital
serving a population exposed to intense transmission
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of P falciparum, WHO criteria for antimicrobial treat¬
ment failed to identify almost a third of children who
had definite invasive bacterial disease. Among those
who were identified by WHO criteria, the isolated
organism was not susceptible to the first recommended
antimicrobial drug in more than half the cases.
As expected, invasive bacterial disease was more
likely in slide negative children than in slide positive
children. In these co-infected children, however, inva¬
sive bacterial disease was not confined to those with
low density infections that are often found incidentally
in African children; a third of the invasive bacterial
disease-Pfalciparum co-infections occurred in children
with high density infections that are highly unlikely to
be due to incidental parasitaemia.22 This finding is con¬
sistent with those of Berkley et al, who have recently
quantified the association ofhigh density malariainfec-
tion and bacterial disease.21 In addition, we found that
invasive bacterial disease was associated with high
mortality irrespective of P falciparum infection, high¬
lighting the importance of considering invasive bacter¬
ial disease in children admitted to hospital irrespective
of whether a malaria slide is positive. The failure of the
WHO criteria to identify many of these children was to
a large extent due to the high prevalence of non-typhi
Salmonella infection and its association with severe
anaemia and other non-specific clinical features that
are not currently included in the WHO criteria.8 The
introduction of pneumococcal and Hib vaccines in
many African countries in the next one to two years
is likely to make these infections relatively more
important.
Our results are consistent with increasing evidence
that malaria is a risk factor for non-typhi Salmonella and
some other Gram negative infections.12242''' Reasons
for this are still unclear but may relate to increased vul¬
nerability to non-typhi Salmonella infection associated
with haemolysis, as the association also applies in chil¬
dren with sickle cell disease and in animals with experi¬
mentally induced haemolysis.2627 The association of
non-typhi Salmonella with "recent malaria" that we
and one previous study have observed suggests that
malaria may result in relatively prolonged increased
vulnerability to bacterial infection, especially by
enteric organisms.3
Validity and generaiisability of findings
Although no study can automatically be generalised to
other settings, our findings are similar to those of Berk¬
ley et al, who found that in an area of moderate Pfalci¬
parum transmission the WHO criteria correctly
identified 66% of invasive bacterial disease in slide
positive children and 76% in slide negative children
(after the exclusion of "sick young infants," a group at
high risk of invasive bacterial disease who are all
recommended for antimicrobial treatment by these
guidelines).9 These figures are only slightly higher
than our estimates; the difference may be due to a
higher proportion of non-typhi Salmonella infections
in our study.
The diagnostic performance of the WHO criteria is
likely to vary with local epidemiology, especially in
relation to bacterial disease and malaria, but the con¬
sistency of our findings with several others in identify¬
ing non-typhi Salmonella and other Gram negative
infections as leading causes of bacteraemia in African
children suggest that our findings are likely to apply
widely.10142833 In addition, the low level of anti¬
microbial susceptibility that we found is also consistent
with others.1032343" The association between malaria
and bacterial disease identified in our study is consis¬
tent with several other studies and was slightly weaker
than found by Berkley et al.18 Similarly, the association
of increased mortality with bacterial disease is similar
to that found in several other studies,1837 although a
study in Malawi did not find an association between
mortality and bacterial disease among children with
severe malaria admitted to a paediatric intensive care
unit."
Table S | Sensitivity, specificity, and predictive values of selected additions to WHO "guidelines for care at first-referral level" criteria for presumptive




(95% rn PPV (%) NPV (%) NHT*
% fatal cases with
IDD tieateJE
Blood slide positive for P falciparum
A—guidelines criteria 60.0 (58.0 to 62.1) 53.5(51.4 to 55.6) 5.8 96.6 17.3 69.2
B—A or HIV 62.0 (60.0 to 64.0) 52.5 (50.4 to 54.6) 5.9 96.7 17.1 69.2
C—B or severe anaemia 68.0 (66.1 to 70.0) 45.3 (43.2 to 47.4) 5.6 96.7 17.9 84.6
D—C or prostration 72.0 (70.1 to 73.9) 43.4 (41.4 to 45.5) 5.7 97.0 17.5 92.3
E—D or axillary temperature >38°C 86.0 (84.6 to 87.5) 22.3 (20.6 to 24.0) 5.0 97.1 19.9 92.3
Blood slide negative for P falciparum
A—guidelines criteria 70.5 (68.2 to 72.9) 48.1 (45.6 to 50.7) 21.4 89.1 4.7 86.7
B—A or HIV 71.4 (69.0 to 73.7) 46.6 (44.1 to 49.2) 21.1 89.0 4.7 86.7
C—B or severe anaemia 75.5 (73.3 to 77.7) 42.4 (39.9 to 44.9) 20.8 89.6 4.8 88.9
D—C or prostration 75.9 (73.7 to 78.1) 42.0 (39.4 to 44.5) 20.8 89.7 4.8 91.1
E—D or axillary temperature >38°C 86.3 (84.5 to 88.1) 29.3 (26.9 to 31.6) 19.6 91.4 5.1 93.3
NPV=negative predictive value; PPV=positive predictive value.
*Number needed to treat presumptively with antimicrobials to correctly treat one child with IBD.
jProportion of all IBD associated fatalities identified for antimicrobial treatment.
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Table 61 Proportion (%) of bacterial isolates susceptible in vitro to recommended and other commonly available antimicrobials by WHO "guidelines for care
at first-referral level" criteria for antimicrobial treatment*
Amp/chlor Pen/chlor Chlor Pen/gentf Pen Amoxy Co-trimox Amp/gentf Ceftriaxone Pen/cipro Azithromycin
Meningo-
encephalopathy
22/34 (65)t 19/34 (56) 16/32 (50) 22/24 (92) 5/38 (13) 13/34(38) 6/25 (24) 28/29 (97) 31/31 (100) 12/13(92) 26/29 (90)
Malaria with shock 2/6 (33) 2/6 (33)$ 2/6 (33) 4/5 (80) 0/6 (0) 2/6 (33) 3/5 (60) 4/5 (80) 5/6 (83) 5/5 (100) 3/8 (38)
Very severe pneumonia 32/62 (52) 31/63(49) 26/62 (42)$ 54/60 (90) 16/65 (25) 26/62 (42) 17/58 (29) 55/60 (92) 60/61 (98) 53/53 (100) 38/55 (69)
Severe pneumonia 20/29 (69) 19/30 (63) 17/29(59) 29/29 (100) 10/30 (33)$ 18/29 (62) 9/26 (35) 29/29 (100) 30/30 (100) 23/23 (100) 27/35 (77)
Non-severe pneumonia 38/69 (55) 36/69 (52) 30/66 (46) 63/72 (88) 16/76 (21) 32/71 (45)$ 21/66 (32) 63/72 (88) 71/72 (996) 67/67 (100) 57/86 (66)
Septicaemia 1/2 (50) 1/2 (50)$ 1/2 (50) 3/3 (100) 1/3 (33) 1/2 (50) 1/2 (50) 3/3 (100) 2/2 (100) 3/3 (100) 4/5 (75)
Severe acute
malnutrition
5/6 (83) 5/6 (83) 5/6 (83) 5/5 (100) 1/6(17) 4/6 (67) 3/5 (60) 6/6 (100)$ 6/6 (100) 5/5 (100) 3/5 (60)
Amoxy=amoxicillin; amp=ampicillin; chlor=chloramphenicol; co-trimox=co-trimoxazole; cipro=ciprofloxacin; gent=gentamicin; pen=penicillin.
^Susceptibility includes "full" or "intermediate" susceptibility and follows Clinical Laboratory Standards Institute (CLSI) guidelines with exception of susceptibility of Salmonella isolates
(noted below)20; not all isolates were tested for all antibiotics.
■\Salmonella susceptibilities to gentamicin are shown as actual in vitro results, although CLSI guidelines recommend that for clinical practice all Salmonella should be reported as "not
susceptible" owing to poor intracellular penetration of gentamicin.
JFirst recommendation treatment.
A limitation of our study was our inability to enrol
children at night; case fatality was higher in children
admitted outside study hours, probably because "out
ofhours" admissions are more severely ill and possibly
because initial clinical management is of lower quality
at these times.38 Mortality was also high in children
who were excluded from the study because of missing
data (often because they died soon after admission),
and our findings are thus likely to underestimate mor¬
tality in children whose need for antimicrobials was not
recognised by WHO criteria. However, children who
die soon after admission probably present too late to
benefit from antimicrobial treatment.
WHO guidelines
We evaluated the WHO manual "Management of the
child with severe infection or severe malnutrition:
guidelines for care at first-referral level,"8 as this is the
standard WHO guide for paediatric inpatient care and
has been adopted as policy by the ministries of health
of many resource poor countries. A WHO guideline
for treatment of malaria (2006) also exists; it proposes
a "low threshold" for the use of antimicrobials in chil¬
dren with severe malaria to treat Salmonella infections
in particular.17 The existence of separate clinical guide¬
lines for malaria and general paediatric care is an
unfortunate consequence of the vertical approach to
malaria. Possibly as a result of this, antimicrobial treat¬
ment is not mentioned in the Tanzanian or Kenyan
national guidelines for the treatment of severe malaria.
Additional indications for antimicrobials in children
Among children in this study, the addition of "severe
anaemia" and "prostration" to current indications
resulted in a significant improvement in the detection
of invasive bacterial disease in both fatal and non-fatal
cases. This is consistent with several studies that have
shown an association between severe anaemia and
invasive bacterial disease.112939 "Current fever"' has
previously been associated with invasive bacterial
disease,40 and its inclusion as a criterion for anti¬
microbials resulted in a gain in sensitivity, although
this was at the expense of a substantial drop in specifi¬
city. However, even in children with malaria, applica¬
tion of these more inclusive criteria resulted in fewer
than 20 children qualifying for presumptive anti¬
microbial treatment to correctly identify one child
with invasive bacterial disease, a figure that compares
favourably with policies that recommend presumptive
treatment of non-severe malaria.17 Given the increase
in mortality associated with invasive bacterial disease,
this seems a reasonable proposition; however, a need
exists for a more formal economic evaluation that
includes such factors as the financial cost of newer
Table 71 Proportion (%) of bacterial isolates susceptible in vitro to commonly available antimicrobials
Penicillin/amoxicillin Chloramphenicol Co-trimoxazole Gentamicin
Non-typhi Salmonella* 49/148 (33) 53/153 (35) 49/145 (34) 147/152 (97)t
Strep pneumoniae 51/51 (100) 41/48 (85) 22/45 (49) -
Haemophilus influenzae 12/38 (32) 16/38(42) 2/28 (7) 22/23 (96)
E coli 2/21 (10) 5/18 (28) 1/20 (5) 9/20 (45)
Staph aureus 1/15(7) 11/13(85) 10/14(71) 13/16(81)
Susceptibility includes "full" or "intermediate" susceptibility and follows Clinical Laboratory Standards Institute (CLSI) guidelines with exception of
susceptibility of Salmonella isolates (noted below).20
*Salmonella isolates were multi-resistant (resistant to amoxicillin, chloramphenicol, and co-trimoxazole) in 85/141 (60.3%) cases,
tSalmonella susceptibilities to gentamicin are shown as actual in vitro results, although CLSI guidelines recommend that for clinical practice all
Salmonella should be reported as "not susceptible" owing to poor intracellular penetration of gentamicin.
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WHAT IS KNOWN ON THIS TOPIC
Presumptive diagnosis of malaria is common in children admitted to hospital in Africa and is
associated with failure to provide treatment for bacterial disease
Invasive bacterial disease is a major cause of mortality in African children, alone and in
association with malaria
Overlapping clinical features create difficulties in distinguishing between invasive bacterial
disease and malaria in African children
WHAT THIS STUDY ADDS
in a malaria endemic area, almost a third of the children with definite invasive bacterial
disease were not identified by WHO criteria for the presumptive use of antimicrobials
The high prevalence of non-typhi Salmonella and other Gram negative infections may
contribute to the poor performance of the WHO guidelines in this setting
More than half of the isolates from children in a malaria endemic area were not susceptible to
the WHO recommended antimicrobial
antimicrobials and the selection of resistance that may
result from their wider use.
For routine care, the high mortality associated with
invasive bacterial disease, the low sensitivity of a single
blood culture,4142 the poor quality of routine slide
results, and the apparently strong bias of hospital clin¬
icians towards the diagnosis of malaria all suggest that
inclusive rather than restrictive indications for pre¬
sumptive antimicrobial treatment are needed to ensure
more effective treatment for children admitted to hos¬
pitals in resource poor settings.64344
Choice of antimicrobials
Our results, which are consistent with those of other
studies, show that commonly used antimicrobials
often lack activity against the Gram negative organ¬
isms that are often the most common cause of bacterial
infection in African children.103234"36 In our study, two
thirds of the organisms identified in children who met
the WFIO criteria for severe pneumonia were resistant
to penicillin (the first recommended antimicrobial) and
more than a third were resistant to chloramphenicol or
ampicillin (which might be used as an alternative). Our
in vitro estimate ofsusceptibility to gentamicin is likely
to overestimate its in vivo efficacy as, although some
extracellular effect against salmonellas can be
expected, salmonella is a largely intracellular organism
and the limited penetration of gentamicin is likely to
limit its effect.4546 As a consequence, gentamicin is not
usually recommended for treatment of invasive
salmonellosis.20
The choice of antimicrobials in resource poor set¬
tings is obviously constrained by cost and availability.
However, as recently highlighted by Graham and
English,47 the high incidence and fatality of non-typhi
Salmonella bacteraemia in Africa, which is often resis¬
tant to commonly used antimicrobials, constitutes a
serious and neglected public health challenge. Better
evidence to guide antimicrobial choices is needed,
but current evidence suggests that in malaria endemic
areas ofAfrica ciprofloxacin (not usually available par-
enterally) plus penicillin or ceftriaxone alone are the
leading candidates for first choice antimicrobials in
severely ill children.
Clinical trials of antibiotic indications in sick children
Our results raise questions that ideally should be
informed by the results of a randomised clinical trial
of clinical indications for the use of antibiotics. How¬
ever, such a trial would need to be large. According to
the data from our study and an assumption that anti¬
microbials in children with severe malarial anaemia
and no WHO indication for antimicrobials would
reduce their mortality by 50% (although a much smal¬
ler reduction would still be worthwhile), 2670 children
would need to be randomised from more than 17 000
children with severe malaria. In addition, ethical con¬
cerns could exist about randomising severely anaemic
children to a "no antimicrobial" arm given the strength
of current evidence.112939 WHO and others need to
reach a consensus on this question; if a clinical trial is
feasible and ethical, it should be set up with urgency. If
not, existing evidence should be used to help to modify
current guidelines for the treatment of children with
invasive bacterial disease in malaria endemic areas.
Conclusions
The WHO criteria for presumptive antimicrobial
treatment have poor sensitivity in children living in
this area endemic for P falciparum in Africa, and the
guidelines should be re-examined. This study shows
that simple and available clinical criteria may signifi¬
cantly increase detection of invasive bacterial disease
in severe and fatal illness in African children. Cur¬
rently recommended antimicrobials often lack activity
against common bacterial infections in Africa, and
more effective diagnosis and treatment ofbacterial dis¬
ease in resource poor settings are urgently needed.
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Summary background and objective Children are often admitted to district hospitals in Africa without an
adequate record of clinical examination, a problem that could be reduced by greater involvement of
nurses in their assessment. We aimed to ascertain whether hospital nurses in a district hospital could
conduct paediatric examinations as reliably as clinical staff, when provided with a short structured
training session.
methods Hospital nurses (HN), hospital clinical officers (HCO) and research clinical officers (RCO)
repeated examinations on children admitted to the paediatric ward shortly after the first examination
by an RCO. Kappa scores were used to compare the agreement on the presence or absence of basic
clinical signs by different categories of staff.
results Among 439 paired examinations the agreement between RCOs on clinical signs was slightly
higher than for HCOs or HNs; the mean (median) Kappa scores for all signs examined were 0.54 (0.57)
for RCO-RCO, 0.49 (0.49) for RCO-HCO and 0.50 (0.49) for RCO-HN. Levels of agreement were
lower if children were under the age of 18 months or if they cried during the examination.
conclusions Nurses with basic training appear to perform as well as clinically trained staff in eliciting
essential signs in acutely ill children. Their role in the initial and ongoing assessment of these children
should be reviewed in light of the critical shortages in clinically trained staff in African hospitals.
keywords hospital, paediatric, clinical signs, variability, staff category, training
Introduction
A relatively small number of standard clinical signs are in
common use to assess children admitted to district
hospitals in resource-poor settings. Many of these are
specified in the integrated management of childhood illness
(IMCI) and some have originated from clinical research
(e.g. prostration or the Blantyre coma scale). (Molyneux
et al. 1989; WHO 2000) Studies that have assessed the
repeatability of these signs in African children suggest
variable levels of agreement between two independent
raters (English et al. 1995; Otieno et al. 2004), these
tend to fall where signs rely on subjective judgement,
require a method other than inspection or when infants are
examined (Kahigwa et al. 2002).
WHO guidelines for care rely primarily on basic
paediatric clinical signs but they are often not sought or
recorded in the case notes in African district hospitals
(English et al. 2004; Reyburn et al. 2008). The reasons
are complex but include lack of time to assess sick children
at the point of admission, often a busy and crowded
outpatient clinic where clinical staff may be very stretched.
In this context nursing staff may be able to contribute
by checking children either before the medical consultation
or after admission to the ward.
In this study we compared the repeatability of a group of
standard clinical paediatric signs elicited by clinical officers
who had been trained in research data collection with
hospital clinical officers and hospital nurses who repeated
examinations in children admitted to a busy district
hospital in Tanzania. The findings may serve to increase
the available options to ensure that sick children are
properly assessed at or shortly after their admission to
hospital.
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Methods
The study and site
The study was conducted in the third and fourth month of
a 1-year study into the causes of illness in children aged 2
months to 13 years with a history of fever in the previous
48 h who were admitted to a district hospital in NE
Tanzania. The study was initially undertaken to assess the
suitability of routine staff to contribute to a standard
clinical assessment that was made on admission for all
children in the study.
Staff in the study
Staff in the study consisted of clinical officers (a grade of
non-physician clinician with 3 years of basic clinical
training) and hospital nurses (with 3-4 years of training in
nursing). Clinical officers were either specifically employed
as research assistants (RCOs) for the 1-year study or were
employed by the hospital to provide routine care (HCOs).
Hospital nurses (HNs) were all regular hospital staff. Both
HNs and HCOs regularly worked on the paediatric wards.
RCOs had received didactic teaching supported by video
clips that demonstrated the signs in the study; these were
assembled from recordings that had been used for IMCI
training or had been recorded by experienced paediatri¬
cians to demonstrate specific signs. In addition RCOs
received bedside supervision on clinical examination for 3
months before the start of the study and their assessments
of children in the main study were regularly checked by
study physicians (BN, GM) who provided feedback and
corrected any observed errors.
HCOs and HNs had a 1-h training session on clinical
examination using the same training materials as had been
used for RCOs followed by an interactive teaching session
conducted by an experienced physician (BJ). In addition,
each staff member received a 30-min individual training
session where they examined children on the ward under
supervision (BJ). Definitions of clinical signs were consis¬
tent throughout and are shown in Table 1.
IMCI had been part of Clinical Officer training in
Tanzania since 2000 but was not in routine use at the
hospital prior to the study.
Examination procedure and data analysis
On arrival at the ward all children were triaged and
resuscitated as needed before the first examination. After
consenting procedures, children were examined initially by
a research clinical officer (RCO) followed within 1 h by a
second examiner (RCO, HCO or HN according to a duty
roster). Examinations were performed with no other staff
present in a well-lit, quiet part of the ward, with results
recorded on a standardised form listing the 17 clinical signs
defined in Table 1. All examiners were blind to any clinical
information (previous clinical examination, investigations
or treatment) at the time of examination.
Data were double-entered in MS Access (MS Corp.,
Redmond, VA, USA) and analysed in Stata-8 (Statacorp,
TX, USA). Correlation of findings between examiners was
assessed using Cohen's Kappa score and classified by
categories proposed by Landis and Koch (1977) (Table 2).
Ethics
The study was approved by the Ethics Committees of the
National Institute of Medical Research, Tanzania
(HQ/R.8a/Vol.IX/392) and the London School of
Hygiene and Tropical Medicine (2087). Informed consent
to participate was obtained from the parent or guardian in
each case.
Results
A total of 439 children were examined by a RCO and then
examined a second time by an HN (189), HCO (129) or
another RCO (121). Table 3 shows the numbers of repeat
examinations undertaken by individuals in each of the staff
categories. The median time between examinations was
14.2, 13.4 and 14.2 min for RCO-HN, RCO-HCO or
RCO-RCO respectively. The mean (median) age of chil¬
dren examined was 25 (18) months and 39% cried during
the first or second examination; neither age nor crying
varied by category of staff who re-examined children
(P = 0.13 and 0.11 respectively).
Overall, the agreement between RCOs on clinical signs
was slightly higher than for HCOs or HNs; the mean
(median) Kappa scores for all signs examined were 0.54
(0.57) for RCO-RCO, 0.49 (0.49) for RCO-HCO and
0.50 (0.49) for RCO-HN pairs of examiners (Figure la).
Level of consciousness or prostration are important
predictors of outcome in severely ill children and all grades
of staff reached 'moderate' or 'substantial' levels of
agreement for these. However, agreement on the presence
of 'chest wall indrawing' between RCOs or HNs compared
to the first RCO examination was 'poor' (Table 4).
Agreement between examiners, particularly RCOs and
HNs, for the presence of 'delayed capillary refill' and
'temperature difference' was 'poor'. Since the ability to see
capillary refill depends on a colour change in the nailbed
we calculated the overall agreement (irrespective of staff
grade) on 'delayed refill' (Kappa = 0.14, 95% CI 0.06-
0.22) and then in the 159 children whose haemoglobin
levels were <7 g/dl (Kappa = 0.083, 95% CI: 0.04-0.20)
1214 © 2008 Blackwell Publishing Ltd
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Table I Definition of clinical signs






















Oedema of both feet
Measured by digital thermometer in the axilla for two
bleep cycles
Counted over 1 min in a non feeding child who is not crying
A conscious child who takes no interest in its surroundings
Ability to sit unsupported if aged 8 months or more
Observed ability to breast feed or drink from a cup
A subjective assessment of sunken eyes
A full thickness pinch of skin taken in a longitudinal
plane midway between umbilicus and the side of the
body. Longer than two (2) seconds to return to normal is
considered a positive response
Bluish tinge to the buccal mucosa
Undirected or closed eyes, score 0
Directed eye movements, score 1
No movement or abnormal flexion/extension, score 0
Other movements without localisation, score 1
Movements to localise pain, score 2
No vocal response' score 0
Weak/high pitched cry. score 1
Normal cry/speech, score 2
A subjective assessment based on inspection of the
sclera or palms
Noted by examination of the conjunctiva and palms
The anterior fontanelle is assessed by palpation
Assessed by observing resistance to voluntary neck
flexion and passive flexion of the neck by the researcher
Inward movement of the lower chest wall on inspiration
in a non-crying child
Assessed by depressing the fingernail or fingertip pulp
for 3 s and counting the time it takes to re-perfuse.
A count of greater than 3 s is considered positive
Detected by running the back of the hand down the limb
Detected by pressing a thumb on the dorsum of the foot
compared to repeatability in the 280 children with
haemoglobin >7 g/dl (Kappa = 0.21, 95% CI: 0.15-0.29).
We tested the repeatability of a combination of signs that
would indicate the need for parenteral therapy according
to IMCI criteria. These corresponded to the IMCI defini¬
tions of severe or very severe pneumonia or severe
Table 2 Classification of Kappa scores according to Landis and
Koch (1977)
dehydration. The agreement between hospital nurses and
research clinical officers for the presence or absence of one
of these combinations was 'moderate' (Kappa = 0.51, 95%
Table 3 Numbers of repeat examinations by individual and staff
category!








No. of No. of No. of
RCO examined HCO examined HN examined
1 20 1 44 1 46
2 25 2 28 2 41
3 42 3 27 3 31




Total 121 129 189
fFirst examinations were all by one of the four RCO's; no RCO
examined the same child twice.
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CI: 0.39-0.57) for severe or very severe pneumonia and
substantial (Kappa = 0.61, 95% CI: 0.49-0.73) for severe
dehydration.
A composite sign of 'severe disease' was constructed
from a combination of respiratory signs, reduced con¬
sciousness, severe pallor or jaundice (Table 4). The overall
Kappa value (irrespective of staff grade) was 0.61 (95% CI:
0.56-0.76) while the weighted mean Kappa of its compo¬
nents was 0.56.
Forty percent of signs in children over 18 months of age
reached 'substantial' or better levels of agreement com¬
pared to only 10% in children under 18 months of age.
Similarly, 38% of elicited signs reached substantial or
better agreement in children who did not cry compared to
only 25% in children who did cry. Most children (66%)
were examined within 15 min of the first examination and
repeatability of examination results was no better in these
than the minority (34%) who were examined with a delay
of more than 15 min (Figure 1 b—d).
Discussion
Clinical signs elicited by different grades of staff
Up to half of paediatric deaths in African district hospitals
occur within 24 h of admission (Berkley et al. 2003;
Reyburn et al. 2008) and accurate assessment and prompt
treatment are essential to reduce mortality. Limited labo¬
ratory support in many of these settings means that
treatment decisions are generally taken on the basis of the
presence or absence of basic clinical paediatric signs but
these are often not sought or recorded. Clinical staff are
often over-worked and the human resource crisis in African
hospitals is unlikely to be resolved in the near future (Chen
et al. 2004). In such an environment, multi-tasking among
existing staff seems essential and inevitable and this could
do much to address the unacceptably low levels of
recording basic clinical assessments in sick children.
Our findings suggest that hospital nurses provided with
basic training can reach similar levels of agreement with
research-trained and hospital clinical officers in eliciting a
Figure I Number of signs falling into different categories of
Kappa values for agreement between first (by RCO) and second
examinations (by a second research RCO, HCO or HN). For
different grades of staff (research clinical officers, hospital clinical
officers or nurses) . (a) Where there was more or less than 15 min
delay between the end of the first examination and the beginning
of the second, (b) Where children cried or did not cry during the
examination, (c) Where children were more or less than 18 months
of age. (b—d) The findings from the second examination by dif¬
ferent grades of staff have been aggregated.
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Table 4 Agreement on the presence of clinical signs as elicited by nurses, hospital and research clinical officers compared to first
examination by research clinical officers
HN HCO RCO ALL
Prevalence*
(%) Kappa (95% CI) Kappa (95% CI) Kappa (95% CI) Kappa (95% CI)
Respiratory signs
Raised resp. rate for agef 294/416 (71) 0.46 (0.32-0.60) 0.54 (0.36-0.72) 0.46 (0.28-0.64) 0.47 (0.37-0.57)
Lower chest wall indrawing 60/435 (14) 0.13 (0.01-0.25) 0.63 (0.45-0.81) 0.18 (0.00.0.36) 0.31 (0.21-0.41)
Conscious level
Prostration 64/439 (15) 0.83 (0.69-0.97) 0.83 (0.65-1.01) 0.88 (0.70-1.06) 0.84 (0.74-0.94)
Unable to sit over 8 months! 49/436 (11) 0.63 (0.47-0.79) 0.68 (0.50-0.86) 0.85 (0.67-1.03) 0.71 (0.61-0.81)
Unable to breast feed/drink 22/439 (5) 0.69 (0.55-0.83) 0.56 (0.38-0.74) 0.71 (0.59-0.83) 0.66 (0.58-0.74)
Lethargy 68/436 (16) 0.84 (0.70-0.98) 0.57 (0.39-0.75) 0.72 (0.54-0.90) 0.63 (0.53-0.74)
Blantyre score 0.45 (0.35-0.55) 0.35 (0.23-0.47) 0.44 (0.32-0.56) 0.42 (0.34-0.50)
Eyes 39/439 (9) 0.68 (0.54-0.82) 0.64 (0.46-0.82) 0.71 (0.53-0.89) 0.68 (0.60-0.76)
Motor 38/439 (9) 0.51 (0.39-0.63) 0.09 (-0.07-0.25) 0.7 (0.54-0.86) 0.55 (0.47-0.63)
Verbal 46/439 (10) 0.57 (0.45-0.69) 0.45 (0.27-0.63) 0.62 (0.46-0.78) 0.56 (0.48-0.64)
Any reduced BCS 65/438 (15) 0.67 (0.53-0.81) 0.45 (0.27-0.63) 0.67 (0.49-0.85) 0.61 (0.53-0.69)
Any reduced consciousness 92/435 (21) 0.63 (0.49-0.77) 0.47 (0.29-0.65) 0.6 (0.42-0.78) 0.47 (0.39-0.55)
Perfusion
Oedema of both feet 22/439 (5) 0.89 (0.75-1.03) 0.24 (0.12-0.36) 0.49 (0.31-0.67) 0.47 (0.39-0.55)
Slow Capillary refill 43/438 (10) 0.13 (0.03-0.23) 0.24 (0.12-0.36) -0.02 (-0.20-0.16) 0.14 (0.06-0.22)
Temp difference 59/439 (13) 0.11 (-0.03 to 0.25) 0.48 (0.30-0.66) 0.19 (0.01-0.37) 0.17 (0.09-0.25)
Sunken eyes 24/439 (5) 0.27 (0.15-0.39) 0.48 (0.34-0.62) 0.47 (0.31-0.63) 0.43 (0.33-0.53)
Very slow skin pinch 15/439 (3) 0.49 (0.35-0.63) 0.32 (0.18-0.46) 0.66 (0.48-0.84) 0.48 (0.38-0.58)
Other
Jaundice 10/439 (2) 0.49 (0.35-0.63) 0.85 (0.67-1.03) 0.49 (0.33-0.65) 0.66 (0.58-0.74)
Severe Pallor 115/439 (26) 0.48 (0.34-0.62) 0.56 (0.38-0.74) 0.5 (0.32-0.68) 0.5 (0.42-0.58)
Any sign of severe disease^ 226/439 (51) 0.44 (0.30-0.58) 0.5 (0.34-0.68) 0.54 (0.36-0.72) 0.66 (0.56-0.76)
'Prevalence defined as any positive/sign examined at least once.
fBreaths per minute >50 if aged 2-11 months, >40 if aged 1-5 years, 23 children over the age of 5 years excluded.
^Fourteen children under 8 months of age excluded.
§ Any one of respiratory rate >70 b/min, chest indrawing, any reduction in Blantyre score, jaundice, severe pallor, or prostration. Three
signs ('neck stiffness', 'bulging fontanelle', 'cyanosis') were dropped due to low prevalence (<3%).
range of common clinical signs. This is consistent with a
previous study of primary care workers in Swaziland
showing that, with training, nurses and other health workers
can diagnose pneumonia and other WHO defined syn¬
dromes with acceptable sensitivity and specificity (Simoes 8c
McGrath 1992). A study from Ethiopia similarly demon¬
strated that after training primary care health workers can
recognise common syndromes and signs with good sensi¬
tivities compared with a paediatrician (88% for pneumo¬
nia/severe pneumonia, 76% for some/severe dehydration)
(Simoes et al. 1997). The importance of ongoing training has
been emphasised by other studies showing poorer perfor¬
mance where it had not been recently provided or reinforced
(Brewster et al. 1993; Gadomski et al. 1993).
Clinical examination is traditionally the reserve of
medical staff and this is to some extent justified by the fact
that doctors take treatment decisions and have training in
full clinical examination (e.g. auscultation, neurological
examination). However, the essential signs tested in our
study have been designed to guide care in resource-poor
settings where staff may have quite basic levels of training.
In a hospital setting nurses may not be authorised to take
treatment decisions (unless in an emergency) and reporting
the presence of clinical signs to medical staff, especially
where the finding differs from one already recently
recorded in the case notes, could be seen as threatening to
medical staff. However, 'medical staff' in many African
countries (including Tanzania) are mostly non-physician
clinicians (Mullan & Frehywot 2007) who themselves have
similar entry qualifications and duration of training as
nurses. Increasing the involvement of nurses in clinical
assessment and decision-making is a complex task and
beyond the scope of this study but our findings and those of
others suggest that there is no justification for any group to
claim the 'high ground' of competence in the difficult area
of eliciting paediatric clinical signs.
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General repeatability of clinical signs
Delay between two examinations is an obvious source of
error in assessing levels of agreement, but this did not
impact on repeatability of signs in our study, possibly
because delays were generally short. English et al. (1995)
used videos of respiratory clinical signs in order to
avoid this source of error, and these seemed to result in
high levels of agreement although some medically
qualified staff still did not agree with the majority on the
presence of 'chest indrawing' in a significant proportion
of cases.
Clinical signs of shock (delayed capillary refill and/or
cool peripheries) in our study appeared to have poor
repeatability and anecdotal experience from district hos¬
pitals in Tanzania suggests that the signs of normovolaemic
shock (e.g. normal skin turgor with delayed capillary refill)
are rarely sought or recorded, possibly due to a general
lack of awareness of its importance. Our finding that the
ability of staff to agree on the presence of delayed capillary
refill may be reduced in anaemic children, although not
reaching statistical significance, is potentially important
given the large proportion of children admitted to hospitals
in sub-Saharan Africa who have severe anaemia (Weber
et al. 1997) and the positive association between shock and
anaemia in sick children in malaria endemic areas (Mait-
land et al. 2005). This might at least partly explain why,
even in a specialist centre, agreement between medical
doctors for a 3-s delay in capillary refill (irrespective of
haemoglobin level) was only 'fair' while for the presence of
a lower limb temperature gradient it was 'substantial'
(Otieno et al. 2004).
We found that signs in young children and where
children had cried at some time during the examination
were unreliable and this is in keeping with the results of
other studies where the effect of crying or irritability on
clinical examination was explored (Simoes et al. 1991;
Kahigwa et al. 2002). It is clear that this group of patients
requires careful and repeated assessments.
In certain areas (chest indrawing, capillary refill) the
research staff agreed less often with each other than with
the hospital staff. This may represent drift that had
occurred over time from the standardised definitions
provided in teaching sessions or training and supervision
delivered over a longer period and may have led to
inconsistencies.
Agreement on composite clinical signs may be higher
than on their individual components. Newton et al. (1997)
found that agreement between examiners on the Blantyre
coma score was higher than for its three components
although this was not confirmed in our study. However, we
did find that overall agreement (irrespective of staff grade)
for 'any sign of severe disease' reached 'substantial'
agreement between first and second examinations while the
mean of its components reached 'moderate' agreement.
None of the signs included in our study were for summary
subjective assessments (e.g. severe respiratory distress) but
in a study conducted in a teaching hospital manned by
medical graduates 'increased work of breathing' showed
'substantial' agreement between examiners despite agree¬
ment varying from 'slight' to 'moderate' for specific
respiratory signs (Walsh et al. 2006).
Our study adds to the large body of literature on the
reproducibility of examination findings. While there is
considerable variation, some signs do appear to be gener¬
ally reproducible: pallor has shown kappa scores ranging
from 0.5 to 0.8 (Weber et al. 1997; Kahigwa et al. 2002)
whilst other signs have been more variable; chest indraw¬
ing shows Kappas from 0.28 to 0.34 and sensitivities from
34 to 82% (Simoes & McGrath 1992; Brewster et al.
1993; Gadomski et al. 1993; Kahigwa et al. 2002). One
can only assume that correctness and consistency of clinical
examinations will be lower under real-life than research
conditions and there is clearly a need for further studies
evaluating simple and sustainable training tools to improve
standards in paediatric clinical examination in resource-
poor settings.
Conclusions
Nurses with basic training appear to perform as well as
clinically trained staff in eliciting essential paediatric
clinical signs in severely ill children admitted to hospital.
This should provide a stimulus to review how children are
assessed after the decision to admit to hospital; the current
situation where sick children can be admitted to hospital
with no more than a few lines written in the case notes is a
serious problem that requires imaginative solutions and
high levels of cooperation between staff grades. The
discordance between staff of any grade in eliciting clinical
signs suggests that sick children, particularly if crying or
under the age of 18 months, need to be reassessed
frequently, with effective dialogue between staff to ensure
that such children receive prompt and appropriate
treatment.
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